main programme - e-ahpba 2017

© Getty Images/ollo

MAIN PROGRAMME

23 May – 26 May, 2017 Mainz · Germany Congress President Prof. Dr. Hauke Lang, MA, FACS

www.eahpba2017.com #EAHPBA2017

Table of Contents ▪ Welcome President E-AHPBA .................................................................................... 4

Selective Internal Radiation Therapy (SIRT)

▪ Welcome Congress President .. .................................................................................. 5

Combining forces against liver metastases

▪ E-AHPBA – Facts and Background ............................................................................. 8

Furth data oer resect n a after S bility presen IRT te here d

▪ Welcome Mayor of Mainz ......................................................................................... 6

▪ Congress Venue....................................................................................................... 9 ▪ Host City Mainz . . ...................................................................................................... 11 ▪ Tuesday, 23rd May - Postgraduate Course „Surgery for Pancreatic Diseases“.. .......................................... 14 - 10th Anniversary of ALPPS.. ................................................................................... 16 - Industry Workshop................................................................................................ 19 ▪ Meet the Professor Sessions .................................................................................. 20 ▪ Scientific Programme - Daily Overview .................................................................................................... 22 ▪ Wednesday, 24th May. . ......................................................................................... 30 - Satellite Symposia ............................................................................................... 78 ▪ Thursday, 25th May. . ............................................................................................ 48 - Satellite Symposia ............................................................................................... 79 - Allied Healthcare Professionals 4.......................................................................... 80 ▪ Friday, 26th May.................................................................................................. 66 - Satellite Symposia ............................................................................................... 81 ▪ Poster Sessions..................................................................................................... 84 ▪ E-Video Sessions................................................................................................... 118

Please join us for our satellite symposium

SIRT and surgery – a perfect partnership for improving long-term outcomes Chairs: Hauke Lang (Mainz) and Jörg Kalff (Bonn)

Thursday 25th May, 12:15 – 13:15 SIR-Spheres® is a registered trademark of Sirtex SIR-Spheres Pty Ltd Sirtex Medical United Kingdom Ltd. Building 3, Chiswick Park, 566 Chiswick High Road, London W4 5YA, United Kingdom www.sirtex.com

▪ Industry - Sponsors. . .......................................................................................................... 122 - Exhibitors .......................................................................................................... 123 - Floor Plan & Transparency .................................................................................. 124 ▪ Travel Grants ...................................................................................................... 125 ▪ Opening Ceremony & Welcome Reception................................................................ 128 ▪ Congress Party ................................................................................................... 129 ▪ General Information . . ............................................................................................ 130 ▪ Imprint ................................................................................................................ 133 3

Welcome President E-AHPBA Dear colleagues,

Dear colleagues and friends,

on behalf of the E-AHPBA I would like to welcome you to the 12th Biennial Congress hosted in the beautiful city of Mainz. This is the most important time on our calendar to progress the aims and objectives of the E-AHPBA. This event is an opportunity to share new knowledge and to listen to the world’s best, meet new friends and reconnect with old ones. There is little doubt that our community is growing as more and more national chapters are created and the harmonisation process with the IHPBA bears fruit for all of us. Thus, the significance of this meeting grows.

it is my great pleasure to welcome you, on behalf of our Local Organising Committee, to the 12th Biennial E-AHPBA Congress!

There has been a huge response to the call for abstracts as this meeting offers a great platform for young and emerging researchers to showcase their work. And so, a special welcome to our younger colleagues who represent the future of our association and HPB medicine in general, we look forward to seeing your best work and meeting you at our specially planned social event. We will also meet the Presidents of all the National Chapters, where we will have the opportunity to hear from them how to take our association forward in the best interests of their members. I look forward to seeing all of you in Mainz and to share with you the great progress the E-AHPBA is making in serving our members through our educational outreach and other activities. We are only as strong as our membership allows us to be and so I encourage all of you who are not members to take this opportunity to become a combined member of the E-AHPBA and the IHPBA. Finally, a huge thank you to Prof Hauke Lang and his team who have worked very hard to ensure this meeting is a memorable event.

Martin Smith President E-AHPBA

XXX Welcome Congress President

It is an honour for us to host this prestigious meeting here in Mainz. The organisation of such a congress is – by its nature – demanding. Therefore we are very grateful for the support which we have received during the last four years of preparation. We have been able to attract worldwide leaders in HPB surgery and liver transplantation for the invited faculty. In addition, colleagues from almost the whole of Europe, more than 10 African countries and 20 countries from the rest of the world have registered for this meeting. HPB surgery has dramatically changed over the past decades. Minimally invasive and robotassisted technologies gain increasing importance and may become the standard in the future. Different technologies for tumour ablation are more and more utilised by HPB surgeons. Parallel to the latter, interdisciplinary management of HPB diseases becomes increasingly significant. The programme of this conference accounts for these shifts in indications, technologies and treatment protocols in more than 30 symposia and special lectures. Furthermore we have put a particular emphasis on promoting young surgeons in symposia by focusing on surgical training as well as giving them a platform to present the results of their surgical research. The E-AHPBA congresses traditionally offer the possibility to network with colleagues from abroad. We have included plenty of opportunities during and after the formal sessions which will enable participants to make new contacts. Again, I would like to express my gratitude to E-AHPBA for their trust and help in the organisation of this congress, and all of you for your contributions and support. I wish us all an outstanding congress and hope that you will enjoy yourselves. May you return home with many inspiring ideas for your work, new contacts and happy memories of your visit here in Mainz.

Hauke Lang Congress President

4

5

Welcome Mayor of Mainz Dear President, Officers, Members and Guests of the E-AHPBA, as the mayor of Mainz, it is a pleasure for me to welcome the 12th Congress of the European-African Hepato-Pancreato-Biliary Association in our city. Situated along the Rhine river in the heart of Germany’s largest and beautiful wine-growing region of Rheinhessen, and with our longstanding academic and scientific tradition since the foundation of the University in 1477, Mainz is very much looking forward to hosting the E-AHPBA meeting. Mainz looks back on more than 2000 years of history. This tremendous historic and cultural heritage starts with its Roman roots, moves on to the revolutionary invention of letterpress printing by Johannes Gutenberg in 1450, and continues as an important centre of science as well as of politics. Mainz is the State Capital of Rheinland-Pfalz and accommodates the federal government. The city’s location in the centre of Germany, the very close proximity to Frankfurt International Airport and the urban infrastructure with the „Rheingoldhalle“ being one of Germany’s largest Convention Centres make our city a perfect venue to welcome the E-AHPBA in 2017. I wish you an interesting, enriching, instructive, successful but also enjoyable conference, and a very pleasant stay in Mainz. Yours sincerely, Michael Ebling Mayor of Mainz

6

E-AHPBA – Facts and Background

Congress Venue

The EHPBA was founded in 1999 as the European Regional Association of the International Hepato-Pancreato-Biliary Association (www.ihpba.org). The Association then expanded to countries of the Middle East and Africa, thus forming the European-African Hepato-PancreatoBiliary Association (E-AHPBA) in 2011. Currently, the Association counts for more than 500 active members from Europe, the Middle East and Africa. Our region also includes ‘National Chapters’ that represent memberships from different countries including: CIS (Russian Federation and CIS Countries), Czech Republic, Egypt, France, Germany, Great Britain and Ireland, Greece, Italy, Kenya, MENA (Middle East and North Africa), Netherlands, Scandinavia, Spain, South Africa and Turkey.

In the heart of the city on the banks of the Rhine and easy to reach from all directions the Rheingoldhalle offers over 7,000 m² of accessible function space in 15 rooms and a maximum of flexibility.

The E-AHPBA is moving forward in playing a major role in improving treatment of HPBdiseases worldwide. The Association is the prime interdisciplinary organisation for HPBsurgical science and scholarship in our region and provides an international forum for presenting the state-of-the-art developments and science of HPB-surgery. This is achieved through conducting the biennial congress (alternating with the IHPBA World congress) and other annual meetings and courses including the preparatory courses for the UEMS examinations, specialised technical courses, consensus conferences and workshops. The E-AHPBA also supports educative and scientific activities from its members and strategic partners where deemed appropriate. Together with IHPBA the E-AHPBA also provides support and development within the outreach programme available to all low income countries within our region.

For more information on the association please visit www.eahpba.org.

In 1884, the Stadthalle (City Hall) was opened in the very place where the Rheingoldhalle is located today. At that time it was Germany’s largest festival hall. The Stadthalle Mainz has already served as a venue for carnival celebrations and large-scale events. The construction work on the Rheingoldhalle officially started on the 27th of February 1966 – a date that was deliberately chosen, since it was the 21st anniversary of the Stadthalle’s destruction by World War II air raids on the city of Mainz. The completion of the Rheingoldhalle marked the last crucial phase of the reconstruction of the city centre of Mainz. Due to growing market shares, the Rheingoldhalle saw its first expansion in the mid-1980s, adding 3 new conference rooms: Dijon-Saal, Zagreb-Saal, Watford-Saal. These rooms were named after Mainz‘ first twin cities. The second major expansion followed in 1989, based on the plans by the renowned architect firm Dissing + Weitling from Copenhagen. The Rheingoldhalle was completely redesigned and became part of a building complex incorporating the city hall with direct access to the Hilton Hotel on the banks of the Rhine. This enabled Mainz to build its reputation as a national and international congress city.

Rheingoldhalle Mainz Rheinstrasse 66 D-55116 Mainz Phone: +49 6131 2420 Email: [email protected] www.mainz-congress.com

E-AHPBA Management Office Carol Nicol E-AHPBA c/o ACS Global Phone: +44 141 530 2760 Email: [email protected]

Kongress-Saal Posterarea Gutenbergsaal A-D

Transit Hilton Hotel

Entrance

Zagreb-Saal Dijon-Saal Watford-Saal

8

9

Host City Mainz For patients requiring tissue sealing, and control of bile leakage and bleeding during hepato-biliary-pancreatic surgery1

VISIT US AT BOOTH #8

Strength and Simplicity to Seal Tissue, Stop Bleeding1-4 • Preferred by surgeons for its flexibility/pliability and tissue adherence5 • Sustained sealing and hemostasis,2-4 even in patients on antiplatelet therapy2,5 • No preparation or premoistening required

References 1. Baxter Healthcare. HEMOPATCH Instructions For Use, April 2015. 2. Fingerhut A. Surg Technol Int 2014;25: 29–35. 3. Lewis KM, et al. Int J Surg 2014;12:940–4. 4. Imkamp F, et al. World J Urol 2015;33:1527–34. 5. Ulrich F, et al. Surg Technol Int 2016; In press. HEMOPATCH comes ready to use in sterile packages and must be handled accordingly. Use only undamaged packages, single use only, do not re-sterilize. For full product information, please refer to the instructions for use. Indication for Use HEMOPATCH is intended as a hemostatic device and surgical sealant for procedures in which control of bleeding or leakage of other body fluids or air by conventional surgical techniques is either ineffective or impractical. HEMOPATCH may be used to close dural defects following traumatic injury, excision, retraction or shrinkage of the dura mater. Contraindications Do not compress HEMOPATCH into blood vessels or use intravascularly. The device must not be used in patients with known hypersensitivity to bovine proteins or brilliant blue (FD&C Blue No. 1 [Blue 1]). Warnings HEMOPATCH is not intended to be used in pulsatile, severe bleedings. The use of HEMOPATCH is not recommended in the presence of an active infection. When used in, around, or in proximity to foramina in bone, areas of bony confine, the spinal cord, the brain and/or cranial nerves, care should be exercised to avoid overpacking, creating the potential for neural damage. HEMOPATCH is not intended as a substitute for meticulous surgical technique and the proper application of ligatures or other conventional procedures for hemostasis and sealing.

© Carsten Costard

© mainzplus CITYMARKETING GmbH

© Landeshauptstadt Mainz

Historical buildings, picturesque locations, impressive monuments – however, Mainz has even more to offer. The state capital of Rhineland-Palatinate combines an ancient culture with joie de vivre. It is the home of both the German Wine Institute and the wine capital of Germany; the largest German wine-growing area is located outside the city, called Rheinhessen, with a number of award-winning vintners. In 2011, Mainz was awarded the designation “City of Science” – this brought fresh momentum to the scientific location and the regional economy until today.

Wide variety of cultural highlights: ▪ Native city of Johannes Gutenberg, the inventor of book printing ▪ Gutenberg Museum ▪ The university was founded in 1477 and is one of Germany’s oldest universities – renamed Johannes Gutenberg University in 1946 ▪ Historical city centre / cathedral ▪ Historical Roman buildings

We offer different tours during the congress for accompanying persons: ▪ The golden city of Mainz and its many attractions ▪ On the trail of Johannes Gutenberg ▪ Chagall windows at St. Stephen’s Church and the old quarter ▪ Wine tasting at Hofgut Laubenheimer Höhe: - 5-glass wine tasting „around the estate“ - „Great Wine Capitals“ wine tasting: Visit the champagne cellar of „Kupferberg“ ▪ Excursion to the Rheingau Region ▪ Excursion to the historical city Frankfurt

For bookings and further questions, please contact:

Baxter and Hemopatch are trademarks for Baxter International Inc., its subsidiaries or affiliates.

Julia Wichter Phone: +49 6131-242 827 Email: [email protected]

Baxter Healthcare S.A. Postbox CH-8010 Zurich

Or visit us on site during the congress at our booth right next to the registration area. Tuesday, Wednesday, Thursday 12.30 pm – 04.30 pm

GLBL/423/0317/0009 April 2017

10

11

Tuesday, 23 May, 2017 In the heart of the city, on the banks of the Rhine and easy to reach from all directions, the Rheingoldhalle offers over 7,000 m² of accessible function space in 15 rooms and a maximum of flexibility.

Rheingoldhalle | © Landeshauptstadt Mainz

Tuesday, 23 May, 2017 Postgraduate Course „Surgery for Pancreatic Diseases“

The Postgraduate Course is part of the E-AHPBA curriculum as preparation of the European Boards of Surgical Qualification (EBSQ). Prof. K. Conlon and Prof. X. Rogiers organise the EBSQ exams which can be taken during the congress on May 26, 2017. Chairs: S. Heinrich, Germany; C. Macutkiewicz, United Kingdom 09.30 am

PLEASE JOIN US AT E-AHPBA 2017 FOR THE LUNCH SYMPOSIUM

Wednesday, 24th May 2017 | 12:30-13:30 Rheingoldhalle Mainz Gutenbergsaal A

Welcome and Introduction S. Heinrich, Germany Imaging Modalities for Pancreatic Lesions – What Does the Surgeon Need? R. Grützmann, Germany Indications for Surgery for Benign and Cystic Pancreatic Lesions W. Uhl, Germany Management of IPMN K. Conlon, Ireland

11.00 am

Coffee Break

11.30 am

Management of Acute Pancreatitis A. Siriwardena, United Kingdom Management of Chronic Pancreatitis C. Dervenis, Greece

How does the LiMAx test use metabolic liver function to provide vital information for clinical practice?

Gutenberg-Saal D

Case Reports 01.00 pm 02.00 pm 02.00 pm

Lunch Break Techniques of Oncological and Parenchyma-Preserving Pancreas Surgery J. Werner, Germany Laparoscopic Pancreas Surgery M. Abu Hilal, United Kingdom

Expert panelists:

Tips and Tricks by the Senior Surgeon M. W. Büchler, Germany

Prof. Dr. Hauke Lang

03.30 pm

Coffee Break

04.00 pm

Preoperative Conditioning of Patients before Pancreas Surgery – Whom to Drain, how to Prevent Complications? H. Friess, Germany Management of Complications in Pancreatic Surgery M. Lesurtel, France Management of Complications in Pancreatic Surgery – Role of Interventional Radiology C. Düber, Germany

Prof. Dr. Martin Stockmann

University Medical Center Mainz Charité Berlin Medical University

Dr. Matthias Büchter

Essen University hospital

Agenda

Introduction: The LiMAx test The development of the LiMAx test in liver surgery LiMAx: the view of a hepatologist Panel discussion and Q&A

Prof. Dr. Hauke Lang Prof. Dr. Martin Stockmann Dr. Matthias Büchter Prof. Dr. Hauke Lang

Case Reports 05.20 pm 14

Wrap-Up

www.LiMAxtest.eu

Tuesday, 23 May, 2017

Tuesday, 23 May, 2017

10th Anniversary of ALPPS

10th Anniversary of ALPPS

About 10 years after the first reported ALPPS procedure, an anniversary meeting was created to discuss the development, the problems and the latest achievements of this revolutionary surgical technique. Gutenberg-Saal A & C

Chairs: H. Lang, Germany; T. van Gulik, Netherlands 11.00 am

03.00 pm

Welcome and Introduction H. Lang, Germany How it Began: The First ALPPS H. J. Schlitt, Germany

Gutenberg-Saal A & C

Anatomical Considerations M. Malago, United Kingdom

Interstage Assessment of Remnant Liver Function in ALPPS using Hepatobiliary Scintigraphy: Introduction of the HIBA Index V. Ardiles, Argentina

04.00 pm

ALPPS in Liver Fibrosis / Cirrhosis A. Chan, China

Chairs: E. Jovine, Italy; K.-J. Oldhafer, Germany 02.00 pm

04.50 pm


Lunch Break

ALPPS vs. PVL Two Stage Liver Resections: Matching Surgical and Oncological Outcomes A. Isaeva, Russian Federation

FP

Boehringer Ingelheim Foundation Grant Discussion D. Azoulay, France ALPPS procedure in patients with locally advanced liver malignancy-single center experience T.-H. Huang, V. P. Nr, C.-C. Chang, Y.-J. Chen, W.-F. Li, T.-L. Lin, J.-H. Wang, S.-N. Lu, C.-C. Wang, Taiwan MINI-ALPPS Achieves Adequate Future Liver Remnant (FLR) Hypertrophy to Allow Safe Two Stage Liver Resection T. Duncan, S. Junnarkar, Z. Kaposztas, D. O‘Reilly, J. Rees, C. Parry, R. Ellis-Owen, N. Kumar, United Kingdom

Mechanisms of Liver Regeneration in ALPPS P.-A. Clavien, Switzerland Laparoscopic ALPPS M. A. Machado, Brazil

Single centre experience with 45 cases of ALPPS for right trisectionectomy: Long-term oncological results I. Capobianco, J. Rolinger, K. Jansen, I. Königsrainer, J. Li, A. Königsrainer, S. Nadalin, Germany

ALPPS for CRC Liver Metastases R. Hernandez, United States

05.40 pm

16

ALPPS in Klatskin-Tumors R. Robles Campos, Spain ALPPS in Liver Fibrosis / Cirrhosis G. M. Ettorre, Italy

FP

How has the expert meeting 2015 changed our practice and results with ALPPS G. A. Stavrou1, M. Donati2, K. C. Wagner1, M. H. Fard-Aghaie1, M. J. Lipp1, K. J. Oldhafer1, 1 Germany, 2Italy 01.00 pm 02.00 pm

Coffee Break

Chairs: E. de Santibañes, Argentina; P. Sandström, Sweden

Boehringer Ingelheim Foundation Grant Discussion H. Petrowsky, Switzerland


Living Donor APOLT-ALPPS : Paradigm Shift in the Management of Irresectable Colorectal Liver Metastases S. Nadalin, S. Templin, I. Koenigsrainer, I. Capobianco, H.-G. Kopp, L. Zender, B. Sipos, L. Kanz, S. Wagner, A. Königsrainer, Germany

Special Surgical Aspects (MHV, Management of Bile Duct; Mini-ALPPS, Partial ALPPS) E. de Santibañes, Argentina 12.30 pm

FP

Boehringer Ingelheim Foundation Grant Discussion M. Lesurtel, France

03.30 pm

Necessary Diagnostics T. van Gulik, Netherlands

Analyses of Mitochondrial Biogenesis and Function after Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy (ALPPS) A. Fulop, Hungary

Discussion / Wrap-up E. de Santibañes, Argentina

17

Tuesday, 23 May, 2017 Workshop: Fluorescence Imaging in Liver Surgery

Hilton Mainz Rheinstrasse 68 D-55116 Mainz

Fluorescence Imaging in Liver Surgery Update on medical findings and state of research

Hilton Mainz | Room Rhein 3

XXX

04.00 pm

Get-together and Welcome

04.15 pm

Opening and Introduction C. Conrad, United States

04.45 pm

Fluorescence Imaging in Hepatic Surgery Clinical Perspectives T. Wilhelm, Germany; D. Fuks, France; G. Wakabayashi, Japan; N. Kokudo, Japan

05.45 pm

Discussion

06.30 pm

Wrap-up and Closing

19

Meet the Professor Sessions Taking place every day from 07.00 am to 07.55 am, these sessions will play an important role in the congress programme, providing a forum for interactive discussions based upon a specific topic on which the chosen professors are leaders in their fields. These sessions are a first-class and one-of-a-kind learning opportunity. Venue: Hilton Hotel Mainz | Rooms Rhein 2-5

Wednesday, 24 May, 2017 1.

ALPPS – Tips and Tricks (E. de Santibañes, Argentina) | Rhein 2

2.

Approach to Intrahepatic Cholangiocarcinoma and Gallbladder Carcinoma – Tips and Tricks (W. Jarnagin, United States) | Rhein 3

3. Laparoscopic Liver Resection and LDLT – Tips and Tricks (G. Wakabayashi, Japan) | Rhein 4 4. Ultrasound Guided Parenchyma Sparing Liver Surgery – How I do it (G. Torzilli, Italy) | Rhein 5 Thursday, 25 May, 2017 1.

Approach to IPMN (C. Bassi, Italy) | Rhein 2

2. Approach to Hilar Cholangiocarcinoma – Tips and Tricks (M. Nagino, Japan) | Rhein 3 3. Approach to CRLM – Tips and Tricks (R. Adam, France) | Rhein 4 4. Robotic Pancreatic Surgery – How I do it. Tips and Tricks (U. Boggi, Italy) | Rhein 5 Friday, 26 May, 2017 1.

Two-step Procedures in CRLM (J.-N. Vauthey, United States) | Rhein 2

2. Approach to Laparoscopic ALPPS – Tips and Tricks? (M. A. Machado, Brazil) | Rhein 3

We take cancer personally Patienten stehen im Mittelpunkt unseres Handelns bei Roche. Sie motivieren und inspirieren uns bei der Erforschung und Entwicklung neuer Arzneimittel und Therapiekonzepte, die das Leben von Krebspatienten weltweit verbessern sollen. Viele Forschungsergebnisse haben schon zu bedeutenden Fortschritten in der Krebstherapie geführt – und unsere Forschung geht ständig weiter.

3. The Difficult Pancreatic Anastomosis – How I do it (J. Weitz, Germany) | Rhein 4 4.

Laparoscopic Pancreatic Surgery – How I do it. Tips and Tricks (M. Besselink, Netherlands) | Rhein 5

The cost is only EUR 40.00 per session, including breakfast. To book your session please refer to the registration desk. 20

Doing now what patients need next

Scientific Programme 07.00 am

Wednesday, 24 May, 2017

Registration & Meet the Professor Sessions Gutenberg-Saal C

Gutenberg-Saal D

Watford-Saal

Zagreb-Saal

Special Lecture 2 Page: 30





08.30 am 09.45 am

Free Paper Session 4 Page: 30






09.45 am 10.15 am

Coffee Break

Symposium 5 The Young Surgeon Page: 36

Allied Healthcare Professionals (1) Page: 36

Symposium 3 In Memorian Rudolf Pichlmayr Page: 35

Page: 78

Page: 78

Symposium 6 Modern Treatment Options for Advanced Pancreatic Cancer Page: 37

Symposium 7 E-AHPBA Meets ILCA: Cutting Edge of HCC Page: 37

Symposium 8 Surgical Training and Assessment in the E-AHPBA Page: 38

The Scandinavian Chapter – Novel Diagnostics and Therapy in HPB Disease Page: 38

Key Note Lecture 2 Page: 38

Allied Healthcare Professionals

Free Video Session 1 Page: 36

Poster Sessions 11-20 (12.50 pm – 01.40 pm) Page: 89

HPB

Update 1 Page: 36 01.45 pm 03.15 pm


Satellite Symposium (12.30 pm – 01.30 pm)

03.15 pm 03.45 pm

Coffee Break

03.45 pm 04.45 pm

Symposium 9 Laparoscopic Liver Surgery Page: 39

Symposium 10 Challenges in the Management of Chronic Pancreatitis Page: 39


Symposium 11 Primary Sclerosing Cholangitis Page: 40

Symposium 12 Centralisation of HPB Surgery Page: 40














04.50 pm 06.00 pm

Opening Ceremony Page: 128

06.30 pm 07.30 pm from 07.30 pm

22

Special

Satellite Symposium (12.30 pm – 01.30 pm)

Transplantation

Symposium 4 Non-alcoholic Steatohepatitis (NASH) Page: 35

Pancreas


Symposium 2 Management of Complications of Acute Pancreatitis Page: 34

Symposium 1 Cystic Liver Disease Page: 34

Lunch Break 12.20 pm 01.45 pm

Poster Area

Bismuth Lecture P.-A. Clavien, Switzerland Page: 34

10.15 am 10.45 am

10.50 am 12.20 pm

Kongress-Saal

Liver

Gutenberg-Saal B


Biliary

Gutenberg-Saal A 08.15 am 08.30 am

Welcome Reception Page: 128

Welcome Reception Page: 128

23


Thursday, 25 May, 2017

Registration & Meet the Professor Sessions Gutenberg-Saal B

Gutenberg-Saal C

Gutenberg-Saal D

08.00 am 08.15 am




08.15 am 09.30 am




Kongress-Saal

Watford-Saal

Zagreb-Saal







5th ECALSS Meeting Page: 54


10.30 am 12.00 pm

E-AHPBA Prize Paper Session Page: 52

Update 2 Page: 53 Free Video Session 3 Page: 53

Symposium 14 Strategies for the Expansion of the Donor Pool Page: 53

Symposium 15 Perioperative Management in HPB Surgery Page: 53

Key Note Lecture 4 Page: 54 Symposium 13 Management of CRC Metastases 1 Page: 54

Lunch Break Satellite Symposium (12.15 pm – 01.15pm)

03.30 pm 04.30 pm

04.35 pm 05.50 pm

06.00 pm 07.00 pm

24

Page: 79

Symposium 16 Management of Complications in HPB Surgery Page: 56

Symposium 19 Ongoing Research in the E-AHPBA: Update from the Research Committee Page: 56

Key Note Lecture 5

Page: 56 Symposium 18 Session of the Turkish National Chapter – Living Donor Liver Transplantation: “A Turkish Perspective” Page: 56

Symposium 17 German Surgical Society/Japanese Surgical Society joint Session: Hilar Cholangiocarcinoma Page: 57

5th ECALSS Meeting Page: 57 Allied Healthcare Professionals (4) (02.00 pm - 04.00 pm)

Key Note Lecture 6

Page: 57


03.00 pm 03.30 pm



HPB

01.30 pm 03.00 pm


Satellite Symposium (12.15 pm – 01.15pm)

Special

Page: 79

Transplantation

Coffee Break

Pancreas

10.05 am 10.30 am

Liver

Presidential Address M. Smith, South Africa Page: 52

09.35 am 10.05 am

12.00 pm 01.30 pm

Poster Area

Biliary

Gutenberg-Saal A

Coffee Break


Symposium 20 Management of IPMN Page: 58

Symposium 21 HPB Surgery in Portal Hypertension Page: 58





Free Paper Session 23 Free Paper Session 24 Page: 60 Page: 60

Symposium 23 Gallbladder Cancer Page: 59

Page: 80

Symposium 22 The Complicated Donor Page: 58 Special Lecture 22 Page: 61







E-AHPBA General Assembly Page: 63

25


Friday, 26 May, 2017

Registration & Meet the Professor Sessions Gutenberg-Saal C

Gutenberg-Saal D

Watford-Saal

Zagreb-Saal






08.15 am 09.25 am









Symposium 24 Management of CRC Metastases 2 Page: 70

Symposium 25 HPB Trauma Page: 71

Update 3: Virtual Reality Surgery and Intraoperative Imaging Page: 71

Symposium 27 Pancreas Surgery Page: 72

Symposium 28 Intrahepatic Cholangiocarcinoma Page: 72

Satellite Symposium 09.30 am 10.30 am

Coffee Break

10.45 am 12.15 pm

Symposium 26 CRC Liver Metastases with Extrahepatic Disease Page: 71

Symposium 29 Rare Indications for Liver Transplantation Page: 73



Lunch Break



Page: 81


Page: 81

26

Symposium 30 Manipulating the Future Liver Remnant Page: 74

Symposium 31 Neuroendocrine Tumours – Joint Session Page: 74

Symposium 32 Keys to Safe Laparoscopic Free Video Session 8 Page: 75 Cholecystectomy Page: 74


03.45 pm 04.45 pm

HPB

Key Note Lecture 7 M. W. Büchler, Germany Page: 74

01.45 pm 02.15 pm

02.20 pm 03.35 pm

Special


Transplantation

10.30 am 10.45 am

12.15 pm 01.45 pm

Poster Area

Pancreas

Page: 81

Kongress-Saal

Liver

Gutenberg-Saal B


Biliary

Gutenberg-Saal A 08.00 am 08.15 am

Symposium 33 OLT: The Complicated Recipient Page: 75 Closing Ceremony & Meeting Wrap-up Page: 75

27

Picturesque Old Town of Mainz | © Carsten Costard

Wednesday, 24 May, 2017 In the picturesque old town around the Romanesque St. Martin’s Cathedral, you can stroll through winding streets. Behind the lovely restored half-timbered Baroque and Rococo facades jewellery and clothing boutiques, little studios, typical Mainz wine taverns, and restaurants invite you to a journey of discovery.

Scientific Programme


08.30 am

Free Paper Session 4

09.06 am

08.30 am

Laparoscopic liver resection for metastatic melanoma D. L. Aghayan, A. M. Kazaryan, Å. A. Fretland, B. I. Røsok, B. Edwin, Norway

Portal and Mesenteric Vein Resection during Pancreaticoduodenectomy and Total Pancreatectomy H. Zakaria1, J. Stauffer2, E. Harada3, H. Asbun2, 1Egypt, 2United States, 3Japan

Outcome of liver resection for non-colorectal, non-neuroendocrine metastases – A single-centre experience J. Theurer, F. Bartsch, J. Baumgart, V. Tripke, S. Heinrich, H. Lang, Germany

09.15 am

08.39 am

Management of vascular complications after pancreaticoduodenectomy (PD): Reducing the numbers of failure to rescue B. M. Zonderhuis1, T. Hellingman1, F. Daams1, K. H. C. DeJong1, I. H. J. T. De Hingh2, K. P. De Jong1, G. Kazemier1, 1Netherlands, 2New Zealand

08.48 am

Isolated and percutaneous liver perfusion for unresectable metastatic liver tumours: A systematic review K. Bramis1, G. Bagias2, E. Panopoulou1, A. Petrou3, N. Alexakis1, K. Toutouzas1, M. Konstadoulakis1, G. Zografos1, 1Greece, 2Germany, 3Cyprus

09.24 am

Total pancreatectomy: Short-term and long-term outcomes at a high-volume pancreas center H. Zakaria1, J. Stauffer2, M. Raimondo2, T. Woodward2, M. Wallace2, H. Asbun2, 1 Egypt, 2United States

08.57 am

The role of hepatectomy for synchronous liver metastases from pancreatic adenocarcinoma A. Andreou, F. Klein, R. Schmuck, A. R. Noltsch, B. Struecker, J. Pratschke, M. Bahra, Germany

09.33 am

The diagnostic dilemma of highly suspicious solid pancreatic head lesions: Repeated tissue diagnosis may not be necessary A. Kanwar, T. Hoskins, A. Amer, D. Majumdar, S. Johnson, J. Scott, M. Nayar, K. Oppong, R. Charnley, United Kingdom

09.06 am

Microwave ablation for breast cancer liver metastasis E. Gringeri, R. Boetto, S. E. Pierobon, F. E. D‘Amico, D. Bassi, M. Di Giunta, E. Fasolo, M. Finotti, C. Aliberti, C. Ghiotto, U. Cillo, Italy

FP

09.15 am

Video-laparoscopic MW ablation in a European high volume centre: Safety and efficacy of 970 procedures U. Cillo, A. Vitale, F. D‘Amico, E. Gringeri, D. Bassi, A. Bertacco, M. Di Giunta, G. Zanus, Italy

09.24 am

Histological Evidence of Reversibility of Chemotherapy associated liver Injury N. Cassar, F. K. Welsh, K. Chandrakumaran, A. B. Cresswell, T. G. John, M. Rees, United Kingdom

09.33 am

Missing Liver Metastases in colorectal cancer as a clinical challenge – Single centre experience R. Garcia-Perez1, D. Calatayud1, E. Delgado1, Á. Garcia-Criado1, M. Jimenez-Lopez2, M. Manyalich1, V. Molina1, M. Pavel1, S. Sánchez-Cabús1, J. Ferrer1, C. Fondevila1, J. Fuster1, J. C. García-Valdecasas1, 1Spain, 2Mexico

Gutenberg-Saal B

Chairs: M. Abu Hilal, United Kingdom; T. Keck, Germany 08.15 am

Special Lecture 2 Laparoscopic Pancreatoduodenectomy I. E. Khatkov, Russian Federation

08.30 am


08.30 am

Laparoscopic Distal Pancreatectomy For Pancreatic Ductal Adenocarcinoma: Long-Term Oncologic Outcomes Following Standard Resection M. Sahakyan1, S. C. Kim2, D. Kleive1, A. Kazaryan1, K. B. Song2, D. Ignjatovic1, T. Buanes1, B. Røsok1, K. J. Labori1, B. Edwin1, 1Norway, 2South Korea

08.39 am

Laparoscopic vs. Open pancreaticoduodenectomy: Preliminary results from a randomized controlled trial (PADULAP TRIAL) O. Morató, I. Poves, F. Burdío, L. Grande, Spain

08.48 am

30

FP

Perioperative and long-term oncological results of minimally invasive pancreaticoduodenectomy – A matched pair analysis of over 100 cases S. Deichmann, U. F. Wellner, K. Honselmann, T. Keck, H. Lapshyn, D. Bausch, Germany

Gutenberg-Saal B

Special Lecture 1 Liver Resection for Non-Colorectal Non-Endocrine Liver Metastases R. Adam, France

08.57 am

08.15 am

300 Laparoscopic Pancreatic Resections: The Largest European Single Centre Experience S. Dokmak, F. S. Fteriche, B. Aussilhou, P. Lévy, P. Ruszniewski, J. Cros, M.-P. Vullierme, L. Khoy Ear, J. Belghiti, O. Soubrane, A. Sauvanet, France

Chairs: O. Busch, Netherlands; R. Robles Campos, Spain

Gutenberg-Saal C

Gutenberg-Saal A

Chairs: J. Figueras, Spain; I. Gockel, Germany

08.15 am

Special Lecture 3 Management of Bile Duct Cysts and Caroli Syndrome J. C. Lendoire, Argentina

08.30 am


08.30 am

De Novo Cholangiocarcinoma after Hepatectomy for Hepatolithiasis: A Comparative Review of 124 cases Y. J. Chen, H. Pahari, C. C. Wang, C. L. Chen, Taiwan

08.39 am

Systematic cysts aspiration facilitating extended Right Hepatectomy for Isolated Polycystic Liver Disease A. Recordare1, 2, M. Nakashidze2, Z. Chikhladze2, S. Putkaradze2, G. Tomadze2, M. Rizzo1, 1Italy, 2Georgia

08.48 am

Long-term follow-up after Surgical Treatment of Intrahepatic Biliary Cysts (Types IV & V) G. Raffin, J. Lendoire, F. Duek, L. Gil, M. Massa, O. Imventarza, Argentina

08.57 am

Extended resection for xanthogranulomatous choleystitis mimicking Gallbladder carcinoma: Review of cases and diagnostic approach S. Begum, M.R. Khan, Pakistan

09.06 am

Laparoscopic common bile duct exploration (LCBDE): A choice over ercp for managing cbd stones, first Sri Lankan experience A. D. S. Perera, B. G. N. Rathnasena, K. D. L. Nanayakkara, M. Mathurageethan, Sri Lanka

09.15 am

Incidental gallbladder cancer – The first report from Africa Z. A. Khan, M. Brand, South Africa

09.24 am

Bile duct infections with multidrug resistant microorganisms in pancreatic surgery T. Herzog, M. Tan, O. Belyaev, A. Luu, W. Uhl, Germany

09.33 am

Biocellulosis induces regeneration of the extrahepatic bile duct F. Rauchfuß, F. Kramer, W. Fried, A. Tannapfel, K. Petzold-Welcke, D. Klemm, U. Settmacher, Germany

FP

31



Chairs: M. Adham, France; R. Andersson, Sweden 08.15 am

Special Lecture 4 Risk Factors for Pancreatic Fistula – Nothing but Fat? M. Glanemann, Germany

08.30 am


08.30 am

Visceral adipose tissue and skeletal muscle index distribution predicts development of severe pancreatic fistula after pancreaticoduodenectomy H. Yamane, T. Abe, H. Amano, N. Fujikuni, H. Okuda, M. Yamaki, T. Minami, K. Hanada, T. Fukuda, S. Yonehara, M. Nakahara, T. Noriyuki, Japan

08.48 am

Severe post-pancreatoduodenectomy haemorrhage: An analytical review based on 118 consecutive pancreatoduodenectomies M. Bernon, J. Krige, E. Jonas, C. Kloppers, S. Burmeister, N. Naidoo, S. Beningfield, South Africa

08.57 am

Polyester sutures for pancreaticojejunostomy protect against postoperative pancreatic fistula: A case-control risk adjusted analysis S. Andrianello, G. Marchegiani, G. Malleo, V. Allegrini, A. Pulvirenti, A. Giardino, G. Butturini, R. Girelli, R. Salvia, C. Bassi, Italy

09.06 am

Best methods to minimize pancreatic fistula after pancreatoduodenectomy: 15 years experience H. S. Kim, J. H. Lim, J. S. Park, D. S. Yoon, South Korea

09.15 am

A multicentre, prospective, randomized trial evaluating the effect of matrix-bound sealant on pancreatic fistula after partial pancreaticoduodenectomy M. Schindl, R. Fuegger, F. Laengle, P. Goetzinger, M. Zitt, S. Staettner, P. Kornprat, K. Sahora, M. Gnant, Austria

09.24 am

09.33 am

Intraabdominal vacuum therapy with postoperative pancreatic fistula after pancreaticoduodenectomy I. Dimitriou, U. Bultmann, M. Niedergethmann, Germany The role of abdominal drainage in pancreatic resection – A multicenter validation for early drain removal R. Linnemann, G. Patijn, B. van Rijssen, M. Besselink, T. Mungroop, I. de Hingh, G. Kazemier, S. Festen, K. de Jong, C. van Eijck, J. Scheepers, H. van Goor, M. den Dulk, K. Bosscha, D. Boerma, E. van der Harst, V. Nieuwenhuijs, Dutch Pancreatic Cancer Group, Netherlands

Watford-Saal

Chairs: O. C. Andriani, Argentina; A. Weimann, Germany

32

08.15 am

Special Lecture 5 Fast-Track Recovery in HPB Surgery C. Sturesson, Sweden

08.30 am


08.30 am

Impact of the implementation of ERAS programme in complex liver resections: A propensity score-based analysis between open and laparoscopic approach F. Ratti, F. Cipriani, G. Fiorentini, A. Cardella, M. Catena, M. Paganelli, L. Aldrighetti, Italy

Watford-Saal

Intraoperative Fistula Risk Score (iFRS) In Pancreatoduodenectomy: Development and Validation in Three Datasets T. Mungroop1, L. B. van Rijssen1, D. van Klaveren1, F. J. Smits1, V. van Woerden1, R. Linnemann1, B. L. Ecker2, S. van Dieren1, B. Bonsing1, O. Busch1, R. van Dam1, J. Erdmann1, C. van Eijck1, M. Gerhards1, H. van Goor1, E. van der Harst1, I. de Hingh1, K. de Jong1, G. Kazemier1, M. Luyer1, A. Shamali3, S. Barbaro3, T. Armstrong3, A. Takhar3, Z. Hamady3, J. Klaase1, D. Lips1, I. Q. Molenaar1, V. Nieuwenhuis1, C. Rupert1, H. van Santvoort1, J. Scheepers1, G. van der Schelling1, C. Vollmer2, E. Steyerberg1, M. Abu Hilal3, B. Groot Koerkamp1, M. Besselink1, 1Netherlands, 2United States, 3United Kingdom

A randomized controlled trial for enhanced recovery in liver surgery: Improved perioperative management using the LiMAx test M. Stockmann, F. Vondran, U. Settmacher, H.-M. Tautenhahn, H. Lang, J. Pratschke, C.-T. Germer, I. Klein, J. F. Lock, Germany

08.48 am

Randomized Clinical Trial of Abdominal Wound Catheters (AWC) versus Epidural Analgesia (EP) following Open Liver Resection (OLR): An Interim Analysis R. Bell, J. Jeffery, D. Ward, E. Hidalgo, United Kingdom

08.57 am

Pain treatment in open liver resection, systemic multimodal analgesia vs. epidural analgesia: A randomized controlled trial (data from Oslo-Comet study) J. Hausken, Å. A. Fretland, M. H. Andersen, G. Kvarstein, B. Edwin, T. I. Tønnessen, Norway

09.06 am

RCT of open versus laparoscopic left lateral hepatic sectionectomy within an enhanced recovery after surgery programme (ORANGE II study) E. Wong-Lun-Hing1, R. M. van Dam1, G. J. P. van Breukelen1, P. J. Tanis1, F. Ratti2, R. van Hillegersberg1, G. D. Slooter1, J. H. W. de Wilt1, M. S. L. Liem1, M. T. de Boer1, J. M. Klaase1, U. P. Neumann3, L. A. Aldrighetti2, C. H. C. Dejong1, 1Netherlands, 2Italy, 3Germany

09.15 am

Role of inflammatory and nutritional scores for predicting complications after major pancreatic resections F. J. Tejero Pintor, M. Rodriguez Lopez, B. Perez Saborido, A. Barrera Rebollo, D. Pacheco Sánchez, E. Asensio Díaz, P. Pinto Fuentes, S. Mambrilla Herrero, M. Bailon Cuadrado, K. T. Plua muniz, J. L. Marcos Rodriguez, Spain

09.24 am

Effects of preoperative immunonutrition on surgical outcomes after major pancreatic resections: A non-randomized controlled analysis M. Rodriguez-Lopez, F. J. Tejero Pintor, A. Barrera-Rebollo, B. Perez-Saborido, E. AsensioDiaz, R. Velasco-Lopez, M. Bailon-Cuadrado, K. T. Plua-Muniz, E. Choolani-Bhojwani, J. L. Marcos-Rodriguez, Spain

09.33 am

Clinical Impact of Nonselective beta blockers on Survival in Patients with Pancreatic Cancer – Revival of well known drugs? B.W. Renz1, S. Graf1, Z. Dantes1, M. Macchini2, S. Vecchiarelli3, C. Ricci3, T. C. Wang2, R. Casadei3, M. Di Marco3, M. Reichert1, A. Kleespies1, J. Werner1, 1Germany, 2United States, 3Italy

Chairs: H. J. Mischinger, Austria; A. Serrablo, Spain

Zagreb-Saal

Gutenberg-Saal D

08.39 am

FP

08.39 am

08.15 am

Special Lecture 6 Prognosis after Resection of CRLM – Role of Immunology S. Fichtner-Feigl, Germany

08.30 am


08.30 am

RAS mutation for metastatic colorectal cancer treated with potentially curative intent: Impact of metastasis site G. Passot1, B. Kim2, O. Glehen1, J. Mehran2, C. Conrad2, T. Aloia2, J. N. Vauthey2, 1 France, 2United States

08.39 am

Prognostic role of KRAS mutational status and response to preoperative chemotherapy in patients undergoing hepatectomy for colorectal liver metastases G. Zimmitti, C. Mele, F. Ardito, E. Panettieri, I. Scoleri, E. Rosso, F. Giuliante, Italy

08.48 am

Prognostic determinants in patients with multiple colorectal liver metastases: The relevance of the primary tumor features L. Vigano, S. S. Darwish, F. Procopio, J. Galvanin, M. Cimino, M. Donadon, D. Del Fabbro, G. Torzilli, Italy

08.57 am

The effect of histopathological growth patterns on recurrence after resection of colorectal liver metastasis B. Galjart1, E. P. van der Stok1, R. R. Coebergh van den Braak1, P. M. Nierop1, J. Rothbarth1, D. J. Grünhagen1, P. B. Vermeulen2, C. Verhoef1, 1Netherlands, 2Belgium

FP

FP

33

Scientific Programme Impact of the Width of Resection Margin from Colorectal Liver Metastasis on Post-Operative Survival and Recurrence Y. Boteon, A. Carvalheiro, M. Abradelo, B. Dasari, R. Sutcliffe, K. Roberts, R. Marudanayagam, J. Isaac, P. Muiesan, D. MirzaUnited Kingdom

09.15 am

Embryonic Origin of Primary Colon Cancer Predicts Pathologic Response and Survival in Patients Undergoing Resection for Colon Cancer Liver Metastases S. Yamashita, B. Odisio, S. Huang, S. Kopetz, K. Ahrar, Y. S. Chun, C. Conrad, T. Aloia, M. Hicks, S. Gupta, J.-N. Vauthey, United States

09.24 am

Worse survival in liver metastatic right-sided versus left-sided colorectal cancer J. Engstrand1, H. Nilsson1, C. Strömberg1, E. Jonas2, J. Freedman1, 1Sweden, 2 South Africa

09.33 am

The role of genetic instability in stimulation of angiogenesis in liver metastases of sporadic colorectal cancer W. Otto1, F. Macrae2, J. Sierdzinski1, M. Król1, M. Feliksbrot-Bratosiewicz1, U. Wilkowojska1, E. Wolińska1, 1Poland, 2Australia

Gutenberg-Saal B

Zagreb-Saal

09.06 am


09.45 am Coffee Break KongressSaal

Chairs: M. D. Smith, South Africa; H. Lang, Germany 10.15 am

Bismuth Lecture The Future of HPB Surgery – The Inevitable Switch! P.-A. Clavien, Switzerland

11.05 am

Acute Pancreatitis and the Risk of Pancreatic Cancer J. Kirkegård, Denmark

11.15 am

Boehringer Ingelheim Foundation Grant Discussion H. Friess, Germany

11.20 am

Strategies to Prevent Necrosis Infection M. Besselink, Netherlands

11.35 am

Timing of Intervention C. R. Carter, United Kingdom

11.50 am

Minimally Invasive and Endoscopic Options for Necrotising Pancreatitis H. C. Santvoort, Netherlands

12.05 pm

The 2016 Update of the Definition and Grading of POPF: Clinical Validation on 775 Consecutive Pancreatic Resections G. Marchegiani, Italy

12.15 pm

Boehringer Ingelheim Foundation Grant Discussion M. Adham, France

Chairs: G. Ercolani, Italy; P. Galle, Germany

10.50 am

Key Note Lecture 1 How Will New Treatment Options for Viral Hepatitis Influence OLT and Liver Resection? S. Zeuzem, Germany

11.20 am

Symposium 4 Non-alcoholic Steatohepatitis (NASH)

11.20 am

Definition and Quantification of Liver Fat B. Straub, Germany

11.35 am

Who is at Risk to Develop NAFLD or NASH – Who Requires Cancer Surveillance, Who Needs OLT? A. Canbay, Germany

11.50 am

How to Handle the Fatty Liver – Surgical Aspects in Liver Resection H. Petrowsky, Switzerland

12.05 pm

OLT for NASH – Brasilian Experience L. A. Carneiro D‘Albuquerque, Brazil

Symposium 1 Cystic Liver Diseases

10.50 am

Surgical Options for Cystic Echinococcus Disease M. Milicevic, Serbia

11.05 am

Surgical Options for Alveolar Echinococcus Disease A. Serrablo, Spain

11.20 am

Competitive Prospects of Minimally Invasive Interventions in Surgery of Liver Echinococcosis F. Nazyrov, Uzbekistan

11.35 am

Hepatic alveolar echinococcosis – Sixteen years 237 cases G. Ozturk, E. Korkut, N. Aksungur, B. Aydinli, Turkey

FP

11.42 am

Single center experience with 120 patients treated for alveolar echinococcosis G. Beldi, A. Lachenmayer, D. Gebbers, S. Akifi, D. Candinas, G. Beldi, Switzerland

FP

11.49 am

Total laparoscopic pericystectomy for non-complicated hydatid cyst C. Muñoz1, 2, G. Sepulveda1, V. Molina2, 1Chile, 2Spain

FV

11.59 am

Double thoracoabdominal approach in hepato-pericardial hydatidosis J. Quiñones-Sampedro, M. d. C. Esteban-Velasco, L. M. Gonzalez-Fernandez, M. Iglesias, M. Caraballo-Angeli, L. Muñoz Bellvis, Spain

FV

12.09 pm

Laparoscopic Management of Hepatopulmonary fistula from Hepatic Hydatid Disease H. Ezzedine, M. Khalife, M. Kanso, W. Faraj, Lebanon

FV

GutenbergSaal B

Chairs: B. Andersson, Sweden; A. Siriwardena, United Kingdom

34

Gutenberg-Saal D

10.50 am

Chairs: C. E. Broelsch, Germany; H.-J. Meyer, Germany; J. Klempnauer, Germany

Kongress-Saal

Gutenberg-Saal A

Chairs: O. Abbasoglu, Turkey; C. Agalianos, Greece

10.50 am

Symposium 3 In Memorian Rudolf Pichlmayr

10.50 am

The Life of Rudolf Pichlmayr E. Nagel, Germany

11.05 am

Surgery for Hilar Cholangiocarcinoma H. Lang, Germany

11.20 am

In-situ, Ante-situm, Ex-situ Resection K.-J. Oldhafer, Germany

10.50 am

Symposium 2 Management of Complications of Acute Pancreatitis

11.35 am

Split-Liver Transplantation and Auxiliary Liver Transplantation H. J. Schlitt, Germany

10.50 am

Current Classification of Acute Pancreatitis and Treatment of Abdominal Compartment Syndrome during AP D. Radenkovic, Serbia

11.50 am

The Work of Rudolf Pichlmayr H. Bismuth, France

35



10.50 am

Symposium 5 The Young Surgeon

10.50 am

What Defines the HPB Surgeon? E. Dixon, Canada

11.05 am

How Did I become HPB / Liver Transplant Surgeon? C. Dejong, Netherlands

11.20 am

What do HPB Trainees Expect? S. Jegatheeswaran, United Kingdom

11.35 am

Gender Development 2030 – The Role of Women in HPB Surgery M. De Oliveira, Switzerland

11.50 am

Training Programmes for HPB Surgery and Liver Transplantation in Europe R. W. Parks, United Kingdom

12.05 am

BRG1 Promotes Hepatocarcinogenesis by Modulating Cyclin B, D, E and Matrix Metalloproteinase 7 B. Kaufmann, Germany

12.15 pm

Gutenberg-Saal A

Watford-Saal

Chairs: C. Dervenis, Greece; M. Linecker, Switzerland 02.25 pm

Laparoscopic right hepatectomy with portal vein reconstruction for hepatocellular carcinoma with tumoral portal vein thrombosis in a cirrhotic patient R. Cañada Surjan, T. Basseres, F. Ferrari Makdissi, M. Autran Cesar Machado, Brazil

02.35 pm

Laparoscopic Left Hepatectomy for Mucinous Cystic Neoplasm of the Liver N. Smerieri, G. Fiorentini, F. Ratti, F. Cipriani, A. Belli, L. Aldrighetti, Italy

02.45 pm

Laparoscopic ALPPS Procedure for Large Hepatocellular Carcinoma M. F. Can, Turkey

02.55 pm

Clipless hepatic parenchyma transection with an energy device with no forward frictional energy M. Papoulas, E. Kontis, O. Hadjicosta, S. Abdul-Hamid, Y. Kumar, N. Heaton, K. Menon, United Kingdom

03.05 pm

Right Inferior transversal hepatectomy (S5-S6) using Takasaki’s operative technique A. Karamarković, Serbia

Chairs: A. Coker, Turkey; G. L. Grazi, Italy 01.45 pm

Symposium 6 Modern Treatment Options for Advanced Pancreatic Cancer

01.45 pm

Preoperative Evaluation of (Borderline) Resectability in Pancreatic Adenocarcinoma for Neoadjuvant Treatment J. Klempnauer, Germany

02.00 pm

Irreversible Electroporation and Local Ablation for Unresectable Pancreatic Cancer D. Panchenkov, Russian Federation

02.15 pm

Surgery for Cancer of the Body and Tail J. Werner, Germany

02.30 pm

Surgical Options in Metastatic Pancreatic Cancer M. M. Erkan, Turkey

02.45 pm

Intraoperative R1-Situation or PanIN3: How to Proceed? O. Strobel, Germany

03.00 pm

FOLFIRINOX in Locally Advanced Pancreatic Cancer (LAPC): Current Results and Presentation of a New Scandinavian Protocol P. Pfeiffer, Denmark

Boehringer Ingelheim Foundation Grant Discussion J. Marquardt, Germany

10.50 am

Allied Healthcare Professionals 1

10.50 am

Contrast Enhanced Ultrasound (CEUS) of the Liver – Basics R. Stoll, Germany

11.05 am

Criteria for Organ Donation and Donor Selection A. Barreiros, Germany

11.20 am

Standard Procedures in Liver Surgery and Orthotopic Liver Transplantation J. Mittler, Germany

11.40 am

HPB Surgery at the University Hospital of Mainz – The OR Nurses` View M. Pocha, Germany

12.00 pm

Gutenberg-Saal B

Zagreb-Saal

Chairs: M. Paschold, Germany; H. Jung-Reeder, Germany

Rationale for Laparoscopic and Robotic HPB Surgery T. Schlick, Germany

12.30 pm 01.20 pm 12.50 pm 01.40 pm

Chairs: M. Manns, Germany; M. Massani, Italy

Free Poster Sessions 1-10 Page: 84 Free Poster Sessions 11-20 Page: 89

Gutenberg-Saal C

Poster Area

12.20 pm Lunch Break

Gutenberg-Saal A

Chairs: L. A. Aldrighetti, Italy; B. Edwin, Norway

36

01.45 pm

Update 1 The Southampton Guidelines of Laparoscopic Liver Surgery M. Abu Hilal, United Kingdom

02.15 pm

Free Video Session 1

02.15 pm

4K laparoscopic right hepatectomy F. Ratti, F. Cipriani, G. Fiorentini, M. Catena, M. Paganelli, L. Aldrighetti, Italy

01.45 pm

Symposium 7 E-AHPBA Meets ILCA: Cutting Edge of HCC

01.45 pm

Pathology of HCC – New Molecular Insights P. Schirmacher, Germany

02.03 pm

New Treatment Options in HCC P. R. Galle, Germany

02.21 pm

Liver Resection in BCLC B / C Hepatocellular Carcinoma N. Kokudo, Japan

02.39 pm

Whom Should We Transplant with the Current Knowlegde? Squaring the Circle of Selection in OLT for HCC T. Becker, Germany

02.57 pm

Treatment of Recurrent HCC after Ablation / Resection / Transplantation – Sequential Therapeutic Approaches in the Management of HCC U. Cillo, Italy

FV

37

Symposium 8 Surgical Training and Assessment in the E-AHPBA

01.45 pm

Global Differences in Surgical Training – What Does Europe Need for Training HPB Surgery? A. A. Roeth, Germany

02.00 pm

How to Integrate Basic Research in Training HPB Surgery? M. D‘Angelica, United States

02.15 pm

Perspective for HPB Training in Low Budget Countries – “On the Spot” Training in Ethiopia M. Hoffmann, Germany

02.30 pm

Assessing the Emerging Role of the UEMS Examination in HPB Surgery K. Conlon, Ireland

02.45 pm

Key Note Lecture 2 The IHPBA Humanitarian Outreach Programme and the Responsibilities of the E-AHPBA A. Siriwardena, United Kingdom

Chairs: R. Andersson, Sweden; G. Lindell, Sweden 01.45 pm

The Scandinavian Chapter – Novel Diagnostics and Therapy in HPB Disease

01.45 pm

Nordic Multicenter Study on Preoperative Chemotherapy in Patients With Resectable Biliary Tract Carcinomas (BTC) P. Pfeiffer, Denmark

01.52 pm

Oslo CoMet – A Randomized Controlled Trial of Open vs. Laparoscopic Resection of CRC Liver Metastases A. A. Fretland, Norway

Watford-Saal

01.59 pm

03.45 pm

Symposium 9 Laparoscopic Liver Surgery

03.45 pm

Management of Venous Bleeding in Laparoscopic Liver Resection – Tips and Tricks L. A. Aldrighetti, Italy

04.00 pm

Repeat Laparoscopic Liver Resection for Tumor Recurrence G. Belli, Italy

04.15 pm

Laparoscopic Liver Resection: Essential Lessons Learned at the High Volume HPB Center R. Alikhanov, Russian Federation

04.30 pm

Right Hepatic Vein Injury and Control during Laparoscopic Surgery C. Redondo, J. Mir, E. Artigues, R. Fabra, C. Bases, A. De Andres, C. Zaragoza, Spain

FV

Chairs: J. Klempnauer, Germany; D. Radenkovic, Serbia 03.45 pm

Symposium 10 Challenges in the Management of Chronic Pancreatitis

03.45 pm

Managing the Cancer Risk in Chronic Pancreatitis T. A. Buanes, Norway

04.00 pm

Treatment Options in Chronic Pancreatitis: Endoscopy vs. Surgery M. A. Boermeester, Netherlands

04.15 pm

Matching Disease Phenotype to Surgery H. Friess, Germany

04.30 pm

Total Pancreatectomy and Islet Cell Transplantation S. A. Ahmad, United States

Chairs: J. Figueras, Spain; N. Bassi, Italy

The Effect of Oncological Neoadjuvant Treatment on Liver Growth in Patients Treated with ALPPS K. Hasselgren, Sweden

03.45 pm


03.45 pm

A vascular variant allows to resect „en bloc“ cholangiocarcinoma Bismuth IV E. Delgado Oliver, R. Garcia, V. Molina, J. Ferrer, M. Pavel, S. Sanchez Cabús, D. Calatayud, C. Fondevila, J. Fuster, J.C. Garcia-Valdecasas, Spain

03.55 pm

Left trisectionectomy plus caudate lobectomy (S1) and resection of biliary duct for Bismuth type IV perihilar cholangiocarcinoma A. Ruzzenente, S. Conci, A. Ciangherotti, C. Iacono, A. Guglielmi, Italy

04.05 pm

Multimodal three-dimensional resection planning for extended liver resection in a severe case of Echinococcus multilocularis T. Huber, M. Paschold, W. Kneist, C. Hansen, S. Heinrich, H. Lang, Germany

04.15 pm

Right extended hepatectomy for alveolar echinococcosis, with portal reconstruction under total vascular exclusion and liver cooling D. Sommacale, R. Brustia, F. Perdigao, T. Piardi, M. Khalfallah, O. Scatton,France

02.06 pm

Liver First in CRC Liver Metastases – Where Do We Stand? C. Sturesson, Sweden

02.13 pm

Novel Improved Diagnostics in Pancreatic Cancer D. Ansari, Sweden

02.20 pm

Randomized Trial of Invagination vs. Duct-to-Mucosa Reconstruction Following Pancreaticduodenectomy C. Ansorge, Sweden

02.27 pm

Pancreatic Resection – To Drain or not to Drain C. Williamsson, Sweden

02.34 pm

Does Reinforcement of Staple Line in Left Pancreatectomy Reduce the Rate of PF J. Wennerblom, Sweden

04.25 pm

02.48 pm

Update on MARS in PHLF S. Gilg, Sweden

Laparoscopic right hemihepatectomy R. Kleinert, C. Bruns, D. Stippel, Germany

04.35 pm

Laparoscopic left lateral section resection for hydatid cyst of the liver S. Usta, K. Karabulut, Turkey

03.15 pm Coffee Break

38

Gutenberg-Saal A

01.45 pm

Chairs: D. Cherqui, France; R. M. van Dam, Netherlands

Gutenberg-Saal C

Gutenberg-Saal D

Chairs: R. W. Parks, United Kingdom; M. D. Smith, South Africa


Gutenberg-Saal B


FV

39



03.45 pm

Symposium 11 Primary Sclerosing Cholangitis

03.45 pm

Novel Diagnostic Tools for the Differentiation of Dominant Stenoses from Cancer M. Manns, Germany

04.00 pm

Which is the Ideal Timing for Orthotopic Liver Transplantation? J. Pratschke, Germany

04.15 pm

Managing the Colon in IBD: Proctocolectomy Prior to Orthotopic Liver Transplantation? C. Germer, Germany

04.30 pm

How to Reconstruct the Bile Duct after Orthotopic Liver Transplantation in PSC A. Paul, Germany

Gutenberg-Saal A

Gutenberg-Saal D

Chairs: L. A. Carneiro D‘Albuquerque, Brazil; P. R. Galle, Germany

Watford-Saal

Chairs: M. Lesurtel, France; J. Devar, South Africa 03.45 pm

Symposium 12 Centralisation of HPB Surgery

03.45 pm

The Evidence for Centralisation: Surgeon and Hospital Volume and Outcome D. O‘Reilly, United Kingdom

04.00 pm

The challenge of Centralisation R. Andersson, Sweden

04.15 pm

Benchmarking and Quality Assessment P.-A. Clavien, Switzerland

04.30 pm

Variation in hospital mortality after pancreatoduodenectomy is related to failure to rescue rather than major complications: A nationwide audit L. van Rijssen, M. Zwart, S. Van Dieren, T. De Rooij, B. Bonsing, K. Bosscha, R. van Dam, C. Van Eijck, M. Gerhards, J. Gerritsen, E. Van Der Harst, I. De Hingh, K. De Jong, G. Kazemier, J. Klaase, M. Van Der Kolk, C. van Laarhoven, M. Luyer, I. Molenaar, G. Patijn, C. Rupert, J. Scheepers, G. Van Der Schelling, A. Vahrmeijer, O. Busch, H. Van Santvoort, B. Groot Koerkamp, M. Besselink, Netherlands

05.20 pm


05.20 pm

A Longitudinal Study of Hepatocellular Adenoma Behavior After Oral Contraceptive Pill Cessation M. P. D. Haring, K. P. de Jong, V. E. de Meijer, Netherlands

05.27 pm

Longitudinal Study of Hepatocellular Adenoma Formation and Behavior in Patients With Hepatic GSD M. P. D. Haring, T. C. M. A. Schreuder, M. H. Oosterveer, T. G. J. Derks, V. E. de Meijer, Netherlands

05.34 pm

Superselective Transarterial Chemoembolization as an Alternative to Surgery in Symptomatic / Enlarging Liver Hemangiomas I. Özden, A. Poyanlı, Y. Önal, A. A. Demir, G. Hoş, B. Acunaş, Turkey

05.41 pm

Systematic review of transarterial embolization in the management of hepatocellular Adenomas B. V. van Rosmalen, R. J. Coelen, M. Bieze, O. M. van Delden, J. Verheij, C. H. Dejong, T. M. van Gulik, Netherlands

05.48 pm

Resection of benign liver tumours: An analysis of 62 consecutive cases treated in an academic referral centre C. Kloppers, E. Jonas, J. Krige, M. Bernon, S. Burmeister, S. Beningfield, A. Booth, U. Kotze, South Africa

Chairs: R. Salvia, Italy; W. Uhl, Germany

FP

04.50 pm

Special Lecture 8 Surgical Options in Chronic Pancreatitis with Portal Hypertension and Cavernous Transformation J. Izbicki, Germany

05.05 pm


05.05 pm

Haemoconcentration on admission is a predictor of pancreatic necrosis: The association with BUN rising at 24h predicts severity in acute pancreatitis E. Pando Rau, P. Alberti Delgado, L. Vidal Piñeiro, C. Dopazo Taboada, M. Caralt Barba, L. Blanco Cuso, J. L. Lázaro Fernández, I. Bilbao Aguirre, J. Balsells Valls, R. Charco Torra, Spain

05.12 pm

The role of laparoscopy in the diagnosis and treatment of pancreonecrosis K. Rizaev, B. Altiyev, S. Baymuradov, Uzbekistan

05.19 pm

Combined ultrasound assisted drainage and focused open necrosectomy in the management of sepsis in patients with necrotizing pancreatitis G. Pupelis, V. Fokins, Latvia

05.26 pm

Shaheed Procedure – New surgical technique in the management of chronic calculous pancreatitis S. Rahman, Bangladesh

05.33 pm

Internal pancreatic fistula with pancreatic ascites in chronic pancreatitis: Diagnosis and surgical management Y. Baravik, S. Rashchynski, S. Tretsyak, N. Rashchynskay, Belarus

05.39 pm

Small intestinal bacterial overgrowth in chronic pancreatitis patients with pancreatic exocrine insufficiency: A prospective cohort study H. Ní Chonchubhair, Y. Bashir, M. Dobson, B. Ryan, S. Duggan, K.C. Conlon, Ireland

05.46 pm

New-onset Pancreatogenic Diabetes Mellitus after Pancreatoduodenectomy L. Scholten, T. Mungroop, S. A. L. Haijtink, L. B. van Rijssen, Y. Issa, B. Groot Koerkamp, C. H. van Eijck, O. R. Busch, J. H. DeVries, M. G. Besselink, Netherlands

05.53 pm

Sarcopenia is an independent risk factor for delayed gastric emptying after pancreaticoduodenectomy J. Tankel, E. Vainberg, E. Boaz, A. Dagan, P. Reissman, M. Ben Haim, Israel


03.45 pm

Predicting Outcome of Major Liver Surgery Preoperatively R. Kohnen, E. de Buijzer, Germany

04.00 pm

Patient Checklist of the World Health Organization R. Weckenbrock, Germany

04.15 pm

Back to the Future – The Hybrid OR O. Meissner, Germany

04.30 pm

Novel Training Alternatives for OR Personnel J. Ruppert, Germany

Gutenberg-Saal A

Chairs: T. van Gulik, Netherlands; M. Glanemann, Germany

40

04.50 pm

Special Lecture 7

04.50 pm

Genetic Profiling of Liver Adenoma – Which Adenoma Requires Resection? M.-A. Wörns, Germany

05.05 pm

Surgery for Benign Liver Tumors – Is Less More? S. Dokmak, France

Gutenberg-Saal B

Zagreb-Saal

Chairs: C. Pek, Netherlands; P. Gassmann, Germany 03.45 pm

FP

FP

41



05.05 pm


05.05 pm

Surgical repair for bile duct injuries after cholecystectomy in a tertiary referral center: Long term results E. Panettieri, A. M. De Rose, F. Ardito, A. Coppola, G. Nuzzo, F. Giuliante, Italy

05.12 pm

Percutaneous transhepatic and endoscopic minimally invasive treatment of benign bilioenteric strictures and intrahepatic cholangiolithiasis Y. Arlouski, Belarus

FP

Experimental Porcine Model in Pancreas Transplantation J. Ferrer1, V. Molina1, J.N. Hidalgo1, R. Pujol1, L. Gómez1, P. De la Calle2, M. A. López-Boado1, J. Fuster1, J. C. García-Valdecasas1, 1Spain, 2South Africa

05.43 pm

Does early tracolimus exposure affect long-term outcome in patients treated de novo with once-daily tacrolimus after liver transplantation? M. Gastaca, J. Bustamante, A. Valdivieso, P. Ruiz, A. Ventoso, J. R. Fernandez, I. Palomares, M. Prieto, M. Testillano, P. Salvador, M. Senosiain, A. Matarranz, M. J. Suarez, J. Ortiz de Urbina, Spain

Chairs: S. Breitenstein, Switzerland; U. Cillo, Italy 04.50 pm

Special Lecture 10 Postoperative Complications in Liver Surgery – Impact on Long-term Outcome O. C. Andriani, Argentina

05.05 pm


05.05 pm

First 100 hepatic resections: Short-term outcomes from a low volume centre in a developing country S. Begum, M. R. Khan, Pakistan

Long-term effects and the quality of life following definitive bile duct reconstruction W. Otto, J. Sierdzinski, B. Najnigier, J. Smaga, K. Dudek, K. Zieniewicz, Poland

05.26 pm

Bile duct injuries after minimally invasive and open cholecystectomy – Management, treatment and results in a hepato-biliary center P. Fikatas, R. Harms, R. Öllinger, M. Biebl, M. Bahra, J. Pratschke, S. Chopra, Germany

05.33 pm

Surgical Treatment of Bile Duct Injuries Associated with Cholecystectomy O. Abbasoglu, M. Kerem, S. Hazinedaroglu, A. Dogrul, M. Sare, D. Balci, K. Karayalcin, Turkey

05.12 pm

Prognostic score of 90-day in-hospital mortality after hepatectomy K. Hoffmann, C. Stravodimos, U. Hinz, A. Mehrabi, Germany

05.40 pm

Repair of Major Bile Duct Injuries by Specialist Hepatobiliary Surgeons Results in Fewer Long-Term Biliary Complications and Invasive Procedures J. Halle-Smith, J. Hodson, D. Mirza, K. Roberts, United Kingdom

05.19 pm

05.47 pm

Short and long term outcomes of a Rendezvous prodecure for bile duct injury after laparoscopic cholecystectomy A. M. Schreuder, K. A. Booij, P. R. de Reuver, E. Roos, M. G. Besselink, O. R. Busch, D. J. Gouma, K. P. van Lienden, O. M. van Delden, E. A. Rauws, T. M. van Gulik, Netherlands

A risk score to predict severe posthepatectomy biliary leakage after elective liver resection: A prospective multicenter observational study K. Mohkam, O. Farges, E. Vibert, O. Soubrane, R. Adam, F.-R. Pruvot, J.-M. Regimbeau, M. Adham, E. Boleslawski, J.-Y. Mabrut, ACHBT French Hepatectomy Study Group, France

05.26 pm

05.54 pm

The impact of service reconfiguration on the provision of laparoscopic cholecystectomy for patients admitted with acute gallstone related disorders V. V. Chandrabalan, J. L. Redfern, A. K. Siriwardena, S. Jamdar, A. J. Sheen, United Kingdom

Incidence and management of post-operative bile leaks. A prospective cohort analysis of 467 liver resections M. Bernon, A. Dell, E. Jonas, J. Krige, S. Thomson, S. Beningfield, U. Kotze, S. Tromp, S. Burmeister, P. Bornman, South Africa

05.33 pm

Sphincterotomy with stent may reduce post-operative bile leaks: A randomized controlled trial J. Joneberg, A. Jansson, L. Lundell, C. Strömberg, B. Isaksson, Sweden

05.40 pm

Defining risk factors and outcomes in 537 patients with simultaneous liver and pancreas resection B. Kim, T. Vreeland, C. Davis, N. Narula, M. Kim, M. Katz, J. Lee, J. Fleming, C.-W. D. Tzeng, Y.S. Chun Segraves, C. Conrad, J.-N. Vauthey, T. Aloia, United States

05.47 pm

Portal pressure and somatostatin: Variations and effects after major hepatectomy R. Rhaiem, T. Piardi, A. Cagniet, Y. Renard, R. Kianmanesh, D. Sommacale, France

05.54 pm

The influence of gender on frailty syndrome in surgical patients undergoing major hepatic resections D. Wagner, A. Tomberger, M. Murauer, H. Cerwenka, J. Haybaeck, P. Kornprat, J. Waha, G. Werkgartner, H. J. Mischinger, Austria

04.50 pm

Gutenberg-Saal D

05.36 pm

05.19 pm

Chairs: W. O. Bechstein, Germany; K. Zieniewicz, Poland

42

Gutenberg-Saal D

04.50 pm

Special Lecture 9 Management of Complex Iatrogenic Biliary Injury O. Busch, Netherlands

Key Note Lecture 3 Liver Transplantation – A European Perspective J. Lerut, Belgium

05.20 pm


05.22 pm

Development and results of a novel programme of pancreas transplantation L. Muñoz - Bellvís, M. d. C. Esteban-Velasco, M. Iglesias Iglesias, L. M. GonzalezFernandez, J. I. Gonzalez-Muñoz, J. Quiñones-Sampedro, C. Muñoz-Gonzalez, G. Tabernero, R. A. Iglesias Iglesias, J. M. Sayagués-Manzano, P. Fraile, Spain

05.29 pm

Engineering an endocrine Neo-Pancreas by repopulation of a decellularized rat pancreas with islets of Langerhans B. Struecker, H. Napierala, K. Hillebrandt, N. Haep, P. Tang, M. Tintemann, J. Gassner, M. Nösser, H. Everwien, N. Seiffert, M. Kluge, E. Teegen, D. Polenz, S. Lippert, D. Geisel, A. Reutzel-Selke, N. Rschzok, A. Andreou, J. Pratschke, I. Sauer, Germany

FP

Watford-Saal

Gutenberg-Saal C

Chairs: J. Rystedt, Sweden; K. Søreide, Norway

FP

43

Scientific Programme Wednesday, 24 May, 2017

Notes

KongressSaal

Zagreb-Saal

Chairs: I. Popescu, Romania; M. Kreis, Germany

44

04.50 pm

Special Lecture 11 Minimally Invasive Surgery in Stage IV CRC C. Conrad, United States

05.05 pm


05.05 pm

Optimizing prognostication in patients with synchronous liver metastases from rectal cancer treated according to the liver-first approach M. Nierop, M. Verseveld, B. Galjart, J. Rothbarth, J. Nuyttens, E. van Meerten, J. Burger, D. Grünhagen, C. Verhoef, Netherlands

05.12 pm

Comparative analysis between simultaneous resection and staged resections in patients with synchronous colorectal liver metastases S.T. Alexandrescu, R. Grigorie, A. Diaconescu, C. Zlate, Z. Ionel, S. Dima, V. Brasoveanu, I. Gramaticu, D. Tomescu, I. Popescu, Romania

05.19 pm

Simultaneous Laparoscopic Resection of Colorectal Cancer and Liver Metastases-Initial Experience N. Belev, Bulgaria

05.26 pm

Outcomes of liver-first strategy and classical approach for synchronous colorectal liver metastases in Sweden V. Valdimarson, A. Noren, P. Sandström, G. Lindell, I. Syk, B. Isaksson, M. Rizell, B. Ardnor, C. Sturesson, Sweden

05.33 pm

Simultaneous laparoscopic colorectal and hepatic resection for patients with colorectal cancer and synchronous liver metastases: a multicenter series M. van der Poel1, P. Tanis1, A. Rijken2, E. Gertsen1, M. Gerhards1, M. Besselink1, M. D‘Hondt2, P. Gobardhan1, 1Netherlands, 2Belgium

05.40 pm

Simultaneous resection for synchronous colorectal liver metastases: Are major hepatectomy and / or rectal surgery real contraindications? G. Fallani, M. Ravaioli, M. Serenari, M. Cescon, M. Del Gaudio, A. Cucchetti, V. Bertuzzo, A. Amaduzzi, V. De Pace, A. D. Pinna, Italy

05.47 pm

Intraoperative ultrasound staging for colorectal liver metastases in the era of liver-specific magnetic resonance imaging: Is it still worthwhile? S. Langella, N. Russolillo, S. Perotti, E. Ostuni, F. Forchino, A. Ferrero, Italy

05.54 pm

REsect: Blinded assessment of resectability of previously unresectable colorectal cancer liver metastases following chemotherapy±Y90-RadioEmbolization B. Garlipp1, P. Gibbs2, G. van Hazel2, R. Jeyarajah3, R. Martin3, C. Bruns1, H. Lang1, D. Manas4, G.M. Ettorre5, F. Pardo Sanchez6, V. Donckier7, C. Benckert1, T. van Gulik8, D. Goéré9, M. Schön1, J. Pratschke1, W. Bechstein1, S. Adeyemi1, M. Seidensticker1, 1 Germany, 2Australia, 3United States, 4United Kingdom, 5Italy, 6Spain, 7Belgium, 8 Netherlands, 9France

06.30 pm

Opening Ceremony & Welcome Reception

FP

45

„Chagall Fenster“ | © mainzplus CITYMARKETING GmbH

Thursday, 25 May, 2017 Lovers of the works of Marc Chagall make a pilgrimage to St. Stephan’s Church with its famous blue stained glass windows, unique in Germany. Blue light shines through the stained glass into the interior of St. Stephen’s, and not only angels but other Biblical figures move apparently ethereally in this light. In 1978, the first Chagall window by the then 91-year-old artist was fitted. A further eight followed, six for the east chancel and three in the transept. Marc Chagall, who became an honorary citizen of Mainz, but never got to know the city, completed his final window shortly before his death at the age of 97.



08.00 am

Special lecture 12 The Perfect Sealing Technology for Liver Surgery J. Amaral, United States

08.42 am

Surgery after downstaging of Stage IV pancreatic carcinoma: Are we facing a new scenario? I. Frigerio, P. Regi, A. Giardino, R. Girelli, F. Scopelliti, P. Tinazzi Martini, E. Barbi, A. Pulvirenti, L. Maggino, C. Bassi, G. Butturini, Italy

08.15 am


08.51 am

08.15 am

Evaluation of an augmented reality based image guidance system for laparoscopic liver surgery C. Schneider, S. Thompson, K. Gurusamy, D. Stoyanov, D. J. Hawkes, M. J. Clarkson, B. R. Davidson, United Kingdom

Body composition change during chemotherapy for Borderline Resectable Pancreatic Cancer O. Griffin, R. Ryan, S. Duggan, J. Geoghegan, K. Conlon, Ireland

09.00 am

Nationwide outcomes in patients undergoing surgical exploration without resection for pancreatic cancer L. van der Geest, V. Lemmens, I. de Hingh, K. van Laarhoven, T. Bollen, Y. Nio, C. van Eijck, O. Busch, M. Besselink, Dutch Pancreatic Cancer Group (DPCG), Netherlands

Multivariate analysis of preoperative risk factors for prolonged operating time in laparoscopic liver resection A. Sultana, R. P. Sutcliffe, K. J. Roberts, P. Muiesan, P. Nightingale, R. Marudanayagam, United Kingdom

09.09 am

Radiofrequency ablation of Locally Advanced Pancreatic Cancer: Immunostimulation Patterns A. Giardino, G. Innamorati, R. Girelli, I. Frigerio, P. Regi, F. Scopelliti, S. Paiella, P. Pederzoli, C. Bassi, G. Butturini, Italy

Laparoscopic Glissonian approach is safe and efficient when compared to standard laparoscopic liver resection M. A. Machado1, F. Makdissi1, R. Surjan1, T. Basseres1, E. Schadde2, 1Brazil, 2Switzerland

09.18 am

08.42 am

Cross-sectional imaging, margin status and survival in pancreatic cancer – Proposal of refined criteria for borderline resectable pancreatic cancer U. F. Wellner, K. May, K. Reddemann, J. Knief, L. Frohneberg, H. Lapshyn, D. Bausch, C. Thorns, T. Keck, Germany

08.51 am

Open versus laparoscopic liver resection for colorectal metastases located in the posterosuperior segments D. L. Aghayan, Å. A. Fretland, A. M. Kazaryan, B. A. Bjørnbeth, B. Edwin, Norway

08.33 am

Evaluation of the learning curve for laparoscopic liver resection by risk-adjusted CUSUM analysis using the Iwate difficulty index A. Sultana, P. Nightingale, R. Marudanayagam, R. P. Sutcliffe, United Kingdom

09.00 am

Intention to treat Laparoscopic versus Open Hemihepatectomy: A pair-matched case-control study V. K. Mavroeidis, J. Clark, B. Lemmon, C. Briggs, M. Bowles, D. Stell, S. Aroori, United Kingdom

09.09 am

Is laparoscopic resection for lesions in the posterior segment better than open surgery? J. Li, S. Del pino, L. Fischer, E. Achilles, U. Herden, M. Koch, B. Nashan, Germany

09.18 am

Laparoscopic versus open major hepatectomies: Analysis of surgical outcomes and cost effectiveness in a high-volume centre F. Cipriani, A. Cardella, F. Ratti, G. Fiorentini, M. Catena, M. Paganelli, L. Aldrighetti, Italy

Gutenberg-Saal B

Chairs: J. Schmidt, Switzerland; D. Panchenkov, Russian Federation

48

Chairs: G. Belli, Italy; M. Schmelzle, Germany

Gutenberg-Saal C

Gutenberg-Saal A

08.24 am

FP

Gutenberg-Saal B

Chairs: I. Cameron, United Kingdom; M. Milicevic, Serbia

08.00 am

Special Lecture 14 Laparoscopic Surgery of the Biliary Tract J. Pekolj, Argentina

08.15 am


08.15 am

Quarter century experience of pancreatic surgery in a high volume Center – A SWOT analysis of 2925 consecutive pancreatic resections F. Klein, M. Felsenstein, U. Pelzer, H. Riess, T. Denecke, J. Pratschke, M. Bahra, Germany

08.24 am

Nationwide prospective audit of pancreatic surgery: Design, accuracy, and outcomes of the Dutch Pancreatic Cancer Audit L. van Rijssen, B. Groot Koerkamp, M. Zwart, B. Bonsing, K. Bosscha, R. van Dam, C. Van Eijck, M. Gerhards, E. Van Der Harst, I. De Hingh, K. De Jong, G. Kazemier, J. Klaase, C. van Laarhoven, I. Molenaar, G. Patijn, C. Rupert, H. Van Santvoort, J. Scheepers, G. Van Der Schelling, O. Busch, M. Besselink, Netherlands

08.33 am

The impact of hospital volume and charlson score on postoperative mortality of pancreatic surgery for tumors. A Nationwide Study of 12286 patients M. el Amrani, X. Lenne, G. Clement, C. Laueriere, d. theis, F.-R. Pruvot, S. Truant, France

08.42 am

Postoperative complications and outcomes after pancreatic surgery in the pediatric, adolescent and young adult population B. K. Pranger, V. E. de Meijer, Netherlands

08.00 am

Special Lecture 13 Palliation for Inoperable Pancreatic Cancer N. Habib, United Kingdom

08.15 am


08.15 am

A matched survival analysis of patients treated with neoadjuvant FOLFIRINOX prior to pancreatic surgery: Prognosis changes with downstaging of disease M. Sodergren, G. Brogan, J. Thompson, S. Mudan, A. Khan, United Kingdom

08.24 am

Neoadjuvant therapy decreases rates of local recurrence but not of distant metastasis in pancreatic cancer – A systematic review and meta-analysis S. Schorn, I. E. Demir, G.O. Ceyhan, H. Friess, Germany

08.51 am

Ninety day mortality following pancreatoduodenectomy in England K. Roberts, J. Zhangdaihong, I. Peneva, D. Mirza, R. Savage, P. Moss, F. Envison, United Kingdom

09.00 am

08.33 am

Neoadjuvant Therapy for Borderline Resectable Pancreatic Ductal Adenocarcinoma (PDA) Involving a High Volume Pancreatic Centre in Ireland R. Abdul Rahman, L. Bonanni, S. O‘Sullivan, M. Greally, A. N. Patel, J. McHugh, I. Ismail, S. Alken, D. Maguire, E. Hoti, J. Geogheghan, K. Conlon, M. Moriarty, G. McVey, R. McDermott, Ireland

Volume-outcome effects in pancreatic surgery in Germany – An observational study of hospital discharge data C. Krautz, U. Nimptsch, T. Mansky, R. Grützmann, Germany

FP

FP

49

GutenbergSaal C


09.09 am


Predictors of hospital readmission after pancreaticoduodenectomy: Development of a risk score A. Carvalheiro, K. Mohkam, H. Chidgey, J. Isaac, R. Marudanayagam, D. Mirza, P. Muiesan, K. Roberts, R. Sutcliffe, United Kingdom

Special Lecture 15 Orthotopic Liver Transplantation for CRC Liver Metastases A. Pinna, Italy

08.15 am


08.15 am

Benefits of laparoscopic liver resection in patients with Hepatocellular carcinoma and portal hypertension: A casematched study V. Molina, J. Sampson, C. Muñoz, J. Ferrer, S. Sanchez-Cabus, D. Calatayud, M. Pavel, R. García, C. Fondevila, J. C. García-Valdecasas, J. Fuster, Spain

08.24 am

Hepatectomy with or without the thoraco-abdominal approach: Impact on perioperative outcome A. Mimmo, M. Donadon, D. Cosola, A. Terrone, F. Procopio, D. Del Fabbro, M. Cimino, L. Viganò, G. Torzilli, Italy

08.33 am

Postoperative thrombocytopenia aggravates liver dysfunction after resection of hepatocellular carcinoma in the cirrhotic liver A. M. El-Badry, M. A. Abusedera, H. M. Ali, Egypt

08.42 am

The Albumin-Bilirubin(ALBI) score stratifies short-term and long-term outcomes within Child-Pugh A patients undergoing surgery for HCC M. De Angelis, S. Conci, A. Ruzzenente, T. Campagnaro, F. Bagante, M. Piccino, A. Ciangherotti, R. Ziello, C. Iacono, A. Guglielmi, Italy

08.51 am

Liver transplantation or liver resection for cirrhotic patients with hepatocellular carcinoma: Comparison of long-term survival A. Andreou, F. Krenzien, B. Struecker, N. Raschzok, R. Öllinger, M. Bahra, I. Sauer, A. Pascher, M. Schmelzle, J. Pratschke, Germany

09.09 am

09.18 am

FP

Outcomes of transarterial chemoembolization (cTACE) in elderly patients with non-resectable hepatocellular carcinoma G. Noaro1, 2, H. Ireland2, J. Gordon-Smith2, N. Masson2, A. Adair2, E. Harrison2, E. Fasolo1, S. J. Wigmore2, 1Italy, 2United Kingdom

Watford-Saal

50

First results from the Swedish National Pancreatic and Periampullary Cancer Registry B. Tingstedt, C. Jönsson, S.-O. Bratlie, M. Öman, B. M. Karlson, C. Ansorge, R. Segersvärd, T. Gasslander, Sweden

08.42 am

High grade of neural Invasion is the strongest predictor for local recurrence in pancreatic cancer G. O. Ceyhan, S. Schorn, A. Brock, I. E. Demir, C. Jäger, H. Friess, Germany

08.51 am

Validation of the American Joint Commission on Cancer (AJCC) 8th Staging Edition in Patients with Pancreatic Adenocarcinoma: A SEER Database Analysis S. Kathir Kamarajah1, W. Burns2, T. Frankel2, C. Cho2, H. Nathan2, 1United Kingdom, 2 United States

09.00 am

Results of 27 pancreas-preserving duodenectomies not associated with FAP V. Egorov, R. Petrov, Russian Federation

09.09 am

Fractional uptake of Circulating Tumor Cells across liver-lung compartments during resections of periampullary cancer aimed at cure C. Vilhav, C. Engstrom, P. Naredi, A. Novotny, J. Bourghardt-Fagman, C. Biörserud, B.-M. Iresjö, K. Lundholm, A. Gustafsson-Asting, Sweden

09.18 am

A Reliable and Accurate Algorithm to Quantify the Tumor Stroma (QTS) across Tumor Entities R. C. Miksch, J. Hao, K. Dötzer, F. Schlüter, M. Weniger, S. Ormanns, J. G. D‘Haese, B. Mayer, A.V. Bazhin, J. Werner, M. B. Schoenberg, Germany

Chairs: E. Dixon, Canada; S. Fichtner-Feigl, Germany

Transplantable HCC in resectable cirrhosis – To resect or to transplant? J. Mittler, S. Heinrich, M. Heise, M. Hoppe-Lotichius, G. Otto, R. Klöckner, C. Düber, T. Zimmermann, P.R. Galle, H. Lang, Germany

Chairs: T. A. Buanes, Norway; J. Werner, Germany 08.00 am

Watford-Saal

08.00 am

Zagreb-Saal

Gutenberg-Saal D

Chairs: X. Rogiers, Belgium; E. Hoti, Ireland

08.33 am

08.00 am

Special Lecture 17 The Small Future Liver Remnant – Preoperative Assessment of Liver Function T. van Gulik, Netherlands

08.15 am


08.15 am

Transient elastography is an effective method of predicting posthepatectomy outcomes in patients undergoing hepatectomy for hepatocellular carcinoma M. Rajakannu, D. Cherqui, A. SaCunha, D. Castaing, R. Adam, D. Samuel, E. Vibert, France

08.24 am

Hepatobiliary scintigraphy for risk assessment of posthepatctomy liver failure R. Alikhanov, P. P. Kim, V. V. Tsvirkun, Yu. V. Kulezneva, O. V. Melekhina, L. V. Bondar, N. S. Starostina, B. S. Nikitin, E. V. Vinnickaya, S. G. Khomeriki, M. G. Efanov, Russian Federation

08.33 am

Multicentric evaluation of liver function in ALPPS using hepatobiliary scintigraphy – Liver volume overestimates liver function P. B. Olthof1, P. E. Huespe2, S. Truant3, F. R. Pruvot3, E. Schadde4, R. Axelsson5, E. Sparrelid5, R. J. Bennink1, T. M. van Gulik1, T. M. van Gulik1, 1Netherlands, 2Argentina, 3 France, 4United States, 5Sweden

08.42 am

A Novel Clinical Score Including Future Liver Remnant Volume and Indocyanine Green Retention Test to Predict Post-hepatectomy Liver Failure F. Bagante, A. Ruzzenente, N. Russolillo, A. Dorna, S. Valcanover, S. Langella, T. Campagnaro, S. Conci, F. Bertuzzo, C. Iacono, A. Ferrero, A. Guglielmi, Italy

08.51 am

Sarcopenia affects liver regeneration and postoperative course after a major hepatectomy. A prospective study on 125 patients using HIDA scintigraphy M. Fulbert, M. El Amrani, C. Baillet, A. C. Deshorgue, K. Lecolle, C. Ratajczak, O. Ernst, D. Huglo, F. R. Pruvot, S. Truant, France

Special Lecture 16 Ampullary Cancer: Tumor Differentiation Matters W. Roth, Germany

08.15 am


08.15 am

Pancreatoduodenectomy for pancreatic head and periampullary adenocarcinomas: Outcomes and predictive factors for long-term survival T. S. Chauhan, R. A. Tankshali, India

08.24 am

Spanish National Registry of patients undergoing pancreaticoduodenectomy for periampullary tumors: Effects of hospital volume on outcomes E. Martin-Perez, I. Poves, A. Moya-Herraiz, and Members of the Spanish Association of Surgeons (AEC), Section of Hepatic-Biliary-Pancreatic Surgery, Spain

FP

FP

51

09.00 am

Estimated remnant liver function prior to hepatectomy for CR metastasis is a better predictor of post-hepatectomy liver failure than APRI score T. Chapelle, G. Roeyen, B. Op de Beeck, B. Bracke, V. Hartman, O. Ginghina, D. Ysebaert, S. Francque, Belgium

09.09 am

Search for a new dynamic formula to predict the liver volume: The energy expenditure model M. Donadon, A. Mimmo, G. Costa, M. Morenghi, M. Cimino, L. Viganò, G. Torzilli, Italy

09.18 am

Portal vein embolization with stem cells application for increasing future liver remnant volume in primary non-resectable colorectal liver metastases V. Treska, J. Fichtl, D. Lysak, J. Bruha, P. Duras, V. Liska, J. Finek, Czech Republic

KongressSaal

Chair: C. Dervenis, Greece 09.35 am

Presidential Address E-AHPBA - Can We Make a Difference to Surgical Care in Our Region? M. D. Smith, South Africa

Thursday, 25 May, 2017 Chairs: M. Besselink, Netherlands; K. C. Conlon, Ireland

Gutenberg-Saal B

Zagreb-Saal


10.05 am Coffee Break Chairs: M. Lesurtel, France; A. Siriwardena, United Kingdom 10.30 am

E-AHPBA Prize Paper Session

10.30 am

Preoperative endoscopic versus percutaneous transhepatic biliary drainage in resectable perihilar cholangiocarcinoma: A randomized controlled trial R. Coelen, E. Roos, J. Wiggers, E. Rauws, O. van Delden, K. van Lienden, B. Groot Koerkamp, C. van Eijck, J. de Jonge, R. Porte, C. Buis, C. Dejong, V. van Woerden, D. Gouma, M. Besselink, O. Busch, M. Dijkgraaf, T. van Gulik, Netherlands

52

11.00 am

Early Enteral Versus Total Parenteral Nutrition in Patients Undergoing Pancreaticoduodenectomy: A Randomized Multicenter Controlled Trial (Nutri-DPC) J. Perinel, C. Mariette, B. Dousset, I. Sielezneff, A. Gainant, J. Y. Mabrut, S. Bin Dorel, M. EL Bechwaty, D. Delaunay, L. Bernard, A. Sauvanet, M. Pocard, E. Buc, M. Adham, France

11.15 am

No Need for Routine Drainage After Pancreatic Head Resection: The Dual Center Randomized Controlled PANDRA-Trial (ISRCTN04937707) M. K. Diener, S. Kissenkötter, T. Bruckner, B. Werner, O. Pridöhl, O. RadulovaMauersberger, H. Lauer, P. Knebel, O. Strobel, T. Hackert, A. Ulrich, A. Ulrich, M. W. Büchler, H. Witzigmann, Germany

11.30 am

Adjuvant chemotherapy did not improve gallbladder cancer prognosis C. Bouzid, M. Kheloufi, A. Salmi, C. Sedkaoui, K. Cherchar, M. Boubnider, N. Smail, K. Bentabak, Algeria

11.45 am

SA Randomized Controlled Trial of Postoperative Thoracic Epidural Analgesia Versus Intravenous Patient Controlled Analgesia after Major HPB Surgery T. Aloia, B. Kim, Y. S. Chun Segraves, J. Cata, M. Truty, A. Holmes, J. Soliz, K. Popat, D. Kennamer, T. Rahlfs, J. Lee, V. Gottumukkala, J.-N. Vauthey, United States

11.00 am


11.00 am

Laparoscopic doudenopancreatectomy (LPD) – Our approach. How to do it? N. Belev, Bulgaria

11.10 am

Laparoscopic pancreaticoduodenectomy with reconstruction of the mesentericoportal vein with the falciform ligament S. Dokmak, B. Aussilhou, F. S. Fteriche, A. Sauvanet, France

11.20 am

Robotic pancreaticoduodenectomy – Initial experience in Germany H. Aselmann, J.-H. Egberts, T. Becker, Germany

11.30 am

Laparoscopic anterior RAMPS for pancreatic ductal adenocarcinoma A. Manzoni, G. Zimmitti, F. Guerini, V. Sega, C. Codignola, M. Garatti, E. M. Rosso, Italy

11.40 am

Laparoscopic multivisceral distal pancreatectomy S. Barbaro, G. Spoletini, N. Siddiqi, L. Tanno, M. Fontana, M. Abu Hilal, United Kingdom

11.50 am

Robotic Pancreaticoduodenectomy S. Shrikhande, India

FV

Gutenberg-Saal C

10.30 am

Symposium 14 Strategies for the Expansion of the Donor Pool

10.30 am

The Use of Marginal Livers S. Nadalin, Germany

10.45 am

Split and Reduced Graft OLT X. Rogiers, Belgium

11.00 am

Warm vs. Cold Split for OLT C. Toso, Switzerland

11.15 am

Preclinical Results of Perfusion Techniques P. Dutkowski, Switzerland

11.30 am

Evaluation of Safety of Concomitant Splenectomy in Living Donor Liver Transplantation A. Badawy, Japan and Egypt

11.40 am

Boehringer Ingelheim Foundation Grant Discussion T. Becker, Germany

Chairs: C. Werner, Germany; C. Sturesson, Sweden

Gutenberg-Saal D

Gutenberg-Saal A

10.45 am

Update 2 IHPBA 2016 Consensus on Minimally Invasive Pancreas Cancer Surgery U. Boggi, Italy

Chairs: I. Klein, Germany; S. Gruttadauria, Italy

Minimally invasive versus open distal pancreatectomy for ductal adenocarcinoma (DIPLOMA): A pan-European propensity score matched study

J. van Hilst1, T. de Rooij1, S. Klompmaker1, M. Rawashdeh2, F. Aleotti3, B. Al-Sarireh2, A. Alseidi4, Z. Ateeb5, G. Balzano3, F. Berrevoet6, B. Björnsson5, U. Boggi3, O. Busch1, G. Butturini3, R. Casadei3, M. del Chiaro5, F. Cipriani2, R. van Dam1, I. Damoli3, S. Dokmak7, B. Edwin8, C. van Eijck1, J. Fabre7, M. Falconi3, O. Farges7, L. Fernández-Cruz9, A. Forgione3, I. Frigerio3, D. Fuks7, F. Gavazzi3, B. Gayet7, A. Giardino3, B. Groot Koerkamp1, T. Hackert10, M. Hassenpflug10, I. Kabir2, T. Keck10, I. Khatkov11, A. Klock10, M. Kusar12, C. Lombardo3, G. Marchegiani3, R. Marshall4, K. Menon2, M. Montorsi3, N. Nowbray2, M. Orville7, A. Pietrabissa3, I. Poves9, J. Primrose2, R. Pugliese3, C. Ricci3, K. Roberts2, B. Røsok8, M. Sahakyan8, S. Sánchez-Cabús9, P. Sandström5, L. Scovel4, L. Solaini3, Z. Soonawalla2, R. Souche7, R. Sutcliffe2, G. Tiberio3, A. Tomazic12, R. Troisi6, U. Wellner10, S. White2, U. Wittel10, A. Zerbi3, C. Bassi3, M. Besselink1, M. Abu Hilal2, for the European Consortium on Minimally Invasive Pancreatic Surgery (E-MIPS)1, 1Netherlands, 2United Kingdom, 3Italy, 4United States, 5Sweden, 6 Belgium, 7France, 8Norway, 9Spain, 10Germany, 11Russian Federation, 12Slovenia

10.30 am

10.30 am

Symposium 15 Perioperative Management in HPB Surgery

10.30 am

Preoperative Risk Assessment before Liver Surgery S. Breitenstein, Switzerland

10.45 am

HPB Surgery in the Patient with Anticoagulation Therapy – Management and Prevention of Bleeding Complications S. Heinrich, Germany

11.00 am

Improving Patient Outcome by Perioperative Nutrition? A. Weimann, Germany

11.15 am

Lactate and Liver Enzymes as Predictors for the Postoperative Course E. Vibert, France

53

11.37 am

If you want to know the best anesthetic plan for liver surgery, just ask the patient: Comparative assessment of 174 patient-reported outcomes B. Kim, R. Day, N. Narula, C. Davis, C.-W.D. Tzeng, Y.S. Chun Segraves, C. Conrad, J.-N. Vauthey, V. Gottumukkala, T. Aloia, United States

11.44 am

Efficacy and safety of pharmacological venous thromboembolism prophylaxis following liver resection: A systematic review and meta-analysis M. Baltatzis, P. Stathakis, A. Sheen, A. Siriwardena, S. Jamdar, United Kingdom

11.51 am

Perioperative blood transfusion is associated with poor long-term survival in among patients with pancreatic adenocarcinoma T. Abe, H. Amano, K. Hanada, J. Ikemoto, N. Fujikuni, H. Okuda, A. Okazaki, T. Minami, S. Yonehara, T. Fukuda, M. Nakahara, T. Noriyuki, Japan

10.30 am

Key Note Lecture 4 CRLM: Consequences of Molecular Profiling on Surgery J.-N. Vauthey, United States

11.00 am

Symposium 13 Management of CRC Metastases 1

11.00 am

Extent of CRC Liver Metastases at Diagnosis: How Does it Influence the MDT Decision? T. Gruenberger, Austria

11.15 am

Conversion of CRC Liver Metastases – Myth or Reality? A Medical Oncology Perspective G. Folprecht, Germany

11.30 am

Synchronous Metastasized Colon or Rectal Cancer: Is there a Difference? A Treatment Algorithm C. Verhoef, Netherlands

11.45 am

Surgical Options in Responding CRC Liver Metastases: Advanced Liver Surgery. Is there an Indication for Tumor Debulking? R. Adam, France

FP

Watford-Saal

Pancreas exocrine replacement therapy is associated with increased survival following pancreatoduodenectomy for periampullary malignancy K. Roberts, J. Hodson, R. Angelico, B. Dasari, R. Marudanayagam, R. Sutcliffe, P. Muiesan, J. Isaac, D. Mirza,United Kingdom

10.30 am

Update: Image-Guided and Computer-Assisted Percutaneous Liver Interventions P. Wiggermann, Germany

10.40 am

New Perspectives on Planning and Navigation in Laparoscopic Liver Resection B. Edwin, Norway

10.50 am

Laparoscopic CAS-guided IRE of locally advanced pancreatic cancer J. Freedman; H. Nilsson; E. Jonas, Sweden

11.00 am

Augmented Liver Surgery: Combining image Guidance and Computer Science S. Cotin, France

11.10 am

Ultrasound-based navigation in laparoscopic soft tissue surgery R. Mårvik; T. Lango, Norway

11.20 am

Updates on minimally invasive liver navigation techniques from Bern P. Tinguely; S. Weber; D. Candinas, Switzerland

11.40 am

Development and First Results of a Perfusion Model of Resected Whole Livers and Partial Liver Resection Specimens to Optimize Predictability of Ablation Zones During Ex-situ CT-guided Thermoablation S. J. S. Ruiter; K. P. de Jong, Netherlands

10.30 am


10.30 am

Coordination of Diagnostics and Treatment for Patients with Klatskin Tumor A. Schoorlemmer, Netherlands

10.45 am

Management of Percutaneous Transhepatic Biliary Drainage Catheters for Patients with Obstructive Jaundice C. Pek, Netherlands

11.00 am

Enhanced Perioperative Care in Elective Liver and Pancreas Surgery L. Corpelijn, Netherlands

11.15 am

Optimisiation of Treatment and Quality of Life in Patients with Exocrine Pancreatic Insufficiency after Pancreatic Resection A. Roele, Netherlands

11.30 am

Postoperative Nutrition after Pancreatic and Biliary Surgery N. Tintel, Netherlands

11.45 am

Technical Notes of Pancreas Surgery for Chronic Pancreatitis and Pancreatic Cancer S. Heinrich, Germany

12.10 pm 01.00 pm

Free Poster Sessions 21-30 Page: 95

12.40 pm 01.30 pm


Chairs: M. Abu Hilal, United Kingdom; R. Alikhanov, Russian Federation

Gutenberg-Saal A

Watford-Saal

54

5th ECALSS meeting

An Augmented Reality Image Guidance System for Laparoscopic Liver Resection – Surgical perception of Benefits and Limitations C. Schneider, United Kingdom


Chairs: H. Nilsson, Sweden; D. Candinas, Switzerland 10.30 am

11.30 am

Chairs: J. Ruppert, Germany; F. Corvinus, Germany

Zagreb-Saal

11.30 am

Chairs: G. Torzilli, Italy; M. Möhler, Germany

Kongress-Saal


Poster Area

Gutenberg-Saal D


01.30 pm


01.30 pm

Totally Laparoscopic ALPPS Procedure and Extended Right Liver Resection M. R. Schön, Germany

01.40 pm

Anatomical challenges during laparoscopic right hepatectomy after Right Portal Vein embolisation E. Kontis, M. Papoulas, S. Abdul-Hamid, O. Hadjicosta, Y. Kumar, N. Heaton, K. MenonUnited Kingdom

01.50 pm

Laparoscopic right hepatectomy after portal vein ligation: Second step of two stage hepatectomy for colorectal liver metastases R. Lo Tesoriere, N. Russolillo, S. Langella, F. Forchino, S. Perotti, A. Ferrero, Italy

02.00 pm

Laparoscopic posterior sectionectomy for HCC A. Laurenzi, D. Cherqui, France

02.10 pm

Laparoscopic caudate lobe resection for hepatocellular carcinoma in cirrhosis A. Ruzzenente, S. Conci, A. Ciangherotti, C. Iacono, A. Guglielmi, Italy

FV

55


02.20 pm

Fully laparoscopic resection of segment VII: Tips and tricks M. Tedeschi, C. Mini, D. Cherqui, France

02.30 pm

Laparoscopic hemihepatectomy – Benefits of hand-assisted and hybrid techniques M. Schmelzle, J. Pratschke, Germany

02.40 pm

Laparoscopic right hepatectomy for fibrolamellar HCC A. Laurenzi, D. Cherqui, A. Sa Cunha, France

GutenbergSaal D

Gutenberg-Saal A


01.30 pm

Managing the Pancreatic Leak R. Salvia, Italy

01.45 pm

Management of Vascular (Arterial and Venous) Complications and Pseudoaneurysms in Pancreatic Surgery – Role of Radiology C. Düber, Germany

02.00 pm

Management of Vascular Complications and Hepatic Necrosis after Pancreas Surgery – Role of Surgery W. T. Knoefel, Germany

02.15 pm

Prevention / Treatment of Bile Leak after Liver Surgery P. Lodge, United Kingdom

02.30 pm

Liver Failure after Hepatectomy R. Deshpande, United Kingdom

Kongress-Saal

Gutenberg-Saal B

01.30 pm

Symposium 19 Ongoing Research in the E-AHPBA: Update from the Research Committee

01.30 pm

What is the Place of the Scientific & Research Committee in the E-AHPBA? M. Lesurtel, France

01.45 pm

How to Organize Surgical Trials Across Borders? M. M. Erkan, Turkey

02.00 pm

Why Multicenter has been Highly Successful in the Netherlands? M. Besselink, Netherlands

02.15 pm

Reports of the Multicenter Collaborative Retrospective Studies from the E-AHPBA Scientific & Research Committee S. Klompmaker, Netherlands; C. Sturesson, Sweden

02.30 pm

Worldwide trends in volume and quality of published protocols of randomized controlled trials B. V. van Rosmalen1, I. Alldinger2, K. P. Cieslak1, R. Wennink1, M. Clarke3, U. Ahmed Ali1, M. G. Besselink1, 1Netherlands, 2Germany, 3Ireland

Watford-Saal

Gutenberg-Saal C

01.30 pm

FP

02.00 pm

Optimal Recipient and Donor Characteristics for LDLT I. Özden, Turkey

01.30 pm

Symposium 17 German Surgical Society / Japanese Surgical Society Joint Session: Hilar Cholangiocarcinoma

01.30 pm

Hilar Cholangiocarcinoma: Mode of Tumor Growth and Metastatic Spread, New Molecular Insights C. Wittekind, Germany

01.50 pm

Bile Duct Anatomy and Preoperative Management of Hilar Cholangiocarcinoma: When and How to Drain? Y. Nimura, Japan

02.10 pm

Hilar en-Bloc Resection as an Oncological Principle U. P. Neumann, Germany

02.30 pm

Key Note Lecture 6 Surgical Treatment of Hilar Cholangiocarcinoma – Where are the Limits? M. Nagino, Japan

01.30 pm

5th ECALSS meeting

01.30 pm

Multiple Ablations for Widespread Colorectal Liver Metastasis – An Update J. Freedman; H. Nilsson; E. Jonas, Sweden

01.40 pm

Adherence to Manufacturers’ Protocols of Thermoablation: Is Applied Energy Related to Ablation Zone Volume? W. J. Heerink; K. P. de Jong, Netherlands

01.50 pm

Navigated Liver Surgery – Experiences, Limitations and Indications T. Huber; H. Lang, Germany

02.00 pm

The Future of Liver Surgery? Augmented Reality and Fluorescent-guided Anatomic Resection C. Conrad, United States

02.10 pm

Annual Meeting of the ECALSS Society

Chairs: J. Pekolj, Argentina; S. Shrikhande, India

Gutenberg-Saal A

Gutenberg-Saal D

56

02.00 pm

Symposium 18 Session of the National Turkish Chapter | Living Donor Liver Transplantation: “A Turkish Perspective”

Results of LDLT in Turkey S. Yilmaz, Turkey

03.00 pm Coffee Break

Chairs: O. Abbasoglu, Turkey; M. Malago, United Kingdom 01.30 pm

02.40 pm

Chairs: J. Freedman, Sweden; C. Conrad, United States

Chairs: C. Dejong, Netherlands; M. Lesurtel, France

Key Note Lecture 5 The Evolution of Living-Related Liver Transplantation C. E. Broelsch, Germany

Living Donor Hepatectomy Y. Yankol, Turkey

Chairs: H.-J. Meyer, Germany; J. Pratschke, Germany; Y. Yamamoto, Japan

Chairs: R. Grützmann, Germany; P. Jagannath, India Symposium 16 Management of Complications in HPB Surgery

02.20 pm

03.30 pm


03.30 pm

Laparoscopic repair of post-cholecystectomy bile duct injury S. Dokmak, B. Aussilhou, F. Cauchy, J. Belghiti, A. Sauvanet, O. Soubrane, France

03.40 pm

Video Choledochoscopy: A renaissance of an old technique? H. Neeff, P. Holzner, S. Lang, S. Fichtner-Feigl, Germany

03.50 pm

Robot-assisted resection of a Type I choledochal cyst and Roux-en-Y hepaticojejunostomy O. Mownah, B. Visser, United Kingdom

FV

57

04.00 pm

Laparoscopic Lymphadenectomy for Intrahepatic Cholangiocarcinoma: Still a Contraindication to Surgery? G. Fiorentini, F. Ratti, F. Cipriani, D. Palombo, M. Catena, M. Paganelli, L. Aldrighetti, Italy

04.10 pm

Totally laparoscopic radical resection for incidental gallbladder cancer C. Muñoz, C. Marion V. Molina, Chile and Spain

04.20 pm

Roux-en-Y hepaticojejunostomy using 3D laparoscope W. C. Dai, T. T. Cheung, C. M. Lo, Hong Kong

Gutenberg-Saal B

Chairs: H. Witzigmann, Germany; C. Bassi, Italy 03.30 pm

Symposium 20 Management of IPMN

03.30 pm

Consequences of the Sendai Criteria for the Management of Patients with IPMN M. Falconi, Italy

03.45 pm

Assessment of the Resection Margin – Value of Frozen Sections C. Wittekind, Germany

04.00 pm

Surgical Options for Benign Pancreatic Lesions M. Adham, France

04.15 pm

Biomarkers, Imaging and Multifocality in IPMN – Relevant for Decision-Making? D. Ansari, Sweden

Thursday, 25 May, 2017 Chairs: A. Guglielmi, Italy; S. A. Lang, Germany

Watfor-Saal

Gutenberg-Saal A


03.30 pm

Symposium 23 Gallbladder Cancer

03.30 pm

Extent of Local Resection for Proven Gallbladder Cancer W. Jarnagin, United States

03.45 pm

Treatment of Patients with Accidental Gallbladder Cancer L. Lundgren, Sweden

04.00 pm

Surgery for Locally Advanced Biliary Cancer. T4 Gallbladder Cancer – Still a Surgical Candidate? P. Jagannath, India

04.15 pm

Special Lecture 18 Value of Lymph Node Dissection in Cholangiocarcinoma F. Giuliante, Italy

Chairs: A. Ferrero, Italy; T. Steinmüller, Germany 04.35 pm

Special Lecture 19 Resection of Mesenchymal Tumors of the Liver and the IVC / Portal Vein P. Lodge, United Kingdom

04.50 pm


04.50 pm

Primary malignant mesenchymal tumors of the liver and the inferior Vena cava: A rare tumor entity V. Tripke, T. Huber, M. Heise, S. Heinrich, H. Lang, Germany

04.57 pm

Vascular reconstruction in patients with perihilar and intrahepatic cholangiocarcinoma R. Alikhanov, M. G. Efanov, I. V. Kazakov, P. P. Kim, A. N Vankovich, Russian Federation

05.04 pm

Venous reconstruction with the parietal peritoneum – The long term results in 90 patients S. Dokmak, B. Aussilhou, R. Chérif, L. Barbier, F. Cauchy, J. Belghiti, O. Soubrane, A. Sauvanet, France

05.11 pm

Meta-analysis of concurrent hepatectomy with extrahepatic bile duct resection in hepatocellular carcinoma patients with bile duct tumor thrombi X. Shi, H. Fu, T. Ruan, S. He, L. Xu, C. Liu, China

05.18 pm

Domino compensation of the external iliac vein using an ePTFE graft after its procurement for portal vein reconstruction in pancreatic surgery Y. Yamamoto, M. Yoshioka, H. Uchinami, G. Watanabe, M. Iida, Y. Nakagawa, H. Miyazawa, Japan

05.25 pm

Multiple artery-first approach combined with a C-form resection in radical antegrade modular pancreatoduodenectomy Y.-F. Cui, Z.-D. Wang, K.-M. Leng, China

05.32 pm

Arterial reconstruction due to intraoperative arterial injury or arterial tumor involvement during pancreatectomy – Single centre experience in 35 cases D. Kleive, M. Sahakyan, B. Edwin, B. Fosby, P. D. Line, K. J. Labori, Norway

05.39 pm

Why we don’t need hepatic artery reconstruction during DP-CAR? Experience of 20 modified Appleby procedures V. Egorov, R. Petrov, N. Starostina, T. Zhurenkova, M. Petukhova, J. Zhurina, M. Grigorievsky, Russian Federation

03.30 pm

Symposium 21 HPB Surgery in Portal Hypertension

03.30 pm

Pancreatic Surgery in Patients with Liver Cirrhosis / Portal Hypertension P. Bachellier, France

03.45 pm

Laparoscopic Approach to Portal Hypertension I. I. Dzidzava, Russian Federation

04.00 pm

Laparoscopic Liver Surgery in Patients with Liver Cirrhosis and Portal Hypertension D. Cherqui, France

04.15 pm

TIPSS as Rescue Prior to Major HPB Surgery D. Azoulay, France

Gutenberg-Saal D

Chairs: I. Özden, Turkey; P. Schemmer, Austria

58

03.30 pm

Symposium 22 The Complicated Donor

03.30 pm

Viral Hepatitis Infection – A Contraindication for (Liver) Donation? T. Zimmermann, Germany

03.45 pm

Balancing Risks – How to Match Donor and Recipient? P. Dutkowski, Switzerland

04.00 pm

Domino OLT in Amyloidosis: Problems for the Recipient J. P. Pereira, Portugal

04.15 pm

Ex-house Reanimation – The Spanish Experience R. Garcia, Spain

Gutenberg-Saal A

Gutenberg-Saal C

Chairs: J. Kalff, Germany; B. Kotiv, Russian Federation

FP

59



Chairs: A. Frilling, United Kingdom; G. Ceyhan, Germany


04.50 pm

Pseudopapillary Solid Neoplasms of the Pancreas A. B. Mendes Caldeira, C. Fernandes, T. Machado, M. Oliveira, R. Bessa Melo, L. Graça, J. Costa Maia, M. Almeida, Portugal

04.57 pm

Prognostic factors in non-functional neuroendocrine tumors of the pancreas in a 70 patients series F. Sánchez-Bueno, J. M. Rodriguez, J. De la Peña, E. Ortiz, M. Fuster, L. Frutos, P. Gil, A. Gomez, P. Parrilla, Spain

05.04 pm

Surgical Treatment of Pancreatic Tumors in Children A. Lukashenko, Ukraine

05.11 pm

Pancreatic Neuroendocrine Tumors: Selection and Approach in Surgical Treatment – Single center experience A. Kriger, A. Kaldarov, S. Berelavichus, D. Gorin, Russian Federation

05.18 pm

Pancreatic neuroendocrine tumours (PNETs): Surgical management & factors influencing survival in a multicentre, national study (ACO-ASSO PNET STUDY) F. Primavesi, E. Klieser, K. Marsoner, B. Cardini, U. Fröschl, I. Fischer, R. Urbas, T. Kiesslich, D. Neureiter, H. Wundsam, R. Függer, F. Cakar-Beck, P. Kornprat, S. Stättner, Austria

05.25 pm

FP

Gutenberg-Saal C

04.57 pm

Novel TRAIL-based Therapies for Pancreatic Cancer J. Lemke, A.-L. Kretz, U. Knippschild, H. Walczak, D. Henne-Bruns, Germany

05.04 pm

Development and preclinical validation of an Integrin αvβ6-targeting imaging agent for near-infrared fluorescent-guided surgery in pancreatic cancer W. Tummers1, R.-J. Swijnenburg2, R. Kimura1, L. Abou-Elkacem1, A. Vahrmeijer2, J. Willmann1, S. S. Gambhir1, 1United States, 2Netherlands

05.11 pm

Quantitative proteonomics confirms microRNA targets in pancreas cancer to explain why cetuximab has limited efficacy in prolonging patient survival M. Brand1, E. E. Nweke1, L. Zhou2, C. He2, M. Majole1, G. Candy1, 1South Africa, 2Singapore

05.18 pm

Genetic polymorphisms of interleukin 1β and TNF-α genes and their influence on sporadic pancreatic neuroendocrine tumors predisposition risks D. Karakaxas1, M. Gazouli1, P. Patapis1, T. Liakakos1, A. Coker2, C. Agalianos1, I. Papanikolaou1, A. Sioziou1, G. Aravantinos1, C. Dervenis1, 1Greece, 2Turkey

05.25 pm

Modeling early genomic events of pancreatic cancer using CRISPR / Cas 9 M. Felsenstein, A. Rizzo, M. Skaro, J. R. Eshleman, C. M. Heaphy, N. J. Roberts, R. H. Hruban, L. D. Wood, United States

05.32 pm

Expression of Tn antigen promotes pancreatic carcinogenesis in a transgenic mouse model B. Mercanoglu, C. Güngör, J. R. Izbicki, M. Bockhorn, G. Wolters-Eisfeld, Germany

Chairs: A. Schnitzbauer, Germany; D. Azoulay, France

Pancreaticoduodenectomy for Pancreatic Neuroendocrine Neoplasms: Incidence, Risk and Predictors of Postoperative Morbidity and Mortality D. Tamburrino1, 2, S. Partelli2, R. Cherif3, F. Muffatti2, S. Gaujoux3, A. Sauvanet3, M. Falconi2, G. K. Fusai1, 1United Kingdom, 2Italy, 3France

05.32 pm

Management of neuroendocrine tumors in the Netherlands C. Genc, T. Mackay, M. van Oijen, H.-J. Klumpen, E. Nieveen van Dijkum, Netherlands

05.39 pm

Prognosis of sporadic resected small (≤ 2 cm) nonfunctional pancreatic neuroendocrine tumors – A multi-institutional study V. Sallinen1, T. Le Large2, E. Tieftrunk3, S. Galeev4, Z. Kovalenko4, S.-P. Haugvik5, A. Antila1, O. Franklin6, E. Martinez-Moneo7, S. Robinson8, F. Panzuto9, N. Regenet10, F. Muffatti9, S. Partelli9, D. Wiese3, P. Ruszniewski10, B. Dousset10, B. Edwin5, D. Bartsch3, A. Sauvanet10, F. Massimo9, G. Ceyhan3, S. Gaujoux10, 1Finland, 2Netherlands, 3Germany, 4 Russian Federation, 5Norway, 6Sweden, 7Spain, 8United Kingdom, 9Italy, 10France

Chairs: O. Strobel, Germany; G. L. Grazi, Italy

60

Gutenberg-Saal C

04.50 pm

04.35 pm

Special Lecture 21 Neoadjuvant Therapy for Pancreatic Cancer – Definitions and Effects S. Heinrich, Germany

04.50 pm


04.50 pm

Biperiden and Mepazine inhibit MALT1 paracaspase activity and tumor growth in pancreatic cancer A. El Gammal, L. Konczalla, N. Scholz, C. Klemp, J. Lüdekke, A. Wolski, D. Landschulze, C. Meier, A. Buchholz, D. Yao, G. Wolters-Eisfeld, B.T. Hofmann, J.-K. Baukloh, S. L. Spriestersbach, K. Grupp, U. Schumacher, C. Betzel, S. Kapis, T. Nuguid, P. Steinberg, K. Püschel, G. Sauter, K. Bachmann, F. G. Uzunoglu, J. R. Izbicki, C. Güngör, D. R. Perez, Germany

FP

Gutenberg-Saal D

Gutenberg-Saal B

04.35 pm

Special Lecture 20 Rare Pancreatic Tumors (Acinus-Cell-Ca, Sarcoma, Frantz-Tumor) and Pancreatic Metastases J. Kalff, Germany

04.35 pm

Special Lecture 22 Current Status of Liver Preservation – Why and how to Perfuse the Liver T. Minor, Germany

04.50 pm


04.50 pm

Logistic regression analysis of NK and T-cell content isolated from liver perfusate after procurement procedures in donors after brain death D. Pagano, E. Badami, P. Conaldi, F. Di Francesco, A. Tropea, A. Casu, I. Petridis, F. Tuzzolino, G. Vizzini, A. Luca, S. Gruttadauria, Italy

04.57 pm

Normothermic Machine Perfusion Using an Air / Oxygen Mixer: Reconditioning a Marginal Donor Liver F. Di Francesco, P. Bonsignore, G. Martucci, D. Pagano, D. Cintorino, R. Liotta, A. Arcadipane, R. Volpes, A. Luca, S. Gruttadauria, Italy

05.04 pm

Effects of different remote ischemic conditioning protocols in a rat model of arterialized orthotopic liver transplantation Z. Czigany1, C. Bleilevens1, M. Möhring1, C. Beckers1, A. Fulop2, A. Szijarto1, U. P. Neumann1, R. Tolba1, 1Germany, 2Hungary

05.11 pm

Impact of a National Controlled Donation After Circulatory Death (DCD) Programme on Organ Donation: A 10 Year Study R. Hodgson, A. Young, M. Attia, P. Lodge, United Kingdom

05.18 pm

The impact of individual Extended Donor Criteria on short- and long-term outcome after liver transplant in the MELD-score era V. J. Lozanovski, E. Khajeh, C. W. Michalski, H. Fonouni, R. von Haken, M. Mieth, J. Pfeiffenberger, K. H. Weiss, A. Mehrabi, Germany

05.25 pm

Monocentric Experience on Hepatitis C-Positive Deceased Liver Donors Procurement in the Mediterranean Basin D. Pagano, A. Seidita, A. Tropea, D. Cintorino, G. Pietrosi, F. Di Francesco, G. Vizzini, A. Luca, S. Gruttadauria, Italy

FP

61

Gutenberg-Saal D

Scientific Programme 05.32 pm

Pancreas retrieval for solid organ transplantation A. Laurenzi, G. Pittau, O. Ciacio, M. Tedeschi, N. Golse, B. Trechot, A. Sa Cunha, France

05.39 pm

Pancreas Transplantation: A retroperitoneal graft placement J. Ferrer, S. Espinoza, V. Molina, R. Rull, M.A. López-Boado, S. Sanchez, J. Fuster, J. C. García-Valdecasas, Spain


FV

Special Lecture 23 Mechanism of Liver Regeneration S. Olde Damink, Netherlands

04.50 pm


04.50 pm

Portal vein embolization does not result in microvascular flow differences between the embolized and non-embolized liver lobes Z. Uz, C. Ince, T. M. van Gulik, Netherlands

04.57 pm

Description of an experimental model of two-stage hepatectomy in different extents of cholestasis B. Richter, F. Mussbach, H. Scheuerlein, C. Sänger, U. Settmacher, U. Dahmen, Germany

05.04 pm

The absence of the adaptor proteins CARDIF / STING negatively regulates the proliferation of liver regeneration after partial hepatectomy in mice D. Hartmann1, S. Schulze1, M. Lu1, 2, B. Holzmann1, H. Friess1, N. Hüser1, 1 Germany, 2China

FP Zagreb-Saal

04.35 pm


04.50 pm

Laparoscopic liver resections for hepatocellular carcinoma. Can we extend the surgical indication in cirrhotic patients? F. Cipriani1,2, C. Fantini1, F. Ratti1, R. Lauro1, H. Tranchart3, M. Halls2, V. Scuderi4, L. Barkhatov5, B. Edwin5, R. Troisi4, I. Dagher3, P. Reggiani1, G. Belli1, L. Aldrighetti1, M. Abu Hilal2, F. Cipriani1, 1Italy, 2United Kingdom, 3France, 4Belgium, 5Norway

04.57 pm

Laparoscopic liver resection Versus Transarterial Chemoembolization for Hepatocellular Carcinoma in Child B cirrhosis: A propensity score analysis F. E. D‘Amico, E. Fasolo, D. Bassi, A. Furlanetto, M. Polacco, R. Boetto, G. Noaro, G. Zanus, A. Vitale, E. Gringeri, F. Farinati, U. Cill, Italy

05.04 pm

The role of liver resection in patients with intermediate and advanced stage hepatocellular carcinoma. Retrospective study from two Greek HPB centers G. Glantzounis, A. Paliouras, A. Papalambros, S. Davakis, V. Tatsi, D. Kyrochristos, E. Felekouras, Greece

05.11 pm

Multivisceral resection in locally advanced hepatocellular cancer I. Mohr, M. Hoppe-Lotichius, S. Heinrich, G. Otto, M. Heise, P. R. Galle, H. Lang, J. Mittler, Germany

05.18 pm

Curative Intent Treatment of Hepatocellular Carcinoma- 737 Cases in a Surgical Department R. Grigorie, S. Alexandrescu, Z. Ionel, D. Hrehoret, V. Brasoveanu, S. Dima, N. Picu, G. Moisa, R. Zamfir, L. David, F. Botea, D. Tomescu, I. Lupescu, M. Grasu, R. Dumitru, M. Toma, A. Croitoru, V. Herlea, C. Pechianu, I. Popescu, Romania

05.25 pm

Laparoscopic liver resection for hepatocellular carcinoma: A Single Center experience of more than 100 cases G. B. Levi Sandri, M. Colasanti, P. Lepiane, G. Vennarecci, G. M. Ettorre, Italy

FP

05.11 pm

Gene expression in the liver remnant is significantly affected by the size of partial hepatectomy – An experimental rat study A. R. Knudsen, Denmark

05.32 pm

05.18 pm

ALPPS „Associating Liver Partition with Portal Vein Ligation for Staged Hepatectomy“ (ALPPS) does not promote colorectal tumor growth P. Kambakamba1, M. Linecker1, C. Reiner1, T. D. L. Nguyen Kim1, P. Limani1, I. Romic2, J. Figueras3, H. Petrowsky1, P. A. Clavien1, M. Lesurtel1, 1Switzerland, 2Croatia, 3Spain

External validation of the “ALICE” prediction model for long- and short-term outcomes in resected HCC patients: Results from a western cohort N. Russolillo, F. Forchino, S. Conci, C. Mele, S. Langella, A. Ruzzenente, I. Scoleri, F. Giuliante, A. Guglielmi, Italy

05.25 pm

A new technique for accelerated liver regeneration – An experimental study in rats K. J. Andersen, A. R. Knudsen, B. N. Jepsen, M. Meier, A. P. A. Gunnarsson, U. B. Jensen, J. R. Nyengaard, S. Hamilton-Dutoit, F. V. Mortensen, Denmark

05.39 pm

Results of surgical treatment of hepatocellular carcinoma with portal vein and inferior vena cava invasion O. Kotenko, A. Grinenko, A. Korshak, D. Fedorov, M. Grigorjan, A. Gusev, A. Popov, A. Ostapishen, Urkraine

05.32 pm

Portal vein embolization prior to resection of colorectal liver metastases does not impact oncological outcomes J. Huiskens, P. B. Olthof, E. P. van der Stok, T. Bais, M. van Amerongen, K. P. van Lienden, J. Krumreich, R. Roumen, D. J. Grünhagen, C. J. Punt, J. H. de Wilt, C. Verhoef, T. M. van Gulik, Netherlands

05.39 pm

Performance validation of the ALPPS Risk Model M. Linecker1, P. Kambakamba1, A. Schlegel2, P. Muiesan2, I. Capobianco3, S. Nadalin3, O. Torres 4, A. Mehrabi3, G.A. Stavrou3, K. J. Oldhafer3, G. Lurje3, U. Neumann3, R. RoblesCampos5, R. Hernandez-Alejandro6, 7, M. Malago2, E. De Santibanes8, P.-A. Clavien1, H. Petrowsky1, 1Switzerland, 2United Kingdom, 3Germany, 4Brazil, 5Spain, 6Canada, 7 United States, 8Argentina

KongressSaal

Watford-Saal

Chairs: E. Schadde, Switzerland; F. Mortensen, Denmark

04.50 pm

06.00 pm 07.00 pm

E-AHPBA General Assembly (E-AHPBA Members only)

ZagrebSaal

Chairs: C. Bruns, Germany; J. C. Lendoire, Argentina

62

04.35 pm

Special Lecture 24 HCC in Non-Cirrhotic Liver / Fibrolamellar Cancer S. Jonas, Germany

63

New Synagogue Mainz | © Landeshauptstadt Mainz

Friday, 26 May, 2017 The youngest sight in the city is the new synagogue building of 2008 in the MainzNeustadt district. The synagogue with its eloquent architecture is a special place as a symbol of reconciliation and Jewish life returning to the city.



08.15 am


08.15 am

Local control of hepatic metastases is a prognostic factor for survival of patients with metastatic colon cancer – Results of a single center analysis D. Stippel, S. Mehrgardt, R. Kleinert, R. Wahba, C. Bruns, T. Zander, Germany

08.24 am

Evolution of parenchymal sparing surgery for colorectal metastases: Are we still dealing with “minor” hepatectomies? S. Langella, N. Russolillo, S. Perotti, M. Palisi, A. Bianco, R. Lo Tesoriere, A. Ferrero, Italy

08.33 am

Impact of R1 resection for colorectal liver metastases on local recurrence in the era of modern chemotherapy. Analysis of 1428 resection areas F. Ardito, M. Ferrucci, A. Coppola, E. Panettieri, N. Silvestrini, M. Vellone, F. Giuliante, Italy

08.42 am

Embryonic Origin of Primary Colon Cancer Predicts Pathologic Response and Survival in Patients Undergoing Resection for Colon Cancer Liver Metastases G. Passot1, S. Yamashita2, K. Brudvik2, C. Conrad2, S. Kopetz2, Y. S. Chun2, T. Aloia2, J. N. Vauthey2, 1France, 2United States

FP

08.51 am

Colorectal liver metastases and concomitant extrahepatic disease: Is resection justified? Single center survival analysis of 84 patients E. Panettieri, F. Ardito, A. De Rose, A. Coppola, M. Vellone, F. Giuliante, Italy

09.00 am

Percutaneous Ablation of RAS Mutant Colorectal Liver Metastases is Associated with a High Rate Local Tumor Progression B. Odisio, S. Yamashita, S. Huang, S. Kopetz, C. Conrad, T. Aloia, K. Ahrar, M. Hicks, Y. S. Chun, S. Gupta, J.-N. Vauthey, United States

09.09 am

The behavior of colorectal liver metastases in the interval between the end of chemotherapy and liver resection. A new criterion to select patients L. Vigano, S. S. Darwish, M. Cimino, M. Donadon, F. Procopio, D. Del Fabbro, G. Torzilli, Italy

Gutenberg-Saal B

08.00 am

Special Lecture 25 Liver First Approach in CRC Liver Metastases – What is Proven? D. Gruenhagen, Netherlands

Special Lecture 26 Management of Cystic Pancreatic Lesions C. Bassi, Italy

08.15 am


08.15 am

The actual incidence of pancreatic cystic neoplasm related symptoms: Are we overestimating a major indication for surgery? S. Andrianello, G. Marchegiani, C. Miatello, A. Borin, C. Dal Borgo, G. Perri, G. Malleo, C. Bassi, R. Salvia, Italy

08.24 am

Accuracy and predictive value of the “worrisome features” for the management of Branch duct intraductal papillary mucinous cystic neoplasms M. Massani, P. Maccatrozzo, G. Morana, N. Bassi, Italy

08.33 am

08.42 am

66

FP

Prognostic value of mural nodules and their size in IPMN of the pancreas: High-volume center experience, systematic review and meta-analysis G. Marchegiani, S. Andrianello, A. Borin, C. Dal Borgo, G. Perri, T. Pollini, G. Romanò, M. D‘Onofrio, G. Malleo, C. Bassi, R. Salvia, Italy Validation of 2012 international consensus guidelines for intraductal papillary mucinous neoplasm of the pancreas – A retrospective study L. Calavrezos, S. Flechsenhar, I. E. Demir, C. Jäger, C. Schlag, S. von Delius, H. Friess, G. O. Ceyhan, Germany

Blood fibrinogen levels discriminate low- and high-risk intraductal papillary mucinous neoplasms (IPMNs) M. F. Nentwich, K. Menzel, M. Reeh, F.G. Uzunoglu, T. Ghadban, K. Bachmann, J. Schrader, M. Bockhorn, J. Izbicki, D. Perez, Germany

09.00 am

Prognosis of invasive intraductal papillary mucinous neoplasms of the pancreas after surgical resection: A matched control study M. el Amrani, M. Adham, J. Perinel, A. Sauvanet, L. Chiche, J.-Y. Mabrut, J.-J. Tuech, S. Truant, C. Mariette, N. Regenet, P. Bachelier, F. Paye, J.-R. Delpero, O. Turrini, France

09.09 am

Routine use of chest computed tomography may avoid futile resections in patients with suspected pancreatic head carcinoma D. Leeuw, B.K. Pranger, V. E. De Meijer, J. I. Erdmann, Netherlands

08.00 am

Special Lecture 27 Resection of Carcinoma of the Middle and Distal Extrahepatic Bile Duct – Extend of Resection and Lymphadenectomy? What is Proven? P. Sandström, Sweden

08.15 am


08.15 am

New surgical procedure for perihilar cholangiocarcinoma: Transhepatic hilar approach to confirm a negative margin of proximal bile duct first N. Kuriyama, A. Tanemura, Y. Iizawa, H. Kato, Y. Murata, Y. Azumi, M. Kishiwada, S. Mizuno, M. Usui, H. Sakurai, S. Isaji, Japan

08.24 am

Major hepatectomy with concomitant vascular resection (portal vein and / or hepatic artery) for perihilar cholangiocarcinoma T. Noji, K. Okamura, K. Tanaka, Y. Nakanishi, T. Asano, T. Nakamura, T. Tsuchikawa, S. Hirano, Japan

08.33 am

Outcomes of liver resection for hilar cholangiocarcinoma of Bismuth type III and IV: A minor versus major approach Y.-F. Cui, X.-Y. Zhong, K.-M. Leng, China

08.42 am

Single Center Experience concerning Surgical Treatment for Perihilar Cholangiocarcinoma in 226 patients J. Rolinger, K. Kiendl, I. Capobianco, K. Jansen, J. Strohäker, A. Königsrainer, S. Nadalin, Germany

08.51 am

IgG4-associated cholangitis mimicking perihilar cholangiocarcinoma: A persistent dilemma E. Roos, L. Hubers, R. J. Coelen, J. Verheij, U. Beuers, T. van Gulik, Netherlands

09.00 am

Postoperative liver failure risk score identifying patients with resectable perihilar cholangiocarcinoma who may benefit from portal vein embolization P. B. Olthof1, J. K. Wiggers1, B. Groot Koerkamp1, R. J. Coelen1, P. J. Allen2, M. G. Besselink1, O. R. Busch1, M.I . D‘Angelica2, R. P. DeMatteo2, T. P. Kingham2, K. P. van Lienden1, W. R. Jarnagin2, T. M. van Gulik1, 1Netherlands, 2United States

FP

Chairs: S. Voskanyan, Russian Federation; N. Senninger, Germany

Gutenberg-Saal D

Gutenberg-Saal B

Chairs: D. Ansari, Sweden; K. C. Conlon, Ireland 08.00 am

08.51 am

Chairs: F. Giuliante, Italy; J. Pratschke, Germany

Gutenberg-Saal C

Gutenberg-Saal A

Chairs: W. Kneist, Germany; C. Verhoef, Netherlands

08.00 am

Special Lecture 30 Importance of the Interstage Course – Comparison between ALPPS and Two Stage Hepatectomy E. Jovine, Italy

08.15 am


08.15 am

A Single Center Analysis of Evolving Experience with ALPPS procedure: Towards Better Patient and Graft Selection D. Balci, E. O. Kirimker, M. Ozcelik, E. Ustuner, C. Konca, G. Utkan, H. Akbulut, Y. Urun, F. C. Senler, A. Demirkazik, E. Gecim, Turkey

FP

67

08.24 am

Proper patient selection leading to comparable major complication rate after ALPPS or non-ALPPS – A cohort study in a single institute J. Li, U. Herden, E. Achilles, M. Koch, L. Fischer, B. Nashan, Germany

08.33 am

ALPPS procedure in an experimental colorectal liver metastases model: Hero or villain? R. Garcia-Perez1, J. Ferrer1, R. Pena1, C. Gonzalez-Abos1, C.M. Martínez Cáceres1, B. Revilla-Nuin1, A. Varona1, R. Vilana1, M. Jimenez-Lopez2, J. C. García-Valdecasas1, J. Fuster1, 1Spain, 2Mexico

08.42 am

ALPPS for primary and metastatic liver cancer: The results of single-center study D. Sidorov, M. Lozhkin, L. Petrov, A. Isaeva, Russian Federation

08.51 am

Portal vein collaterals correlate with liver hypertrophy in a pig model of ALPPS E. Schadde1,2, R. Deal1, P. Olthof3, M. Hertl1, S. Breitenstein2, 1United States, 2 Switzerland, 3Netherlands

09.00 am

Portal inflow restriction enhances liver regeneration and decreases liver injury after major liver resection A. Kohler, S. Frey, P. Möller, P. Tinguely, S. Djafarzadeh, D. Candinas, D. Obrist, S. Jakob, G. Beldi, Switzerland Animal models of Associating Liver Partition and Portal vein Ligation for Staged hepatectomy (ALPPS) A. Szijarto, O. Hahn, A. Budai, P. Onody, I. Dudas, L. Harsanyi, A. Fulop, Hungary

Watford-Saal

Chairs: S. Olde Damink, Netherlands; G. Lindell, Sweden 08.00 am

Special Lecture 29 Liquid Biopsy and Free Tumor Cells in HPB Tumors – Consequences on Surgery? C. Bruns, Germany

08.15 am


08.15 am

SHOX2 and SEPT9 Methylation is a potential biomarker for the diagnosis of biliary tract cancer V. Branchi, P. Schaefer, A. Semaan, P. Linghor, J. C. Kalff, N. Schäfer, G. Christiansen, D. Dietrich, H. Matthaei, Germany

08.24 am

Diagnostic value of ultra-deep targeted next-generation sequencing in patients with suspect pancreatic and periampullary lesions B. Sibinga Mulder, S. Mieog, A. Farina Sarasqueta, H. Handgraaf, H. Vasen, R. Swijnenburg, S. Luelmo, S. Feshtali, A. Inderson, A. Vahrmeijer, B. Bonsing, T. van Wezel, H. Morreau, Netherlands

08.33 am

Platelet to lymphozyte ratio is a predictive marker for invasive carcinoma in patients with pancreatic intra epithelial neoplasia G. Werkgartner, D. Wagner, A. Tomberger, J. Haybaeck, J. Waha, H. Cerwenka, P. Kornprat, H. J. Mischinger, Austria

08.42 am

Circulating microRNAs as dynamic biomarkers of response to treatment with FOLFIRINOX in advanced pancreatic ductal adenocarcinoma L. Meijer1, I. Garajová1,2, C. Caparello2, T. Le Large1, N. Funel2, E. Vasile2, B. Zonderhuis1, F. Daams1, E. Giovannetti1,2, G. Kazemier1, 1Netherlands, 2Italy

08.51 am

68

FP

Cholangiocarcinoma-associated macrophages and tumor necrosis impact survival after surgery G. Atanasov, C. Benzing, F. Krenzien, A. Brandl, L. Feldbrügge, H. Morgül, A. ReutzelSelke, S. Jonas, M. Bahra, A. Pascher, J. Pratschke, M. Schmelzle, Germany

09.00 am

Cancer-associated circulating large extracellular vesicles in cholangiocarcinoma (CCA) and hepatocellular carcinoma (HCC) H. Julich-Haertel1, S. K. Urban1, M. Krawczyk1,2, A. Willms1, K. Jankowski2, W. Patkowski2, R. Schwab1, I. Richardsen1, S. Schaaf1, S. Gehlert2, J. M. Banales3, P. Milkiewicz2, F. Lammert1, M. Krawczyk2, V. Lukacs-Kornek1, M. Kornek1, 1Germany, 2Poland, 3Spain

09.09 am

Multi-Operational Selective Computer-Assisted Targeting of Hepatocellular Carcinoma – Evaluation of a novel approach in an animal model P. Tinguely, T. Fuss, M. Schwalbe, D. Günsch, S. Weber, D. Candinas, Switzerland

Chairs: C. E. Broelsch, Germany; U. Settmacher, Germany

Zagreb-Saal

09.09 am

Watford-Saal


08.00 am

Special Lecture 28 Paediatric Liver Transplantation O. Imventarza, Argentina

08.15 am


08.15 am

Symptomatic portal hypertension – Portosystemic shunt surgery or TIPS? A. Canas-Martinez, B. Fiore, D. Houlihan, R. Mac Nicholas, A. McCormick, T. Gallagher, A. Stafford, O. Traynor, D. Maguire, J. Geoghegan, E. Hoti, Ireland

08.24 am

Laparoscopic approach for living donor to paediatric liver transplantation. A single centre experience of the first 5 cases in Spain J. Briceño, R. Ciria, P. Lopez-Cillero, M. D. Ayllon, A. Luque, I. Gomez-Luque, J. M. Sanchez, A. Arjona, S. Rufian, Spain

08.33 am

Liver transplantation for acetaminophen induced acute liver failure – A 10 year retrospective analysis K. Kobryń, T. Wróblewski, K. Kobryń, M. Kotulski, P. Remiszewski, K. Zieniewicz, Poland

08.42 am

Revascularisation techniques in liver transplantation for portal vein thrombosis and stenosis A. Shcherba, S. Korotkov, D. Efimov, A. Dzyadzko, A. Minou, M. Katin, O. Rummo, Balearus

08.51 am

Low Platelet Counts After Liver Transplantation: Validation of the 60-5 Criterion I. Amygdalos1, D. A. Raptis2, N. Müller2, P. Sulser2, E. Giostra2, C. Toso2, N. Semmo2, P. Dutkowski2, P. A. Clavien2, M. Lesurtel3, 1Germany, 2Switzerland, 3France

09.00 am

Five Year Overall Survival Following Mayo Protocol for Hilar Cholangiocarcinoma Justifies its Continued Use; the Dublin Experience B. Fiore, M. Ismail, T. K. Gallagher, D. Houlihan, J. Geoghegan, R. MacNicholas, D. Maguire, A. McCormick, A. Stafford, O. Traynor, E. Hoti, Ireland

09.09 am

Role of Allelic Imbalance in Predicting the Risk of Hepatocellular Carcinoma Recurrence after Liver Transplantation D. Pagano, F. Barbera, P. Conaldi, A. Seidita, G. Vizzini, A. Luca, S. Gruttadauria, Italy

FP

Chairs: P. Bachellier, France; J. Weitz, Germany

Gutenberg-Saal B

Gutenberg-Saal D


09.30 am


09.30 am

Laparoscopic spleen-preserving “tail-only” pancreatectomy for a left-sided neuroendocrine tumor R. Dalla Valle, C. Pellegrino, M. Iaria, Italy

09.40 am

Laparoscopic cystogastrostomy J. Constantino, A. Logrado, A. Lemos, M. Sá, J. Pereira, C. Casimiro, Portugal

09.50 am

Laparoscopic longitudinal pancreatico-gastrostomy with gastric bipartition for chronic pancreatitis I. Poves, O. Morató, F. Burdío, L. Fernández-Cruz, L. Grande, Spain

FV

69


10.00 am

Innovative laparoscopic distal pancreatectomy with splenic preservation mimicking the advantages of a robotic approach R. Cañada Surjan, T. Basseres, F. Ferrari Makdissi, M. Autran Cesar Machado, Brazil

10.10 am

Laparoscopic spleen preserving distal pancreatectomy with intra-operative assessment and frozen section may prevent unnecessary splenectomy L. Tanno, N. Siddiqi, S. Barbaro, M. Fontana, A. Jayyusi, A. Al Rawashdeh, M. Abu Hilal, United Kingdom

10.20 am

Laparoscopic Resection of the Uncinate Process of the Pancreas M. A. Machado, R. Surjan, T. Basseres, F. Makdissi, Brazil

Chairs: K.-J. Oldhafer, Germany; S. Burmeister, South Africa

Watford-Saal

Gutenberg-Saal B


09.30 am

Symposium 25 HPB Trauma

09.30 am

Blunt Liver Trauma H. Petrowsky, Switzerland

09.50 am

Penetrating HPB Trauma E. Jonas, South Africa

10.10 am

The Role of Interventional Radiology in HPB Trauma C. Düber, Germany

09.30 am


09.30 am

Extended Left hepatectomy and Hepatic Vein Reconstruction with Insitu Hypothermic Perfusion and Veno-Venous Bypass for Intrahepatic Cholangiocarcinoma D. Balci, M. Ozcelik, O. A. Cetinkaya, M. Cakici, E. O. Kirimker, Z. Alanoglu, N. Alkis, E. Ustuner, S. Bilgic, R. Akar, Turkey

09.40 am

Ante-Situ Resection: A Novel approach to minimize vascular exclusion complications V. Ardiles, M. de Santibañes, J. Pekolj, E. de Santibañes, Argentina

09.50 am

Left trisectionectomy with long-distance reconstruction of the right hepatic vein for ICC F. Bartsch, T. Huber, H. Lang, Germany

10.00 am

Extended right hepatectomy with IVC replacement for intrahepatic cholangiocarcinoma: Total vascular exclusion – Veno-venous bypass – Topical cooling B. Tréchot, D. Cherqui, France

10.10 am

Extended left hepatectomy with temporary porto-caval shunt under total hepatic vascular exclusion and liver cooling Y. Renard, T. Piardi, A. Cagniet, T. Lestra, R. Kianmanesh, D. Sommacale, France

10.20 am

A dorsal transverse hepatectomy for large hepatocellular carcinoma located in liver segment 9 with cava infiltration T. Y. Tsui, Germany

FV

Chairs: E. de Santibañes, Argentina; S. Weber, Switzerland

Zagreb-Saal

Gutenberg-Saal C

Chairs: G. Stavrou, Germany; P. Lodge, United Kingdom 09.30 am

Update 3: Virtual Reality Surgery and Intraoperative Imaging

09.30 am

Prospective Evaluation for Precision Multimodal Gallbladder Surgery Navigation: Augmented Reality, Fluorescence and X-rax-based Intraoperative Cholangiography M. Diana, L. Soler, D. Mutter, J. Marescaux, P. Pessaux, France

09.45 am

Mixed and Virtual Reality in Surgery – is the Future Around the Corner J. Pratschke, Germany

10.00 am

Planning and navigation in laparoscopic liver surgery with use of Microsoft HoloLens Å. A. Fretland, Norway

10.15 am

Late Breaking Paper

10.30 am Coffee Break Chairs: T. Gruenberger, Austria; U. P. Neumann, Germany 10.45 am

Symposium 26 CRC Liver Metastases with Extrahepatic Disease

10.45 am

Liver and Lung Metastases L. Cameron, United Kingdom

11.00 am

Liver and Peritoneal Metastases (Indication for CRS + HiPEC) P. Piso, Germany

11.15 am

“Multivisceral” Resections in CRC Liver Metastases H. J. Mischinger, Austria

11.30 am

Hilar and Interaortocaval LN Metastases: A Contraindication for Curative Liver Surgery in CRC Metastases? J. Weitz, Germany

11.45 am

Laparoscopic Resolution of Complication Post Metastasectomy C. Bertona, Argentina

70

Gutenberg-Saal A

Gutenberg-Saal D

Chairs: Z. Krska, Czech Republic; S. Stättner, Austria 09.30 am

Symposium 24 Management of CRC Metastases 2

09.30 am

linical Dilemmas: The Dissappeared Metastases and the R1 Situation M. D‘Angelica, United States

09.45 am

Margin and Resectability in Multiple Colorectal Liver Metastases: The Relevance of the Policy G. Torzilli, Italy

10.00 am

Resection of CRC Liver Metastases: Open vs. Laparoscopic – Results of an RCT B. Edwin, Norway

11.55 am

The Liver-first Approach for Synchronous Colorectal Liver Metastasis: Outcomes of a Ten-year Experience M. de Jong, Netherlands

10.15 am

Open and Laparoscopic Ultrasound-Guided Parenchymal Sparing Resections for CRC Liver Metastases A. Ferrero, Italy

12.05 pm

Boehringer Ingelheim Foundation Grant Discussion F. Längle, Austria

FV

71


10.45 am

The Role of Sarcopenia in the Development of Pancreatic Fistula A. Siriwardena, United Kingdom

Chairs: A. Pinna, Italy; G. Sotiropoulos, Greece

11.00 am

Preoperative Relief of Jaundice – Pro´s and Con´s O. Busch, Netherlands

10.45 am

Symposium 29 Rare Indications for Liver Transplantation

11.15 am

Prevention of the Pancreatic Fistula – Where and How to Plug the Pancreas? T. Keck, Germany

10.45 am

Treatment Options for Hemangioendothelioma K. Zieniewicz, Poland

11.30 am

Pancreatic Adenocarcinoma: Patterns of Tumor Growth and Metastatic Spread, New Molecular Insights, Definition of R1 and R0 F. Bergmann, Germany

11.00 am

Liver Transplantation for Cholangiocarcinoma M. De Oliveira, Switzerland

11.15 am

Indications for OLT in Liver Adenomatosis J. Mittler, Germany

11.45 am

External validation of the MDACC clinical classification system for pancreatic cancer in a European multicenter cohort M. Welte1, F. Uzunoglu1, F. Gavazzi2, L. Maggino2, J. Perinel3, R. Salvia2, M. Janot1, M. Reeh1, D. Perez1, M. Montorsi2, A. Zerbi2, M. Adham3, W. Uhl1, C. Bassi2, J. Izbicki1, G. Malleo2, M. Bockhorn1, 1Germany, 2Italy, 3France

FP

11.30 am

Orthotopic Liver Transplantation for Echinococcus Disease B. Aydinli, Turkey

11.45 am

11.54 am

R0 vs R1 resection in pancreatic cancer: Is there a genuine prognostic importance? I. E. Demir, C. Jäger, L. Stecher, H. Friess, G.O. Ceyhan, Germany

FP

Liver Resection vs. OLT for Polycystic Liver Disease S. Dokmak, France

12.00 pm

12.03 pm

Validation of the New R-Status Definitions (1mm margin) for Pancreatic Adenocarcinoma resected by Distal or Total Pancreatectomy T. Hank, U. Hinz, W. Niesen, J. Kaiser, F. Bergmann, T. Hackert, M. Büchler, O. Strobel, Germany

Special Lecture 31 Liver Transplantation as School for Resection and vice versa W. O. Bechtstein, Germany

Gutenberg-Saal B

Chairs: W. T. Knoefel, Germany; A. Coker, Turkey

Gutenberg-Saal D

10.45 am

Symposium 27 Pancreas Surgery

GutenbergSaal C


FP

10.45 am

Update: Surgery for ICC; Extend of Lymphadenectomy? What is Proven? A. Guglielmi, Italy

11.00 am

(Neo)adjuvant Strategies for ICC: A Multidisciplinary Approach J. U. Marquardt, Germany

11.15 am

Surgery for recurrent ICC S. A. Lang, Germany

11.30 am

Recurrence of intrahepatic cholangiocarcinoma – Patterns and Therapy F. Bartsch, Germany

11.39 am

Role of lymph-node dissection in small (≤ 3cm) Intrahepatic Cholangiocarcinoma A. Ruzzenente, L. Viganò, G. Ercolani, S. Conci, A. Fontana, M. Piccino, C. Iacono, A. D. Pinna, G. Torzilli, A. Guglielmi, Italy

11.48 am

Patterns of distribution of hepatic nodules (single, satellites or multifocal) in intrahepatic cholangiocarcinoma: Prognostic impact after surgery S. Conci, L. Viganò, G. Ercolani, A. Ruzzenente, A. Fontana, F. Bertuzzo, A. Dore, C. Iacono, A.D. Pinna, G. Torzilli, A. Guglielmi, Italy

11.57 am

AJCC 8th edition staging system for intrahepatic cholangiocarcinoma: An analysis of 1,154 patients undergoing hepatectomy with curative intent F. Bagante1, G. Spolverato1, M. Weiss2, S. Alexandrescu3, H. P. Marques4, L. Aldrighetti1, S. K. Maithel2, C. Pulitano5, T. W. Bauer2, F. Shen6, G. A. Poultsides2, O. Soubrane7, G. Martel8, B. G. Koerkamp9, E. Itaru10, A. Guglielmi1, T. M. Pawlik2, 1Italy, 2United States, 3 Romania, 4Portugal, 5Australia, 6China, 7France, 8Canada, 9Netherlands, 10Japan

FP

Watford-Saal

Gutenberg-Saal C

72

Symposium 28 Intrahepatic Cholangiocarcinoma

An Externally Validated Risk Score for Intrahepatic Cholangiocarcinoma following Surgical Resection: A SEER Database Analysis S. Kathir Kamarajah, R. Bhogal, C. Coldham, J. Hodson, C. Weston, S. Afford, P. Muiesan, J. Isaac, K. Roberts, R. Marudanayagam, R. Sutcliffe, D. Mirza, United Kingdom

Chairs: E. Jonas, South Africa; E. Klar, Germany

Chairs: N. Bassi, Italy; S. Jonas, Germany 10.45 am

12.06 am

10.45 am


10.45 am

Managing Liver Trauma with Limited (Minimal) Infrastructure C. Güsgen, Germany

11.05 am

521 Cases of Blunt Hepatic & Splenic Injury – Multidisciplinary, Nonoperative Management (NOM) in a Large Western-Europe Trauma Centre S. Stättner, M. Fodor, V. Kranebitter, E. Braunwarth, M. Haselbacher, E. Gassner, M. Blauth, F. Primavesi, Austria

11.14 am

Should AAST Liver Injury Scale Include Hemodynamic Status as Criteria? V. R. Vutukuru, India

11.23 am

Resection of complex pancreatic injuries: Benchmarking postoperative morbidity using the Accordion Severity Grading System S. Burmeister, J. Krige, E. Jonas, S. Thomson, U. Kotze, M. Setshedi, P. Navsaria, A. Nicol, South Africa

11.32 am

The consequences of associated major visceral vascular injuries for outcome in patients with pancreatic injuries: A case-matched analysis C. Kloppers, E. Jonas, J. Krige, U. Kotze, M. Setshedi, P. Navsaria, A. Nicol, South Africa

11.41 am

May liver transaminases substitute for computed tomography in evaluation of blunt liver injury? With special emphasis on serum cut-off levels T. Canbak, A. Acar, F. Basak, A. Ozpek, A. Kilic, G. Bas, E. Unal, Turkey

11.50 am

Careful approach to the treatment of injuries of the pancreas B. Rakhimov, V. Kolesnikov, I. Galkin, A. Kiseleov, Russian Federation

11.59 am

Management of Pancreatic Trauma: Various manifestations – Interdisciplinary therapy B. Globke, F. Klein, P. Schwabe, W. Veltzke-Schliecker, J. Pratschke, M. Bahra, Germany

FP

73



01.10 pm 12.40 pm 01.30 pm


Gutenberg-Saal C

12.20 pm -


KongressSaal

Chair: C. Dervenis, Greece 01.45 pm

Key Note Lecture 7 Surgical Treatment of Pancreatic Cancer – Where are the Limits? M. W. Büchler, Germany

Gutenberg-Saal A

02.32 pm

Management of Gallstone Disease during Pregnancy B. Andersson, Sweden

02.44 pm

Surgical Steps to Prevent Bile Duct Injury C. Agalianos, Greece

02.56 pm

Management of Mirizzi-Syndrome S. Shrikhande, India

03.08 pm

Management of Gallstone Disease in Acute Biliary Pancreatitis H. C. Santvoort Netherlands

03.20 pm

Which Gallbladder Polyp Requires Cholecystectomy M. Schäfer, Germany

Chairs: M. Bockhorn, Germany; M. M. Erkan,Turkey

Chairs: A. Ferrero, Italy; E. de Santibañes, Argentina 02.20 pm

Symposium 30 Manipulating the Future Liver Remnant

02.20 pm

Strategies to Increase the Future Liver Remnant F. Quenet, France

02.35 pm

Optimal Timing of the Second Step in Two-Stage Concepts J.-N. Vauthey, United States

02.50 pm

Lessons learned – Who Does not Qualify for ALPPS? E. Schadde, United States

03.05 pm

Current Studies on ALPPS – What is Evidence-Based? M. Linecker, Switzerland

03.20 pm

Delayed ALPPS: A new concept to reduce operative risk N. Wylie, E. Hidalgo, G. Toogood, P. Lodge, United Kingdom

FP

03.37 pm

Postoperative serum phosphate drop is an early marker of liver growth after ALPPS stage 1 and predicts outcome after ALPPS stage 2 P. Kambakamba, M. Linecker, C. Reiner, T. D. L. Nguyen Kim, P. A. Clavien, H. Petrowsky, Switzerland

FP

Gutenberg-Saal D

Poster-Area


02.20 pm


02.20 pm

Frey Operation for Chronic Pancreatitis J. Constantino, Portugal

02.30 pm

Appleby Procedure – A Challenging Interdisciplinary Treatment for Extensive Pancreatic Body Cancer P. Sanchez Velazquez, Switzerland

02.40 pm

Total Duodenopancreatectomy and Splenectomy with Portal Vein Resection for Borderline Pancreatic Cancer after Neoadjuvant Chemoradiotherapy J. Ferrer, Spain

02.50 pm

How to Perform Laparoscopic Duct-to-Mucosa Pancreatojejunostomy in High-risk Score Patients M. A. Machado, Brazil

03.00 pm

Novel CLASP technique for stump closure following distal pancreatectomy M. Papoulas, United Kingdom

03.10 pm

Laparoscopic-adapted Blumgart Anastomosis in Laparoscopic Pancreaticoduodenectomy I. Poves, Spain

02.20 pm

Symposium 31 Neuroendocrine Tumours – Joint Session

02.20 pm

Surgery for Neuroendocrine Liver Metastases – Does the Origin Matter? T. Musholt, Germany

02.20 pm

Symposium 33 OLT: The Complicated Recipient

02.35 pm

OLT for Non-Resectable Liver Metastases A. Frilling, United Kingdom

02.20 pm

Technical Options in Portal Vein Thrombosis U. Settmacher, Germany

02.50 pm

Systemic Treatment for Metastatic Neuroendocrine Tumors M. Weber, Germany

02.35 pm

03.05 pm

Management of PNET M. Falconi, Italy

Radiological „Preconditioning“ in Case of Vascular Thrombosis / Portosystemic Shunts C. Düber, Germany

02.50 pm

Minimally Invasive Treatment of Billiary Strictures after Liver Transplantation O. Rummo, Belarus

03.20 pm

Peptide Receptor Radionuclide Therapy in Irresectable Liver Metastases M. Miederer, Germany

03.05 pm

The Complicated Arterial Reconstruction M. Malago, United Kingdom

03.20 pm

OLT in the Obese Patient – An Increasing Challenge P. Schemmer, Austria

03.45 pm

Closing Ceremony & Meeting Wrap-up

Chairs: B. Aydinli, Turkey; N. Senninger, Germany

Watford-Saal

Gutenberg-Saal B

Chairs: O. C. Andriani, Argentina; K. Holzer, Germany

74

Symposium 32 Keys to Safe Laparoscopic Cholecystectomy

02.20 pm

Laparoscopic Cholecystectomy: Intraoperative Detection of Complications is Crucial – Lessons Learned from a National Registry J. L. Rystedt, Sweden

KongressSaal

GutenbergSaal C

Chairs: J. Kalff, Germany; Y. Tekant, Turkey 02.20 pm

FV

75

XXX

XXX



Industry Satellite Symposia


12.30 pm – 01.30 pm

12.15 pm – 01.15 pm

Chair: H. Lang, Germany

Chairs: G. Wakabayashi, Japan; M. Walz, Germany

Introduction: The LiMAx test H. Lang, Germany The Development of the LiMAx Test in Liver Surgery M. Stockmann, Germany LiMAx: The View of a Hepatologist M. Büchter, Germany

Technical Aspects of Laparoscopic Liver Surgery Gutenberg-Saal A

Gutenberg-Saal A

How does the LiMAx test use metabolic liver function to provide vital information for clinical practice? H. Lang; M. Stockmann; M. Büchter, Germany

Panel Discussion and Q&A H. Lang, Germany

Laparoscopic Liver Resection – The German Perspective M. Walz, Germany ICG-guided Laparoscopic Anatomical Liver Resection G. Wakabayashi, Japan Technical Challenges of Laparoscopic Liver Resection D. Seehofer, Germany Liver Surgery and Robotics: A New Way and New challenges R. Croner, Germany

12.30 pm – 01.30 pm 12.15 pm – 01.15 pm Chairs: H. Lang; J. Kalff, Germany SIRT and surgery – A perfect partnership for improving long-term outcomes

Does Synapse 3D reconstruction give the same strategy before a liver resection? B. Gayet, France; G. Torzilli, Italy; T. Takamoto, Japan

Welcome and Introduction H. Lang; J. Kalff, Germany Gutenberg-Saal B

Gutenberg-Saal B

Chair: B. Gayet, France

What Surgeons Need to Know about Selective Internal Radiation Therapy (SIRT) R. Klöckner, Germany Stay in the game with SIRT – Downsizing Liver Metastases for Surgery B. Garlipp, Germany Pave the Way for Transplantation with SIRT – Downstaging or Bridging in HCC G. M. Ettorre, Italy Safety of Surgery after SIRT (P4S study) A. D. Pinna, Italy Panel Discussion Chairs and Speakers

78

79





02.00 pm

Allied Healthcare Professionals 4 Experience, Exchange, Evolve – How to Teach your Surgeon

02.00 pm

Baxter Product Portfolio Overview B. Mackie, United States

02.40 pm

Share and Learn

03.00 pm

Hands-on Session

03.50 pm

Feedback / Improvement Opportunities for Products and Applicators

09.30 am – 10.30 am Chair: F. Ulrich, Germany Solutions for Bleeding Challenges in HPB Surgery Gutenberg-Saal A

Zagreb-Saal

02.00 pm – 04.00 pm

Bleeding Challenges in Liver Surgery – A Rationale for Selective Hemostat Use F. Ulrich, Germany Improving Outcomes in Pancreatic Surgery – Is there a Place for Sealants? M. Serradilla Martin, Spain Blood-Saving Techniques in the Laparoscopic Approach to Liver Resection U. Boggi, Italy

Gutenberg-Saal A

12.15 pm– 01.15 pm

Technical Aspects of Major and Extended Liver Resections J.-N. Vauthey, United States

12.30 pm – 01.15 pm

Gutenberg-Saal B

Chair: U. Neumann, Germany Metastatic colorectal cancer: Improving survival through resection of liver metastasis and systemic therapy Treatment Decision in mCRC: A Multidisciplinary Team (MDT) Approach U. Neumann, Germany Converting to Resectability: Cetuximab for Irresectable Liver Metastases D. Modest, Germany Resectability of Liver Metastases: What Can Be Achieved? W. Bechstein, Germany

80

81

XXX

XXX

P1 Liver Transplantation Chairs: G. Sotiropoulos, Greece; S. Farkas, Germany

P1.01

Mediterranean Diet Post-Liver Transplantation: Should it be the Standard of Care? H. Dakhil, R. Abou Eid, M. Kanso, M. Khalife, W. Faraj, Lebanon

P1.02

Graft-versus-host disease and liver transplantation – It can be survived T. May, A. Jafari, J. Kalff, S. Manekeller, Germany

P1.03

Enteric Drainage of Pancreas Transplantation. Clinical impact of intra-abdominal complications J. Ferrer, B. Cano-Vargas, L. Martinez de la Maza, M. A. López-Boado, R. Rull, M. J. Ricart, P. Ventura, E. Esmatjes, S. Sanchez, J. Fuster, J. C. García-Valdecasas, Spain

P1.04

Livers from brain dead donors with chronic active alcohol abuse for liver transplantation U. Maggi, M. Fabbi, E. Melada, G. Fornoni, B. Antonelli, R. Rota, F. Invernizzi, P. Reggiani, G. Rossi, Italy

P1.05

Surgical Duct-to-Duct Reconstruction – A Novel Approach to Biliary Anastomotic Stricture after Deceased Donor Liver Transplantation J. Mittler, S. Heinrich, M. Heise, M. Hoppe-Lotichius, R. Klöckner, A. Schad, T. Zimmermann, P. R. Galle, H. Lang, Germany

P1.06

Development of portal hypertension and spleen size after orthotopic liver transplantation K. Alghdban, T. Zimmermann, R. Klöckner, M. Hoppe-Lotichius, M. Heise, H. Lang, J. Mittler, Germany

Poster Area

12.30 pm 01.20 pm

12.30 pm 01.20 pm

P3 Cholecystectomy Chairs: D. Ockert; I. Klein, Germany

P3.01

Gastrointestinal bleeding due to choledocho-duodenal fistula in a PAVM treated with transarterial embolization F. Sanchez-Bueno, D. Ferreras, F. LLoret, D. Ruiz Angulo, P. Gil, K. Rodrigues, J. Carvajal, P. Parrilla, Spain

P3.02

Feasibility of delayed vascular repair after surgical combined injury to the bile duct and hepatic artery: Case series and systematic review L. F. Grochola, C. Kuemmerli, V. L. Lopez, C. Oberkofler, R. R. Campos, P.-A. Clavien, H. Petrowsky, Switzerland and others

P3.03

Diagnostic features and surgical outcomes in patients with Mirizzi syndrome D. Ievtushenko, V. Syplyviy, A. Ievtushenko, Ukraine

P3.04

Is percutaneous cholecystostomy a reasonable alternative for the treatment of acute cholecystitis in high risk patients? P. Ignatavicius, D. Mikuckyte, I. Dekeryte, G. Barauskas, Lithuania

P3.05

Critical view of safety (cvs) in laparoscopic cholecystectomy; what if you fail to establish? T. A. D. S. Perera, B. G. N. Rathnasena, M. Mathurageethan, Sri Lanka

P3.06

Single Incision Laparoscopic Cholecystectomy at UKM Medical Centre: An Early Experience H. Othman, R. Jarmin, A. Azman, Z. Zuhdi, I. S. Mohammad, A. C. Ariffin, Malaysia

P3.07

Ruralization is protective from gallbladder disease Z. A. Khan, M. U. Khan, M. Brand, South Africa

P3.08

Cholecystectomy In The Laparoscopic Era; More Than 200 Consecutive Cholecystectomies With Zero Conversion Rate; Is There A Necessity For Conversion? T. A. D. S. Perera, B. G. N. Rathnasena, M. Mathurageethan, R. M. M. Theepan, Sri Lanka

P2 Management of Biliary Complications Chairs: A. Canbay, Germany; J. Pekolj, Argentina

P2.01

Surgical Therapy for Hepatolithiasis F. W. Garcia, M. S. Acosta, A. A. Lamberto, D. L. Fernandez, J. P. Grondona, R. A. Bracco, Argentina

P2.02

Management of iatrogenic injuries due to endoscopic sphincterotomy; surgical or conservative? Ö. Bostanci, M. Battal, P. Yazici, U. Demir, C. Alkim, Turkey

12.30 pm 01.20 pm

P4 Bile Duct Injury Chairs: A. Proneth, Germany; Y. Tekant, Turkey

P2.03

The injury model of bile ducts in experiment A. Aliev, N. Maystrenko, P. Romashchenko, A. Pryadko, Russian Federation

P4.01

Hepatolithiasis following “non-Roux-en-Y” hepatico-jejunostomy for common bile duct injury M. Kresoja, S. Knežević- Ušaj, D. Lukić, M. Protic, Serbia

P2.04

Minimally invasive treatment of bile leakage in pancreatobiliary surgery O. Usenko, M. Nichitaylo, P. Ogorodnik, O. Lytvyn, A. Deynichenko, Ukraine

P4.02

P2.05

Bile duct necrosis at hepatic hilum: Description of two cases and role of transhepatic drainage P. Senra, S. Guzman, R. Melendez, E. Casal, F. Ausania, Spain

Total replacement of the extrahepatic bile duct using a jejunal conduit interposition of variable diameter in case of high stricture P. Markov, Russian Federation

P4.03

Bile duct injury repair after laparoscopic cholecystectomy: A call for standardized reporting P. Kambakamba, A. Rickenbacher, M. Linecker, H. Petrowsky, P. A. Clavien, M. de Oliveira, Switzerland

P4.04

Immediate surgical repair of post-laparoscopic cholecyctectomy bile duct injuries: The earlier the better M. Battal, P. Yazıcı, Ö. Bostancı, O. Karatepe, Turkey

P4.05

Intra- and extraglissonian approach with partial resection of IV-V segments for intrahepatic bile duct injuries V. López López, R. Robles Campos, R. Brusadin, A. López Conesa, P. J. Gil Vázquez, P. Parrilla Paricio, Spain

P2.06

84

Poster Area

12.30 pm 01.20 pm

Wednesday, May 24, 2017

A rare complication following laparoscopic cholecystectomy; a case series A. M. Schreuder, T. M. van Gulik, E. A. Rauws, Netherlands

Poster Area

Poster Area

Poster Sessions

85

86

P5.01

Postoperative inflammatory scores associated with major morbidity and mortality after pancreatic resections M. Rodriguez-Lopez, F. J. Tejero Pintor, B. Perez-Saborido, M. Bailon-Cuadrado, S. Mambrilla-Herrero, D. Pacheco-Sanchez, P. Pinto-Fuentes, R. Velasco-Lopez, A. Barrera-Rebollo, Spain

P5.02

Individualized risk estimation for postoperative morbidity after hepatectomy: The Humanitas score M. Donadon, A. Fontana, A. Palmisano, L. Viganò, F. Procopio, M. Cimino, D. Del Fabbro, G. Torzilli, Italy

P5.03

A case for data: Improving surgical performance and patient outcomes through an evidence-based approach to list ordering T. Pike, F. Mushtaq, R. Mann, R. Wilkie, M. Mon-Williams, J. P. A. Lodge, United Kingdom

P5.04

Accuracy comparative analysis between two scores for predicting postoperative complications in pancreatic surgery F. J. Tejero Pintor, M. Rodriguez Lopez, B. Perez Saborido, A. Barrera Rebollo, D. Pacheco Sánchez, E. Asensio Díaz, S. Mambrilla Herrero, M. Bailon Cuadrado, K. T. Plua muniz, E. Choolani-Bhojwani, J. L. Marcos Rodriguez, Spain

Poster Area

P5 Management of HPB Complications Chairs: M. Hoffmann; M. Paschold, Germany

Poster Area

12.30 pm 01.20 pm


P6.06

The Challenges of Diagnosis and Management of Acute Mesenteric Venous Thrombosis in Patients with Liver Cirrhosis: A Single Institution‘s Experience H. Zakaria, K. Ammar, S. Saleh, M. Abbas, N. Gaballa, E. Hammad, Egypt

P6.07

Splenic artery embolisation versus endoscopic therapy for the prevention of recurrent variceal bleedings in CLD patients. A non-randomized pilot trial. S. Savoliuk, Sergii Kozlov, Olexandr Nikishin, Sergii Savoliuk, Petro Fomin, Ukraine

12.30 pm 01.20 pm

P7 Local Treatment of Liver Tumors Chairs: T. Becker, Germany; N. Nüssler, Germany

P7.01

The possibility of using resection and cryoablation procedures in the treatment of liver tumors D. Ionkin, A. Chzhao, V. Vishnevsky, Y. Stepanova, Y. Stepanova, O. Ashivkina, Russian Federation

P7.02

The Efficacy of Radiofrequency Ablation in the Management of Liver Tumours (Systematic Review) A. Najjar, S. Froghi, United Kingdom

P7.03

SIRT for downsizing to resection C. Justinger, K. Kouladouros, K. Tatsch, M. Binnenhei, T. Rüdiger, M. Bentz, P. Reimer, M. R. Schön, Germany

P7.04

Outcomes of laparoscopic radiofrequency ablation of liver tumours M. d. M. Achalandabaso Boira, N. Shaida, T. C. See, J. Richards, A. Jah, United Kingdom

P5.05

Analysis of the International Study Group of Hepatic Surgery definitions of typical complications after liver surgery W. Tesfazgi, M. Knoth, E. Birgin, T. Wilhelm, S. Post, F. Rückert, Germany

P5.06

Implementation of Continuous Wound Infiltration In Pancreatoduodenectomy Reduced Hospital Stay as well as Fluid Resuscitation T. Mungroop, C.-W. Lai, S. Barbaro, M. Alzoubi, T. Armstrong, Z. Hamady, A. Takhar, M. Besselink, D. Veelo, M. Abu Hilal, Netherlands and others

P7.05

Role of hepatic arterial infusion chemotherapy in the treatment of intrahepatic cholangiocarcinoma: Personal experience and review of the literature M. Massani, R. Bonariol, B. Pauletti, A. Greco, N. Bassi, Italy

P5.07

Post pancreatectomy haemorrhage (PPH): Risk assessment and management U. Bultmann, I. Dimitriou, M. Niedergethmann, Germany

P7.06

Microwave Ablation Provided Better Overall Survival Than Liver Resection For Small Hepatocellular Carcinoma In Patients With Borderline Liver Function C. Chong, K.-f. Lee, C. Chu, A. Chan, H.-T. Lok, A. Fung, A. Fong, S. Cheung, J. Wong, S. Chan, S. Yu, P. Lai, Hong Kong

12.30 pm 01.20 pm

P6 Emergencies in HPB Surgery Chairs: S. Klompmaker, Netherlands; D. O‘Reilly, United Kingdom

P7.07

P6.01

Hepatic artery aneurysm in an 82 years old patient M. BIalobrzecka, A. Wunsch, L. Berger, R. Viebahn, Germany

TACE prior to laparoscopic liver resection of hepatocarcinoma on cirrhotic liver. Propensity score matching with open surgery P. J. Gil Vázquez, R. Robles Campos, R. Brusadin, A. López Conesa, V. López López, P. Parrilla Paricio, Spain

P6.02

Liver injury following blunt abdominal trauma – Evaluation of a new mechanism-driven classification F. Bender, T. Bicak, S. Memming, O. Kollmar, Germany

12.30 pm 01.20 pm

P8 Laparsocopic Liver Surgery Chairs: M. Abu Hilal, United Kingdom; M. R. Schön, Germany

P6.03

Treatment of blunt liver injuries after the paradigm shift in liver trauma management E. Tagkalos, M. Jöckel, H. Lang, P. Gassmann, Germany

P8.01

P6.04

Liver trauma in equestrian accidents –A case report R. Latorre-Fragua, A. Manuel-Vazquez, A. López-Marcano, C. García-Amador, A. Medina, C. Ramiro-Pérez, R. de la Plaza, J. M. Ramia, Spain

When laparoscopic liver resection is preferred to liver biopsy – A case of a neuroendocrine metastasis O. Ginghina, A. Spanu, M. Mardare, M. Zamfir, R. Iosifescu, T. Chapelle, C. Capatana, S. Omer, N. Iordache, Romania and others

P8.02

Laparoscopic liver resections: Initial experience in Greece P. Stamopoulos, N. Machairas, I. D. Kostakis, G. C. Sotiropoulos, Greece

P6.05

Hepatic portal venous gas without gastroenterological symptom may be a good sign H. Baba, Y. Ohishi, K. Toritani, M. Maebashi, H. Fujiwara, N. Sugimasa, N. Takahashi, M. Kakizoe, M. Nakashima, H. Ono, M. Sugita, Y. Nakayama, T. Takei, Japan

P8.03

Short- and Long-Term Outcomes of Laparoscopic Liver Resection: A single-center, retrospective, matched-pair analysis K. Kouladouros, C. Justinger, D. Gärtner, I. Tournas, M. R. Schön, Germany

P8.04

One-stage pure laparoscopic resection of primary colorectal cancer and synchronous hepatic metastases: A single institution experience A. Ivanecz, I. Plahuta, B. Krebs, S. Potrc, Slovenia

Poster Area

Poster Area

Poster Area

Poster Sessions

87

Poster Sessions

Poster Area

88

Laparoscopic liver resection: evolution of a single Surgeon‘s experience in MILS with 129 cases E. Jovine, M. Masetti, S. Nicosia, R. Lombardi, M. Chisari, C. Benini, L. Mastrangelo, M. Zanello, S. Selleri, F. Martuzzi, S. Di Saverio, Italy

P10.04

Survival after breast cancer liver metastasis treatment in Sweden C. Hermansson, O. Hemmingsson, Sweden

P10.05

Liver resection for differentiated thyroid cancer metastases J. Ligocka, W. Patkowski, M. Morawski, M. Krasnodębski, M. Grąt, K. Zieniewicz, Poland

P10.06

Multimodal treatment of Rt. gastroepiploic arterial leiomyosarcoma suspected gastrointestinal stromal tumor(GIST) with hepatic metastasis S. P. Yun, H. I. Seo, M. H. Yoon, Republic of Korea

P10.07

Short- and long-term results of surgical treatment of non-colorectal liver metastases B. Pérez-Saborido, M. Rodríguez-López, E. Asensio-Díaz, M. Bailón-Cuadrado, F. J. Tejero, L. M. Díez, D. Pacheco, P. Pinto, A. Barrera, Spain

P10.08

Subdiaphragmatic peritoneal implants secondary to „retroconversed“ immature ovarian teratoma mimicking liver metastases N. Nuamah, C. Ibis, T. Isgorucu, F. Ekiz, A. Kut, Turkey

Laparoscopic liver resection in cirrhotic patients with hepatocellular carcinoma located in posterior segments: Towards the “gold standard”? M. Barabino, R. Santambrogio, N. Mariani, G. Scifo, M. Giovenzana, E. Opocher, Italy

P8.07

Laparoscopic left lateral liver resection is a safe procedure in cirrhotic patients B. Struecker, P. Haber, A. Andreou, N. Raschzok, G. Atanasov, C. Benzing, F. Krenzien, I. Sauer, R. Zorron, M. Biebl, R. Öllinger, M. Bahra, A. Pascher, J. Pratschke, M. Schmelzle, Germany

12.30 pm 01.20 pm

P9 Treatment of CRC Metastases Chairs: R. Alikhanov, Russian Federation; S. Nadalin, Germany

P9.01

Surgical outcomes and prognostic factors for survival for colorectal liver metastases: A 10-year single center experience I. Vasilevski, I. Takorov, V. Mihaylov, N. Vladov, Bulgaria

12.50 pm 01.40 pm

P11 Assessment of Liver Function Chairs: G. M. Ettorre, Italy; M. Glanemann, Germany

P9.02

Predictive factors of survival in liver resections for colorectal cancer metastases A. M. Cosma, E. Mois, R. Elisei, F. Graur, N. Al Hajjar, Romania

P11.01

P9.03

Ten year experience of re-resection of recurrent liver-only colorectal metastases G. Irving, D. Gomez, A. Brooks, A. Navarro, I. Cameron, United Kingdom

Use of the liver maximum function capacity test (LiMAx) – A case of pharyngeal cancer metastasis in a cirrhotic liver S. Cammann, F. Oldhafer, W. R. Ramackers, O. Beetz, K. Timrott, M. Kleine, J. Klempnauer, H. Bektas, F. W. Vondran, Germany

P11.02

P9.04

Neoadjuvant Folfiri+Bevacizumab in resectable liver metastases from CRC: Results and comparison of PET / CT scan vs RECIST in predicting outcome A. Belli, R. Palaia, V. Albino, A. Amore, M. Piccirillo, M. Leongito, G. Nasti, V. Granata, A. Petrillo, S. Lastoria, F. Izzo, Italy

Preoperative Evaluation of Liver Function in Patients with Hepatocellular Carcinoma using the LiMAx Test F. Anger, D. Sperl, G. Singh, I. Klein, S. Löb, O. Götze, A. Geier, J. F. Lock, Germany

P11.03

Monitoring of liver function using the novel liver maximum function capacity test (LiMAx) in a patient undergoing ALPPS F. Oldhafer, K. Ringe, K. Timrott, M. Kleine, W. Ramackers, S. Cammann, M. Jäger, J. Klempnauer, H. Bektas, F. Vondran, Germany

P11.04

The role of functional liver tests in liver cancer surgery D. Sidorov, M. Lozhkin, L. Petrov, A. Isaeva, Russian Federation

P11.05

Functional liver volume following repeated liver resection for colorectal liver metastasis V. Valdimarson, K. Hellberg, E. Sparrelid, T. Brismar, C. Sturesson, Sweden

P11.06

Stress test of liver function using 99mTc-mebrofenin Hepatobiliary Scintigraphy (HBS) F. Rassam, K. Cieslak, P. Olthof, T. van Gulik, R. Bennink, Netherlands

P11.07

Prevention of postop liver failure after major liver resections: The role of functional tests D. Sidorov, N. Rubtsova, A. Leontiev, L. Petrov, M. Lozhkin, A. Isaeva, Russian Federation

P11.08

Impact of modern chemotherapy before hepatectomy – Assessment of hepatocytes function and viability via SPECT-scintigraphy and hepatocytes isolation S. Truant, C. Baillet, V. Gnemmi, M. Fulbert, S. Dardenne, L. Ruoya, M. Hebbar, E. Leteurtre, M. El Amrani, S. Dharancy, D. Huglo, C. Chesné, F. R. Pruvot, France

P9.05

Risk Factors For Early Recurrence After Liver Resection For Colorectal Liver Metastases (CRLM): A Single Centre Study B. Alaraimi, S. S. Raza, M. Ali, F. T. Lam, S. Khan, J. Ahmad, G. Marangoni, United Kingdom

P9.06

Assessment of colorectal liver metastasis: Results of the Dutch Colorectal Cancer Group (DCCG) liver metastases expert panel of the CAIRO5 study J. Huiskens, P. B. Olthof, A. Keijser, K. P. van Lienden, M. R. Engelbrecht, J. J. Hermans, I. Molenaar, C. Verhoef, K. de Jong, C. Dejong, G. Kazemier, T. Ruers, J. de Wilt, A. Rijken, M. Gerhards, M. Liem, G. Patijn, M. van Oijen, C. Punt, T. van Gulik, Netherlands

P9.07

Can liver surgeons really rely on today’s imaging for CRLM? G. A. Stavrou, M. Zeile, M. H. Fard-Aghaie, H. Weilert, K. C. Wagner, A. Stang, R. Bruening, K. J. Oldhafer, Germany

12.30 pm 01.20 pm

P10 Management of non-CRC Liver Metasases Chairs: S. Fichtner-Feigl, Germany; S. Jegatheeswaran, United Kingdom

P10.01

Liver metastasis of squamous cell carcinoma of the pyriform sinus M. Sánchez-Rubio, J. R. Oliver, M. Serradilla, A. Palomares, E. Laviano, A. B. Roche, S. Paterna, A. Serrablo, Spain

P10.02

Results of hepatic resection following breast cancer liver metastasis K. Kobryń, E. Kobryń, K. Kobryń, M. Nowosad, W. Patkowski, K. Zieniewicz, Poland

P10.03

Hepatic Resection for Isolated Breast Cancer Liver Metastasis; Single Center Experience S. P. Yun, M. H. Yoon, H. I. Seo, Republic of Korea

Poster Area

P8.06

Poster Area

Poster Area

Poster Area

P8.05


89

P14 Hepatocellular Carcinoma Chairs: G. Belli, Italy; M.-A. Wörns, Germany

P14.01

Prognostic Impact of OPN and DKK1 in Patient of Hepatocellular Carcinoma after Hepatectomy Y. Seo, H. R. Byeon, S. D. Lee, South Korea

P12.02

Liver hydatid cyst opened into portal vein S. Zribi, Z. Mzoughi, S. Omrani, R. Bayar, G. Talbi, N. Arfa, L. Gharbi, H. Mestiri, T. Khalfallah, Tunisia

P14.02

Developed operation method for patient-derived orthotopic xenograft model of hepatocellular carcinoma H. R. Byeon, Y. Seo, S. D. Lee, South Korea

P12.03

Laparoscopic surgery for hydatid disease of the liver E. Korkut, N. Aksungur, G. Ozturk, R. Yavuz, A. F. Uygur, Turkey

P14.03

MicroRNA-203a is a crucial regulator of self-renewal and tumorigenicity of human hepatocellular carcinoma by directly targeting BMI1 H. Fu, R. Zhang, S. He, L. Xu, C. Liu, China

P12.04

Pancreatic Hydatid Cyst Due to Sinistral Hypertension: Case Report T. Canbak, A. Acar, F. Basak, F. Kulali, G. Bas, Turkey

P14.04

P12.05

Surgical treatment of cyst hydatid disease of the liver in the era of percutanous treatment O. Cennet, M. B. Tirnaksiz, A. B. Dogrul, O. Abbasoglu, Turkey

Inhibitory effect of targeted therapies of different signalling pathways in DEN-induced hepatocarcinogenesis in C57BL/6 mice A. Giakoustidis, P. Andreani, T. Poutahidis, K. Angelopoulou, T. Goulopoulos, E. Louri, A. Papalois, S. Mudan, D. Giakoustidis, D. Azoulay, United Kingdom and others

P12.06

Primary hydatid cyst of the pancreas: difficulties and therapeutic management H. Maghrebi, F. S. Fteriche, A. Makni, M. Jouini, M. Kacem, Z. Bensafta, Tunisia

P14.05

Multimodal treatment modalities are associated with improved long-term outcome in patients with recurrent hepatocellular carcinoma J. Bednarsch, M. Foerster, W. Schoening, F. Ulmer, I. Amygdalos, Z. Czigany, A. Kroh, D. Kroy, U. Neumann, G. Lurje, Germany

P12.07

Peritoneal hydatid cysts: An unusual finding in western countries R. Melendez, P. Senra, R. Carracedo, E. Casal, F. Ausania, Spain

P14.06

Angiogenic miRNAs and related TIE2-expressing monocytes impact outcome in human cholangiocarcinoma G. Atanasov, C. Benzing, F. Krenzien, A. Brandl, L. Feldbrügge, H. Morgül, A. ReutzelSelke, S. Jonas, M. Bahra, A. Pascher, J. Pratschke, M. Schmelzle, Germany

P14.07

Stage adjusted therapy of HCC – Influence of liver function on therapeutic outcome after surgical treatment or TACE N. Heiermann, D. Buchner, R. Kleinert, C. Bruns, D. Stippel, Germany

12.50 pm 01.40 pm

P15 Acute Pancreatitis Chairs: K. Hoffmann, Germany; W. Hiller, Germany

P15.01

The presence of acute cholangitis defined by 2013 Tokyo Guidelines (TG13) in acute necrotising pancreatitis is associated with poor outcomes E. Pando Rau, P. Alberti Delgado, L. Blanco Cuso, M. Caralt Barba, C. Dopazo Taboada, J. L. Lázaro Fernández, I. Bilbao Aguirre, J. Balsells Valls, R. Charco Torra, Spain

P15.02

Protection of acute renal injury in severe experimental acute pancreatitis S. Chuklin, S. Chooklin, B. Pidhirnyy, Ukraine

P15.03

Deep cross pancreatic necrosis and viable parenchyma distal to it determine the development of local complications and mortality in acute pancreatitis T. Dyuzheva, A.V. Shefer, E.V. Dzhus, I.A. Semenenko, E.I. Galperin, Russian Federation

P15.04

IL-6 and CRP are superior in early severity stratification of acute pancreatitis H. Sternby, H. Hartman, H. Thorlacius, S. Regnér, Sweden

P15.05

Evaluation of the Modified CT Severity Index (MCTSI) and CT Severity Index (CTSI) in Assessing Severity And Clinical Outcomes in Acute Pancreatitis P. Alberti Delgado, E. Pando Rau, L. Vidal Piñeiro, L. Blanco Cuso, C. Dopazo Taboada, M. Caralt Barba, J. L. Lázaro Fernández, I. Bilbao Aguirre, J. Balsells Valls, R. Charco Torra, Spain

P12 Hydatid Cyst Chairs: G. Ozturk, Turkey; A. Mehrabi, Germany

P12.01

Hydatid disease in South-Africa – Is it a different disease in patients with HIV co-infection? C. Kloppers, K. Couzens-Bohlin, M. Bernon, S. Burmeister, S. Beningfield, U. Kotze, J. Krige, E. Jonas, South Africa and others

Poster Area

Poster Area

12.50 pm 01.40 pm

12.50 pm 01.40 pm

P12.08

90


Mechanical jaundice as a complication of the liver hydatid disease: Management tactics B. Altiyev, K. Anvarov, F. Khadjibaev, S. Tilemisov, Uzbekistan

12.50 pm 01.40 pm

P13 Vascular Infiltration of Liver Tumors Chairs: J. Pratschke, Germany; C. Hillert, Germany

P13.01

Future Liver Remnant Hypertrophy with Yttrium90Radioembolization in a Patient with Gastric Neuroendocrine Tumour Liver metastasis O. A. Cetinkaya, E. O. Kirimker, A. Demirkazik, M. Ozcelik, S. Bilgic, E. Ustuner, C. Soydal, O. Kucuk, V. Genc, D. Balci, Turkey

P13.02

Extended right hepatectomy and VCI resection to achieve R0 resection of a VCI leiomyosarcoma C. Bilgic, C. Indelen, S. Ates, A. Armutlu, M. Erkan, Turkey

P13.03

Schwannoma, IVC Leiomyosarcoma, and IPMN of heterotopic pancreatic tissue A. Zanellato, R. Thompson, I. Reccia, M. Pai, N. Habib, United Kingdom

P13.04

Solitary fibrous tumors of hepatopancreatobiliary system; 2 Case reports Y. Türk, A. Uğuz, O. V. Unalp, A. Coker, Turkey

P13.05

Our experience in surgical resection of hepatoblastoma J.-R. Oliver, M. Serradilla, S. Genzor, A. Palomares, L. Serrablo, A. Serrablo, Spain

P13.06

Role of A.L.P.P.S. in treatment of perihilar cholangiocarcinoma: Experience of single centre F. Mocchegiani, R. Montalti, M. Vivarelli, Italy

Poster Area

Poster Area

Poster Sessions

91

92

Prognostic Ability Of Inflammation Based Scores In Acute Pancreatitis E. Altintas, M. Bakir Koyuncu, S. Yaras, E. Ucbilek, F. Ates, O. Sezgin, Turkey

P15.07

The role of IL17-A in the second hit of acute pancreatitis J.-E. Thomson, M. Brand, P. Fonteh, South Africa

12.50 pm 01.40 pm

P16 Chronic Pancreatitis Chairs: C. R. Carter, United Kingdom; J. Schmidt, Switzerland

P16.01

Surgical treatment of complicated pseudocyst of pancreas I. A. Kryvoruchko, N. N. Goncharova, Ukraine

P16.02

Endoscopic methods of internal drainage of pancreatic pseudocysts A. Shabunin, V. Bedin, I. Korzheva, V. Vengerov, Russian Federation

P16.03

Pancreaticojejunostomy drainage in chronic pancreatitis surgery A. Varabei, A. Shuleika, Y. Arlouski, E. Vizhinis, Belarus

P16.04

Recurrence after endoscopic treatment of pancreatic pseudocysts – A long-term follow-up F. Rückert, A. Lietzmann, T. Wilhelm, M. Sold, G. Kähler, A. Schneider, Germany

P16.05

The role of double balloon enteroscopy in the diagnosis and treatment of chronic pancreatitis surgery complications A. Varabei, A. Shuleika, Y. Arlouski, E. Vizhinis, Belarus

P16.06

Pancreas-preserving total Duodenectomy: A surgical treatment pathway for duodenal wall polyps A. Heumann, A. Duprée, J. Izbicki, M. Bockhorn, Y. Vashist, Germany

P16.07

Duodenum-preserving pancreatic head resection and resection of the head of the pancreas combined with segmental duodenectomy I. Kozlov, T. Shevchenko, M. Baydarova, V. Vishnevsky, A. Zhao, Russian Federation

12.50 pm 01.40 pm

P17 Rare Pancreatic Tumors Chairs: S. A. Ahmad, United States; M. M. Erkan, Turkey

P17.01

Metastases of kidney clear-cell carcinoma: structural and treatment results Y. Stepanova, A. Teplov, O. Chekhoeva, A. Krieger, V. Vishnevsky, Russian Federation

P17.02

Rare case of pancreatic pseudo tumor C. Anthoni, U. Braun, S. Farkas, Germany

P17.03

A Rare but Curable Pancreatic Tumor M. Sá, J. Constantino, J. Pereira, C. Casimiro, Portugal

P17.04

Primary malignant melanoma of the duodenum with pancreatic involvement treated with pancreaticoduodenectomy R. Cañada Surjan, F. Ferrari Makdissi, T. Basseres, M. Autran Cesar Machado, Brazil

P17.05

Primary malignant melanoma of the duodenum. A case report of surgical management and long-term survival of the rare disease A. Sakharov, K. Shostka, K. Ilyin, L. Roman, Russian Federation

P17.06

Solid Pseudopapillary Tumor of the Pancreas: Experience of a Single Institution P. Sarkut, O. Isik, N. Ugras, I. Tirnova, S. Kilicturgay, Turkey

P17.07

Pancreatic panniculitis in acinar cell carcinoma of the pancreas with liver metastases R. C. Miksch, T. S. Schiergens, M. N. Thomas, M. Ilmer, J. Hidding, A. Papyan, M. Weniger, A. Khandoga, J. Werner, J. G. D‘Haese, Germany

Poster Area

P15.06


Poster Area

Poster Area

Poster Area

Poster Area

Poster Sessions

12.50 pm 01.40 pm

P18 Palliative Therapy of Pancreatic Cancer Chairs: C. Macutkiewicz, United Kingdom; M. Möhler, Germany

P18.01

Tumor-specific intraoperative detection of pancreatic ductal adenocarcinoma using multimodal molecular imaging W. Tummers, R. J. Swijnenburg, S. Miller, T. Teraphongphom, A. Gomez, R. Kothapalli, I. Steinberg, D. Huland, B. Bonsing, A. Vahrmeijer, T. Longacre, G. Fisher, S. S. Gambhir, G. Poultsides, E. Rosenthal, United States and others

P18.02

Modified FOLFIRINOX in locally advanced and metastatic pancreatic cancer: The first prospective study in the Chinese population X. Li, T. Ma, X. Bai, T. Liang, China

P18.03

CA19-9 response and CT-imaging predict resectability of locally advanced pancreatic carcinoma following neoadjuvant chemotherapy E. van Veldhuisen, J. A. Vogel, O. R. Busch, J. W. Wilmink, K. P. van Lienden, H. A. Marsman, M. G. Besselink, Netherlands

P18.04

Pancreatic resections for advanced M1-pancreatic carcinoma A. Uguz, O. Unalp, R. Ortac, G. Akpinar, M. Zeytunlu, E. Goker, A. Coker, Turkey

P18.05

The effect of neoadjuvant therapy on tumor characteristics in pancreatic ductal adenocarcinoma – A systematic review with meta-analysis S. Schorn, I. E. Demir, C. M. Reyes, H. Friess, G. O. Ceyhan, Germany

P18.06

Minimally invasive technologies in destructive pancreatitis surgery A. Mamoshin, A. Alyanov, A. Borsukov, A. Abolmasov, A. Dunaev, Russian Federation

P18.07

Staging laparoscopy combined with laparoscopic ultrasound and near-infrared fluorescence imaging to detect occult pancreatic metastases H. Handgraaf, B. Sibinga Mulder, L. Boogerd, S. Feshtali, A. Fariña Sarasqueta, R. J. Swijnenburg, B. Bonsing, A. Vahrmeijer, J. S. D. Mieog, Netherlands

12.50 pm 01.40 pm

P19 Pancreas Surgery Chairs: J. Werner, Germany; I. E. Khatkov, Russian Federation

P19.01

A new, simple and safe pancreaticojejunal anastomosis. Three Grade B pancreatic leaks after 100 consecutive procedures V. Egorov, R. Petrov, Russian Federation

P19.02

Can hemostasis products prevent postoperative pancreatic fistulas after distal pancreatectomy? An animal model trial C. M. Kühlbrey, S. Kasper, U. T. Hopt, S. Fichtner-Feigl, U. A. Wittel, Germany

P19.03

Safety of Blumgart´s Anastomosis During Traverso Operation is Independent of Diagnosis and Risk Factors for Pancreaticojejunal Anastomotic Failure Z. Hirche, B. von der Linden, S. Klippel, S. Willis, Germany

P19.04

Enveloped double curse-string versus conventional pancreatico-gastrostomy: Comparative study A. M. El-Badry, A. A. Redwan, M. A. Abusedera, H. M. Ali, Egypt

P19.05

Operations on the pancreas using robotic complex A. Kriger, S. Berelavichus, A. Kaldarov, D. Gorin, Russian Federation

P19.06

Pancreaticojejunostomy with seromuscular jejunal flap formation to prevent pancreatic fistula K. Toutouzas, K. Stasinos, D. Panagopoulos, P. Drimousis, S. Stergiopoulos, G. Zografos Greece

93

94

Poster Sessions Thursday, May 25, 2017

Improved telescopic pancreatojejunostomy in pancreatic surgery K. Sementsov, M. Kabanov, D. Yakovleva, Russian Federation

12.10 pm 01.00 pm

P21 Liver Transplantation Chairs: M. L. de Oliveira, Switzerland; I. Klein, Germany

P19.08

Sealing with NHS-PEG patch to prevent postoperative pancreatic fistula after pancreatojejunostomy M. Serradilla, A. Palomares, S. Paterna, J. M. Ramia, A. Serrablo, Spain

P21.01

Pattern of hepatocellular carcinoma recurrence following living donor liver transplantation H. Zakaria, H. Shoreem, A. Aziz, K. Abou El-Ella, T. Ibrahim, Egypt

P21.02

A new possible therapeutical approach to the toxic acute liver failure: Portal vein arterialization A. Recordare, O. Pilishvili, L. Gogichaishvili, S. Beridze, S. Dokmak, M. Rizzo, Italy

P21.03

Long term survival of liver transplantation for hepatocellular carcinoma meeting milan criteria M. Prieto, A. Valdivieso, M. Gastaca, J. Bustamante, A. Ventoso, P. Ruiz, I. Palomares, A. Matarranz, M. Testillano, J. R. Fernández, J. Ortiz de Urbina, Spain

P21.04

Liver volume regeneration after living donor liver transplantation (LD / LDLTx) depends on segmental perfusion A. Nikolic, U. Dahmen, O. Dirsch, R. Fahrner, F. Rauchfuß, U. Settmacher, Germany

P21.05

Recipient celiac trunk stenosis is a significant risk factor for early hepatic artery thrombosis after liver transplantation I. Mohr, M. Albrecht, M. Hoppe-Lotichius, M. Heise, G. Otto, R. Klöckner, P. R. Galle, T. Zimmermann, H. Lang, J. Mittler, Germany

P21.06

Description of a recovery experimental general anesthesia model in rabbits for the study of the late phase of liver ischemia-reperfusion injury A. Mantelou, M. Karamperi, K. Tsarea, E. Karampela, N. Psichalakis, A. Papalois, A. Papoudou-Bai, A. C. Goussia, C. Katsios, G. Glantzounis, Greece

P21.07

Predictive factors for biliary stones after donor brain dead liver transplantation U. Maggi, G. Paone, A. Chierici, G. Fornoni, D. Conte, P. Cantù, M. Fabbi, L. Caccamo, G. Rossi, Italy

12.10 pm 01.00 pm

P22 Enhanced Recovery Surgery Chairs: C. Sturesson, Sweden; A. Weimann, Germany

P22.01

Effects on nutritional parameters and inflammatory scores in a cohort of major pancreatic resections receiving preoperative immunonutrition M. Rodriguez-Lopez, F. J. Tejero Pintor, B. Perez-Saborido, M. Bailon-Cuadrado, L. M. Diez-Gonzalez, E. Asensio-Diaz, K. T. Plua-Muniz, E. Choolani-Bhojwani, A. Barrera-Rebollo, Spain

P22.02

Sustainability of an enhanced recovery program for pancreaticoduodenectomy C. Williamsson, D. Ansari, R. Andersson, B. Tingstedt, Sweden

P22.03

Analysis of Cost Savings Associated with an Enhanced Recovery Program in Liver Surgery C. Davis, B. Kim, N. Narula, T. Aloia, United States

P22.04

Enhanced Recovery After Surgery Program in Open and Laparoscopic Liver Resection C. Chong, W. Y. Chung, P. Yau, P. Wong, H.-T. Lok, A. Fung, A. Fong, S. Cheung, J. Wong, K.-F. Lee, E. Wong, P. Lai, Hong Kong

P22.05

Implementation of enhanced recovery program after surgery (ERAS) in patients undergoing pancreatectomy: A controlled before and after study J. Perinel, A. Duclos, T. Dagonneau, C. Payet, Y. Bouffard, M. C. Le goff, D. Delaunay, C. Colin, J.-C. Lifante, M. Adham, France

P22.06

Enhanced recovery after surgery for pancreaticoduodenectomy: Possible, but justified? J. Tankel, E. Boaz, P. Reissman, M. Ben Haim, A. Dagan, Israel

12.50 pm 01.40 pm

P20 Pancraticoduodenectomy Chairs: D. Panchenkov, Russian Federation; P. Pfeiffer, Denmark

P20.01

Hepatobiliary and pancreatic surgery in a low budget country: Experience from Ayder Referral Hospital, Northern Ethiopia R. Esayas, A. Idris, M. W. Hoffmann, Ethiopia

P20.02

Perioperative outcomes after pancreatoduodenectomy for ampullary carcinoma: A 9-year experience from a tertiary referral centre in the UK J. Chang, V. Mavroeidis, M. Soo, A. Gibbs, P. Osuri, M. Silva, S. Reddy, Z. Soonawalla, United Kingdom

P20.03

One Hundred and Seventy Pancreaticoduodenectomy: No Intensive Care Unit Admission H. Ezzedine, M. Khalife, H. Nassar, J. Obeid, W. Faraj, Lebanon

P20.04

Nontrauma emergency pancreatoduodenectomies – A single-center retrospective analysis M. F. Nentwich, M. Reeh, F. G. Uzunoglu, K. Bachmann, M. Bockhorn, J. Izbicki, Y. Vashist, Germany

P20.05

Pancreaticoduodenectomy in the Middle East: A Single Center Experience M. Khalife, H. Nassar, A. haydar, H. Ezzedine, R. Wehbe, J. Obeid, W. Faraj, Lebanon

P20.06

Short-term results of en bloc pancreaticoduodenectomy for surgical treatment of patients with non-pancreatic malignant tumors K. Shostka, K. Ilyin, K. Arutyunyan, A. Saharov, L. Roman, Russian Federation

P20.07

Updated validation of the PREPARE score from a Spanish prospective cohort of major pancreatic resections M. Rodriguez-Lopez, F. J. Tejero Pintor, B. Perez-Saborido, A. Barrera-Rebollo, E. Asensio-Diaz, L. M. Diez-Gonzalez, M. Bailon-Cuadrado, M. Gonzalez-Sagrado, J. L. Marcos-Rodriguez, Spain

P20.08

Worldwide survey on opinions and use of minimally invasive pancreatic resection J. van Hilst, T. de Rooij, M. Abu Hilal, H. Asbun, J. Barkun, U. Boggi, O. Busch, K. Conlon, M. Dijkgraaf, H. Han, P. Hansen, M. Kendrick, A. Montagnini, C. Palanivelu, B. Røsok, S. Shrikhande, G. Wakabayashi, H. Zeh, C. Vollmer, D. Kooby, M. Besselink, for the 2016 IHPBA state of the art conference on Minimally Invasive Pancreatic Resection, Netherlands and others

Poster Area

P19.07

Poster Area

Poster Area

Poster Area

Poster Sessions Wednesday, May 24, 2017

95

96

P22.08

Early surgery with a ‘fast track’ pathway for periampullary malignancy is associated with an increased rate of pancreatoduodenectomy and reduced costs K. Roberts, P. Prasad, Y. Steele, B. Dasari, M. Abradelo, R. Marudanayagam, R. Sutcliffe, P. Muiesan, D. Mirza, J. Isaac, United Kingdom

12.10 pm 01.00 pm

P23 Liver Surgery Chairs: M. de Jong, Netherlands; O. Kotenko, Ukraine

P23.01

Performance of liver resections in Greece: Factors that dictate postoperative ICU admission G. C. Sotiropoulos, N. Machairas, I. D. Kostakis, P. Stamopoulos, G. Kouraklis, Greece

P23.02

Sixteen Years of Experience in Surgical Management after Extended Hepatectomy – A Single Center Experience D. Pagano, L. Castellana, D. Cintorino, A. Tropea, S. Li Petri, R. Miraglia, S. Gruttadauria, Italy

P23.03

Liver surgery – A single center five year experience E. Malcevs, Z. Visnevska, J. Vilmanis, A. Ozolins, J. Gardovskis, Latvia

P23.04

Assessment of results of a resection of a liver B. Rakhimov, V. Kolesnikov, Russian Federation

Poster Area

Abandoning prophylactic abdominal drainage after hepatic surgery: 10 years of no-drain policy in an ERAS environment V. van Woerden, E. Wong-Lun-hing, T. Lodewick, M. Bemelmans, S. Olde Damink, C. Dejong, R. van Dam, Netherlands

Poster Area

P22.07

Thursday, May 25, 2017

P24.05

Comparison of standard multiport vs. reduced port left lateral liver resection B. Struecker, P. Haber, A. Andreou, N. Raschzok, G. Atanasov, C. Benzing, F. Krenzien, I. Sauer, R. Zorron, M. Biebl, R. Öllinger, M. Bahra, A. Pascher, J. Pratschke, M. Schmelzle, Germany

P24.06

Reporting of risk of bias at trial registration B. V. van Rosmalen, J. Huiskens, E. R. Bruns, M. G. Besselink, C. J. Punt, L. Hooft, T. M. van Gulik, Netherlands

P24.07

A twenty-year experience with fibrin-collagen substance V. Gorskiy, M. D. Polivoda, A. Volenko, Russian Federation

12.10 pm 01.00 pm

P25 ALPPS Chairs: H. Petrowsky, Switzerland; A. Pinna, Italy

P25.01

ALPPS procedure for hepatocellular carcinoma with macrovascular tumoral thrombosis: The San Camillo Experience G. B. Levi Sandri, G. Vennarecci, P. Lepiane, M. Colasanti, G. M. Ettorre, Italy

P25.02

What percentage of patients is considered for a 2-Stage / ALPPS procedure to face their disease? G. A. Stavrou, M. H. Fard-Aghaie, M. Donati, R. Bruening, K. J. Oldhafer, Germany

P25.03

An initial experience with Partial ALPPS vs. palliative chemotherapy in advanced Colorectal Liver Metastases Y. Z. Lee, Z. H. Teo, M. Brand, H. Y. Wu, V. G. Shelat, J. K. Low, Singapore and others

P25.04

ALLPS For a Central Cholangiocarcinoma: A Case Report from the Middle East H. Ezzedine, M. Khalife, R. Wehbe, H. Nassar, J. Obeid, R. Abou Eid, A. Haydar, W. Faraj, Lebanon

P25.05

The ALPPS approach for colorectal liver metastases: Impact of KRAS mutation status on survival M. Serenari, F. Alvarez, V. Ardiles, M. De Santibanes, J. Pekolj, E. De Santibanes, Italy and others

P23.05

Liver surgery at Kenyatta National Hospital – A referral hospital experience W. Kiraitu, W. Kaisha, K. Ondede, Kenya

P23.06

Vascular complications following selective portal venous embolisation – Is post-interventional extended liver resection still possible? S. Memming, P. Kaudel, N. Abusalim, O. Kollmar, Germany

P23.07

Safety and feasibility of caudate lobe resections G. C. Sotiropoulos, P. Stamopoulos, N. Machairas, I. D. Kostakis, G. Kouraklis, Greece

P25.06

P23.08

Tourniquet ALPPS: Minimizing the risk of the first stage of ALPPS R. Robles Campos, R. Brusadin, A. López Conesa, V. López López, P. J. Gil Vázquez, A. Delegido, P. Parrilla Paricio, Spain

ALPPS procedure for extended liver resections: A single centre experience in Algeria K. Bentabak, S. Redouane, M. Kheloufi, C. Bouzid, K. Cherchar, Z. Boudiaf, M. Boubnider, Algeria

P25.07

Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy (ALPPS) – 3 Years oncology outcome M. Vozdvizhenskiy, V. Solovov, A. Orlov, R. Kniazev, A. Turin, Russian Federation

12.10 pm 01.00 pm

P24 Laparoscopic Liver Surgery Chairs: C. Conrad, United States; M. R. Schön, Germany

P25.08

Is there still a place for cholangiocarcinoma in the ALPPS? I. Capobianco, J. Rolinger, K. Jansen, I. Königsrainer, J. Li, A. Königsrainer, S. Nadalin, Germany

P24.01

Live laparoscopic liver resection allows to achieve the necessity of training without negatively affecting the postoperative outcome F. Ratti, F. Cipriani, G. Fiorentini, M. Catena, M. Paganelli, L. Aldrighetti, Italy

P26 Management of CRC Metastases Chairs: M. Möhler, Germany; C. Verhoef, Netherlands

P24.02

Morbidity and Health-related Quality of Life after laparoscopic liver resection C. Benzing, F. Krenzien, D. Gohlke, A. Andreou, M. Biebl, R. Zorron, G. Atanasov, B. Strücker, N. Raschzok, M. Bahra, R. Oellinger, J. Pratschke, M. Schmelzle, Germany

12.10 pm 01.00 pm P26.01

The current limit for resection rate for colorectal liver metastases J. Freedman, J. Engstrand, C. Strömberg, E. Jonas, Sweden and others

P24.03

Lessons learned from 103 Consecutive laparoscopic liver resections T. Piardi, A. Cagniet, R. Rhaiem, Y. Renard, M. Chetboun, D. Sommacale, R. Kianmanesh France

P26.02

The presence of lung metastases does not influence survival in liver metastatic colorectal cancer J. Engstrand, H. Nilsson, C. Strömberg, E. Jonas, J. Freedman, Sweden and others

P24.04

Warm humidified insufflation reduces inflammatory response in patients undergoing laparoscopic liver resection K. Pickles, C. Hammill, S. Jegatheeswaran, D. Subar, United Kingdom

Poster Area

Poster Area

Poster Area

Poster Area

Poster Sessions

97

Poster Sessions

98

Liver resection for colorectal liver metastases: Risk of recurrence from liver-first approach associated with Pringles manoeuvre A. Amer, H. Hayhurst, A. Kanwar, C. Wilson, G. Sen, J. French, D. Manas, S. White, United Kingdom

P26.05

Resection of hepatic metastatics from colorectal carcinoma. Factors related with recurrence and disease-free survival B. Pérez-Saborido, E. Asensio-Díaz, M. Rodríguez-López, M. Bailón-Cuadrado, F. J. Tejero, K. Plúa, S. Mambrilla, E. Choolani, D. Pacheco, L. M. Díez, P. Pinto, A. Barrera, Spain

P26.06

Is there any differences in outcome of synchronous liver resection for colorectal metastases stratified by type of colorectal resection? E. Dulundu, M. Tilki, E. Tanrikulu Simsek, O. Gunal, A. Erdim, C. Yegen, Turkey

P26.07

Comparison between two-stage hepatectomy (TSH) and tourniquet ALPPS for advanced colorectal liver metastases (CRLM) R. Brusadin, R. Robles Campos, A. López Conesa, P. J. Gil Vázquez, V. López López, P. Parrilla Paricio, Spain

12.10 pm 01.00 pm

P28 Management of Pancreatic Fistula Chairs: P. Bachellier, France; C. Genc, Netherlands

P28.01

Validation of a score to predict blood transfusion following pancreatoduodenectomy demonstrates distinct risk factors for early and late transfusion S. S. Bansal, J. Hodson, K. Khalil, B. V. M. Dasari, M. Abradelo, R. Marudanayagam, R. P. Sutcliffe, P. Muiesan, J. Isaac, D. F. Mirza, K. J. Roberts, United Kingdom

P28.02

Risk factors for major intraoperative bleeding during pancreaticoduodenectomy and the impact of bleeding on postoperative outcome B. Andersson, J. Nilsson, C. Ansorge, B. Tingstedt, Sweden

P28.03

Treatment of postoperative chyle leak after pancreatic surgery – A single center experience M. Weniger, J. D‘Haese, E. Faller, S. Becker, M. Ilmer, M. Angele, J. Werner, W. Hartwig, Germany

P28.04

Enzymatic mediastinitis: Case description and review of literature M. Paniagua Garcia Señorans, M. R. Meléndez Villar, P. Senra del Río, C. Zueco Zueco, E. M. García Fontán, J. E. Casal Nuñez, F. Ausania, Spain

P28.05

Effective treatment technique of pancreatic fistula grade C after gastropancreatoduodenal resection D. Kuchin, N. Kiselev, N. Bobrov, V. Zagainov, Russian Federation

P28.06

αSMA activity but not the activated stroma index / ASI is associated with the generation of postoperative pancreatic fistula after distal pancreatectomy M. Sargut, F. Scheufele, R. Schirren, E. Demir, M. Erkan, J. Kleeff, H. Friess, G. Ceyhan, Germany and others

12.10 pm 01.00 pm

P27 Intrahepatic Cholangiocarcinoma Chairs: S. A. Lang, Germany; S. Olde Damink, Netherlands Immunohistochemical and functional analysis of the new cholangiocellular carcinoma cell line CCC-5 J. Grün, S. Zach, A. Bauer, T. Gaiser, S. Dooley, S. Post, F. Rückert, Germany

P28.07

P27.01

Economic impact of postoperative pancreatic fistula in pancreatic surgery O. Strobel, U. Hinz, T. Hank, W. Niesen, T. Hackert, M. Büchler, Germany

P27.02

Is Tumor Detachment from Vascular Structures a Technical Option for Intrahepatic Cholangiocarcinoma? L. Vigano, A. Fontana, F. Procopio, A. Terrone, M. Cimino, M. Donadon, D. Del Fabbro, G. Torzilli, Italy

12.10 pm 01.00 pm

P29 Cystic Diseases Chairs: M. Milicevic, Serbia; Y. Yankol; Turkey

P29.01

Gallbladder Adenosquamous Carcinoma Associated with Biliopancreatic Maljunction: Aggressive resection and survival E. Martin-Perez, E. Colmenarejo, M. di Martino, J. L. Muñoz de Nova, J. L. Martin-Alvarez Spain,

P29.02

A unique choledochal cyst V. K. Mavroeidis, J. Chang, M. Silva, Z. Soonawalla, United Kingdom

P29.03

Undescribed Intra and Extrahepatic Congenital Choledochal Cysts W. Faraj, H. Nassar, R. Abou Eid, G. Kassir, S. Jabre, M. Khalife, A. Haydar, Lebanon

P29.04

A liver trauma many years ago – Today peritoneal hydatidosis – A case report O. Ginghina, R. Iosifescu, A. Spanu, M. Mardare, T. Chapelle, M. Zamfir, S. Omer, N. Iordache, Romania and others

P29.05

Retention cyst after surgical treatment due to echinococcosis (Case Report) E. Eneva, M. Setchanova, S. Sergeev, Bulgaria

P29.06

Surgical therapy of segmental Caroli’s Syndrom – A case of unusual clinical and radiological results M. Kochergin, P. Kaudel, S. Memming, O. Kollmar, Germany

P27.03

Intrahepatic cholangiocarcinoma – 102 resections from a single center F. Bartsch, J. Baumgart, S. Heinrich, H. Lang, Germany

P27.04

Hepatic malignancies infiltrating the hepatocaval confluence – A single center experience with ante situm liver resection F. Oldhafer, K. Timrott, M. Kleine, W. Ramackers, S. Cammann, M. Jäger, J. Klempnauer, H. Bektas, F. Vondran, Germany

P27.05

Intrahepatic Cholangiocarcinoma: Outcome and Prognosis – A single center experience H. Neeff, P. Holzner, M. Menzel, A. Klock, F. Makowiec, S. Lang, S. Fichtner-Feigl, Germany

P27.06

Outcome of liver resection for intrahepatic cholangiocarcinoma with macroscopic vascular invasion. Analysis of a multi-institutional database L. Vigano, S. Conci, G. Ercolani, E. Gonzalez, A. Fontana, A. Ruzzenente, P. Di Gioia, M. de Santibañes, E. de Santibañes, A. D. Pinna, A. Guglielmi, G. Torzilli, Italy and others

Poster Area

Poster Area

Poster Area

P26.04

First long-term follow-up study of near-infrared fluorescence-guided resection of colorectal liver metastases H. Handgraaf, L. Boogerd, D. Höppener, B. Sibinga Mulder, C. Hoogstins, G. J. Liefers, H. Hartgrink, C. van de Velde, J. S. D. Mieog, R. J. Swijnenburg, H. Putter, A. Braat, J. Frangioni, A. Vahrmeijer, Netherlands and others

Poster Area

P26.03


99

100

P29.08

Cholecystocutaneous fistula occurring through the chest wall P. Senra, R. Melendez, S. Guzman, E. Casal, F. Ausania, Spain

12.10 pm 01.00 pm

P30 Echinococcus Alveolaris Chairs: A. Serrablo, Spain; Y. Yilmaz; Turkey

P30.01

Predictive value of CA 19-9 elevation in the evaluation of occult biliocystic communication in uncomplicated liver hydatid disease T. Canbak, A. Acar, H. K. Tolan, E. Unal, Turkey

P30.02

Multivisceral resection for Hepatic Alveolar Echinococcosis E. Korkut, G. Ozturk, N. Aksungur, B. Aydinli, U. Memis, M. Fakirullahoglu, Turkey

P30.03

An extremely rare localization of Echinococcus Alveolaris; pancreas S. Usta, K. Karabulut, Turkey

P30.04

Preoperative percutaneous drainage of the cystic cavity facilitates resectability in hepatic alveolar echinococcosis G. Ozturk, E. Korkut, N. Aksungur, S. Kara, B. Aydinli, M. Yur, Turkey

P30.05

Surgical management of advanced hepatic alveococcosis using transplantation technologies N. Kiselev, D. Kuchin, N. Bobrov, E. Zagainov, V. Zagainov, Russian Federation

P30.06

Technical challenges in major liver resection for alveolar echinococcosis J. Strohäker, S. Nadalin, I. Capobianco, A. Königsrainer, Germany

P30.07

Percutaneous echinococcectomy from the liver S. V. Novikov; M. L. Rogal; K. R. Jagrayev; P. A. Yartsev; V. S. Boyarinov; A.V. Vodyasov, Russian Federation

Poster Area

Results of the treatment of patients who underwent surgery concerning cystic transformation of biliary ducts Y. Stepanova, D. Ionkin, A. Koroleva, A. Shurakova, V. Vishnevsky, Russian Federation

Poster Area

P29.07


P31.06

Liver pecoma: Perivascular epithelioid tumor – A case report A. A. Medina Velasco, Y. Rodrigues, A. Manuel Vázquez, J. M. Ramia Ángel, A. J. López Marcano, J. Valenzuela Torres, C. García Amador, B. González Sierra, V. Arteaga Peralta, R. De la plaza Llamas, Spain

P31.07

Liver PEComa – An extremely rare case report with complicated post-operative course V. Tatsi, D. Kyrochristos, A. Paliouras, H. Milionis, P. Voulgari, A. Goussia, G. Papadopoulos, G. Glantzounis, Greece

P31.08

An ununsual cause of liver abscess in western countries R. Melendez, P. Senra, E. Casal, F. Ausania, Spain

12.40 pm 01.30 pm

P32 Hepatocellular Carcinoma Chairs: D. Azoulay, France; J. P. Pereira, Portugal

P32.01

A case of ruptured Hepatocellular carcinoma (HCC) accompanied with Dubin-Johnson syndrome (DJS) N. Nakamura, T. Sanada, Y. Watanabe, H. Kuwabara, N. Goseki, Japan

P32.02

Liver resection in a Ghanesian patient with hepatocellular carcinoma – Case report L. Staib, J. Yangyuoru, T. Feller, Germany

P32.03

A heavy metal knocking at the door – Transarterial Embolization with Rhenium188 as a bridging strategy for treating Hepatocellular Carcinoma R. Sinha, V. Shanmugam, India

P32.04

Liver resection for ruptured hepatocellular carcinoma – A propensity matched analysis N. Pinsker, M. Papoulas, M. Sodergren, K. Menon, A. Quaglia, S. Khorsandi, A. Suddle, P. Srinivasan, W. Jassem, H. Vilca-Melendez, N. Heaton, United Kingdom

P32.05

Survival after hepatectomy for combined hepatocellular-cholangiocarcinoma: A case-match analysis with hepatocellular carcinoma and cholangiocarcinoma A. Mimmo, M. Donadon, M. Silvestri, L. Viganò, D. Del Fabbro, F. Procopio, M. Cimino, L. Di Tommaso, M. Roncalli, G. Torzilli, Italy

12.10 pm 01.00 pm

P31 Benign Liver Tumors Chairs: R. Garcia, Italy; S. Jonas, Germany

P32.06

Resection for Hepatocellular Carcinoma in Octogenarians is safe N. Wylie, E. Hidalgo, K. R. Prasad, P. Lodge, G. Toogood, United Kingdom

P31.01

Recurrent Biliary Cystoadenoma J. Quiñones-Sampedro, M. Caraballo-Angeli, M. Iglesias-Iglesias, L. M. Gonzalez-Fernandez, M. d. C. Esteban-Velasco, O. Bengoechea, L. Muñoz - Bellvis, Spain

P32.07

P31.02

Benign hepatic lesions, a challenge to the surgeon: Indications and outcomes A. B. Mendes Caldeira, C. Fernandes, R. Bessa Melo, M. Oliveira, L. Graça, J. Costa Maia, Portugal

Hyperammonemic encephalopathy in patients with fibrolamellar hepatocellular carcinoma: A new physiopathological pathway R. Cañada Surjan, E. Santana dos Santos, F. Ferrari Makdissi, T. Basseres, M. Autran Cesar Machado, Brazil

P32.08

Hepatic resection for hepatocellular carcinoma in cirrhotic patients with portal hypertension H. Zakaria, E. Gad, A. Nada, A. Abdelaleem, A. Sabry, N. Gaballa, Egypt

12.40 pm 01.30 pm

P33 Pancreas Surgery Chairs: M. Besselink, Netherlands; N. Habib, United Kingdom

P33.01

Laparoscopic pancreatoduodenectomy in 50 consecutive patients with no mortality: How to beat the learning curve? M. A. Machado, F. Makdissi, T. Basseres, R. Surjan, Brazil

P33.02

Preliminary results in Laparoscopic Pancreatoduodenectomy M. Kerem, O. Karatepe, M. Battal, M. F. Can, P. Yazici, K. Dikmen, H. Bostanci, Turkey

P31.03

Intrahepatic splenosis mimicking hepatocellular carcinoma in a patient with non-alcoholic fatty liver disease: A case report W. S. Toh, R. C. Chong, C. H. Tan, C. Ding, S. Vishalkumar, Singapore

P31.04

Pyogenic liver abscess: Treatment modalities S. Zribi, Z. Mzoughi, H. Ben Romdhane, S. Baccouche, G. Talbi, R. Bayar, L. Gharbi, H. Mestiri, T. Khalfallah, Tunisia

P31.05

Hepatic tuberculoma behaving as metastasis of neuroendocrine carcinoma J. Quiñones-Sampedro, M. F. Anduaga-Peña, M. Iglesias-Iglesias, L. M. Gonzalez-Fernandez, M. Caraballo-Angeli, M. d. C. Esteban-Velasco, L. Muñoz-Bellvis, Spain

Poster Area

Poster Area

Poster Area

Poster Area

Poster Sessions

101

Poster Sessions

Poster Area

P33.05

Laparoscopic pancreaticoduodenectomy: A promising new technique for panreaticojejunostomy using V-Loc suture O. Karatepe, M. Battal, P. Yazici, Turkey

P33.06

A new single-loop omega-shaped reconstruction after pancreaticoduodenectomy reduces severity of postoperative pancreatic fistula in high-risk patients O. Belyaev, I. Aghalarov, T. Herzog, W. Uhl, Germany

P33.07

Which suture material is better for preventing pancreatic fistula (PF) after pancreaticoduodenectomy (PD)? N. Aksungur, E. Korkut, G. Ozturk, M. Yeni, M. Kartal, S. S. Atamanalp, S. S. Atamanalp, Turkey

P33.08

Addition of Braun Enteroenterostomy – Impact on early outcomes in Pancreaticoduodenectomy V. R. Vutukuru, India

12.40 pm 01.30 pm

P34 Vascular Reconstruction in Pancreas Surgery Chairs: S. Dokmak, France; S. Rahman, Bangladesh

P34.01

Prognostic nomogram with radiological parameters to predict overall survival in pancreatic carcinoma after pancreatectomy and venous reconstruction Y.-N. Shen, X.-L. Bai, T. Ma, T.-B. Liang, China

P34.02

Patch reconstruction of the superior mesenteric-portal vein using gonadal vein with three-dimensional planning in pancreatic head cancer N. Yoshida, T. Takamoto, T. Hashimoto, Y. Maruyama, T. Miyazaki, H. Abe, A. Ichida, K. Shimada, M. Makuuchi, Japan

P34.03

Surgical outcome of porto-mesenteric resection for borderline pancreatic cancer – A single tertiary referral centre experience P. Regi, R. Girelli, I. Frigerio, A. Giardino, F. Scopelliti, S. Gobbo, G. Butturini, Italy

P34.04

Portal vein resection during pancreatic resection for inflammation instead of true tumor infiltration – A false positive benefit for overall survival? F. Klein, F. Berresheim, T. Denecke, J. Pratschke, M. Bahra, Germany

12.40 pm 01.30 pm

P35 Surgery of the Pancreatic Tail Chairs: R. Deshpande, United Kingdom; G. Kaiser, Germany

P35.01

Feasibility and Outcomes of Laparoscopic Enucleation J. Chung, Republic of Korea

P35.02

The laparoscopic approach should be the standard for central pancreatectomy: Analysis in 52 patients S. Dokmak, B. Aussilhou, F. S. Fteriche, F. Cauchy, P. Lévy, O. Soubrane, A. Sauvanet France

P35.03

Male gender and increased body mass index independently predict clinically relevant morbidity after spleen-preserving distal pancreatectomy T. Dumitrascu, M. Eftimie, A. Aiordachioaie, C. Stroescu, S. Dima, M. Ionescu, I. Popescu, Romania

P35.04

Laparoscopic distal pancreatectomy should be the standard for neuroendocrine tumors – Analysis of a comparative study F. S. Fteriche, R. Chérif, B. Aussilhou, S. Gaujoux, O. Hentic, P. Ruszniewski, A. Sauvanet, S. Dokmak, France

P35.05

Improved Lymph Node Yield In Laparoscopic Distal Pancreatectomy Specimens In Patients With Pancreatic Adenocarcinoma M. Sahakyan, S. P. Haugvik, C. Verbeke, D. Kleive, Norway

P35.06

Retroperitoneal-placed modified hyaluronic acid and carboxymethylcellulose film to prevent delayed gastric emptying after distal pancreatectomy I. Ohsawa, M. Tabata, T. Sakamoto, Y. Fujimura, K. Maeda, K. Kato, M. Iwata, T. Sanda, Japan

P35.07

RAMPS – Surgical Treatment for a Pancreatic Tumor M. Sá, J. Constantino, J. Pereira, C. Casimiro, Portugal

12.40 pm 01.30 pm

P36 Basic Research in Pancreatic Cancer Chairs: C. Bruns, Germany; M. Bernon, South Africa

P36.01

The Kynurenine Pathway as an alternative energy source in Pancreatic Cancer C. Güngör, C. Kondziella, B. Mercanoglu, G. Wolters-Eisfeld, J. R. Izbicki, M. Bockhorn, Germany

P36.02

Interaction between cancer associated fibroblasts (CAFs) and cancer cells in pancreatic cancer – Effects on therapy response and migration R. Schmuck, E. Hoerschelmann, C. Neumann, A. Schirmeier, I. M. Sauer, J. Pratschke, M. Bahra, Germany

P36.03

Extensive desmoplasia is associated with high expression of ZEB1 in pancreatic cancer cells and cancer associated fibroblasts determine prognosis L. Bolm, P. Bronsert, S. Cigolla, L. Käsmann, U. Wittel, U. Hopt, T. Keck, D. Rades, U. F. Wellner, Germany

P34.05

Surgery for elderly patients with resectable pancreatic cancer; comparison with non-surgical treatments H. M. Park, S.-J. Park, J. R. Shim, E. C. Lee, S. D. Lee, S.-S. Han, S. H. Kim, South Korea

P36.04

P34.06

Pancreaticoduodenectomy in septuagenarian and octuagenarian: Single Center experience with 78 Patients K. Jansen, A. Malpaga, A. Königsrainer, J. Rolinger, I. Capobianco, J. Strohäcker, S. Nadalin, Germany

Automated evaluation of spatial heterogeneity of extracellular matrix and modeling its degradation in pancreatic ductal adenocarcinoma (PC) F. Grizzi, S. Fiorino, F. Patrinicola, A. Fornelli, D. de Biase, M. Masetti, L. Mastrangelo, M. Zanello, R. Lombardi, C. Benini, A. Domanico, E. Accogli, S. Di Saverio, A. Tura, C. Fabbri, S. Giovanelli, V. Cennamo, P. Leandri, L. Di Tommaso, E. Jovine, Italy

Pancreaticoduodenectomy in young patients – A single center experience of 58 cases M. El Sorogy, A. El Nakeeb, Egypt

P36.05

High infiltration of CD3+ and CD8+ T-Lymphocytes correlates with improved survival in pancreatic cancer R. C. Miksch, M. B. H. Schoenberg, M. Weniger, J. Hao, S. Yin, T. S. Schiergens, S. Bächmann, S. Ormanns, B. Mayer, A. V. Bazhin, J. Werner, J. G. D‘Haese, Germany

P36.06

Expression and regulation of mTOR, a key modulator of ageing and age-related disease in pancreatic carcinoma T. Kolokotronis, D. Avramis, K. Kölsch, C. Rubie, M. Glanemann, Germany

P34.07

102

A comparison of transverse and midline incisions for pancreaticoduodenectomy P. Prasad, J. Hodson, C. Coldham, R. Marudanayagam, J. R. Isaac, R. P. Sutcliffe, P. Muiesan, D. F. Mirza, K. J. Roberts, United Kingdom

Poster Area

Poster Area

P33.04

Mapping of the superior mesenteric vessels for artery first pancreatoduodencectomy in patients with high visceral fat A. Aldouri, K. Wang, V. Upasani, H. Yamaue, United Kingdom and others

Poster Area

P33.03


103

P37 Local Treatment of Pancreatic Cancer Chairs: A.Coker, Turkey; R. Salvia; Italy

12.40 pm 01.30 pm

P39 Management of IPMN Chairs: V. Egorov, Russian Federation; D. Hoskovec, Czech Republic

P37.01

Local treatment of pancreatic cancer with magnetic nanoparticles A. A. Roeth, I. Slabu, A. Kessler, U. Engelmann, M. Baumann, T. Schmitz-Rode, U. P. Neumann, Germany

P39.01

Differential radiology diagnostics of rare cystic masses of the pancreas Y. Stepanova, Russian Federation

P39.02

P37.02

Time-dependent impact of irreversible electroporation on pancreas, liver, blood vessels and nerves: A systematic review of experimental studies J. A. Vogel, E. van Veldhuisen, P. A. Agnass, J. Crezee, F. Dijk, J. Verheij, T. M. van Gulik, M. R. Meijerink, L. G. Vroomen, K. P. van Lienden, M. G. Besselink, Netherlands

Surgical management of main duct IPMN and mixed type IPMN: An international survey and case-vignette study among experts L. Scholten, N. C. van Huijgevoort, M. Bruno, C. Fernandez–del Castillo, S. Satoi, A. Sauvanet, C. Wolfgang, P. Fockens, S. T. Chari, M. Del Chiaro, J. E. van Hooft, M. G. Besselink, Netherlands and others

P39.03

P37.03

Irreversible electroporation (none-thermal ablation) in treatment of locally advanced pancreatic cancer D. Panchenkov, Y. Ivanov, N. Soloviev, F. Zabozlaev, A. Nechunaev, D. Astakhov, Russian Federation

Sarcopenic Obesity promotes invasive carcinomas in patients with IPMN or PANin D. Wagner, J. Haybaeck, A. Tomberger, J. Waha, G. Werkgartner, H. Cerwenka, P. Kornprat, H. J. Mischinger, Austria

P39.04

Intraductal papillary mucinous neoplasm A Swedish nationwide register-based study on 238 patients L. Aronsson, D. Ansari, R. Andersson, Sweden

P39.05

Laparoscopic enucleation of Branch Duct IPMN of the head of the pancreas M. Chahdi Beltrame, M. de Santibañes, J. Pekolj, O. Mazza, Argentina

P39.06

Multicenter experience of intraductal papillary mucinous neoplasms (IPMN) A. Manuel-Vazquez, M. Serradilla-Martín, A. Carabias-Hernández, A. Palomares, T. Carrascosa-Mirón, R. Latorre-Fragua, C. Ramiro-Pérez, A. Serrablo, J. M. Jover, J. M. Ramia, Spain

P39.07

Rare Cystic pancreatic mass C. Anthoni, U. Braun, S. Farkas, Germany

12.40 pm 01.30 pm

P40 Pancreas Miscellaneous Chairs: S. Breitenstein, Switzerland; P. Grimminger, Germany

P40.01

Collaborative Storage and Research Use of Human Biospecimens between MSKCC and AUB M. Kanso, R. Abou Eid, H. Nassar, R. Raad, M. Khalife, W. Faraj, Lebanon

P40.02

Skeletal Muscle Index is a useful tool for the nutritional assessment of patients with pancreatic and hepatobiliary cancer I. Lidorik, D. Schizas, E. Mpaili, A. Michalinos, M. Vailas, A. Papalampros, E. Felekouras, T. Liakakos, Greece

P40.03

Hemobilia as a rare condition after Whipple procedure – A case report N. Lakenberg, G. T. Oehlert, H. Rosenthal, P. Geers, L. Hermann, M. Otto, A. Madisch, K. T. Moesta, J. Fangmann, Germany

P40.04

Is the involvement of the hepatic artery lymph node a poor prognostic factor in pancreatic adenocarcinoma? V. Rodrigues, C. Dopazo, L. Blanco, M. Caralt, E. Pando, I. Bilbao, J. Balsells, R. Charco, Spain

P40.05

Prognostic impact of the number of positive lymph nodes and lymph node ratio on the outcome of patients after resection of pancreatic adenocarcinoma S. Kmezic, I. Pejovic, A. Antic, R. Racic Arsovic, D. Radenkovic, Serbia and others

P40.06

Elevated NLR predicts poor prognosis after resection of pancreatic ductal adenocarcinoma and it is superior to PLR as an adverse prognostic factor A. Giakoustidis, K. Neofytou, M. Costa Neves, E. Louri, D. Giakoustidis, D. Cunningham, S. Mudan, United Kingdom and others

P40.07

Evaluation of the Clavien-Dindo classification in pancreatic surgery F. Rückert, F. Bartel, P. Teoule, S. Post, T. Wilhel, Germany

P37.04

Poster Area

Safety and efficacy of perioperative chemoradiotherapy of resectable pancreatic cancer A. Shabunin, V. Bedin, M. Tavobilov, O. Paklina, A. Karpov, G. Setdikova, Russian Federation Electrochemotherapy in advanced pancreatic adenocarcinoma A. Belli, M. Leongito, R. Palaia, V. Albino, A. Amore, M. Piccirillo, S. Tafuto, S. Setola, V. Granata, A. Petrillo, S. Lastoria, F. Izzo, Italy

P37.06

Phosphoproteome networks identify focal adhesion kinase as a new drug target that can be exploited in synergistic combination with paclitaxel T. Le Large, M. Bijlsma, B. El Houssani, B. Zonderhuis, F. Daams, N. Funel, N. van Grieken, J. Knol, S. Piersma, T. Pham, H. Verheul, H. van Laarhoven, C. Jimenez, E. Giovannetti, G. Kazemier, Netherlands and others

P37.07

Minimally invasive interventions in malignant diseases of the hepatopancreatoduodenal zone, complicated with an obstructive jaundice A. Mamoshin, A. Alyanov, A. Borsukov, A. Abolmasov, A. Dunaev, Russian Federation

12.40 pm 01.30 pm

P38 Acute Pancreatitis Chairs: T. A. Buanes, Norway; O. Strobel, Germany

P38.01

“Duodenal dystrophy”, or “groove pancreatitis”, or “paraduodenal pancreatitis?” Does it matter which name you choose? Lessons of 76 cases V. Egorov, R. Petrov, N. Starostina, A. Vankovich, Russian Federation

P38.02

Management of portal annular pancreas during laparoscopic pancreaticoduodenectomy A. Manzoni, G. Zimmitti, F. Guerini, V. Sega, C. Codignola, M. Garatti, E. M. Rosso, Italy

P38.03

Circumportal pancreas: A diagnostic and therapeutic challenge M. Böge, B. Gürses, C. Bilgic, A. Armutlu, P. Bulutay, M. Erkan, Turkey

P38.04

Surgical treatment of paraduodenal pancreatitis A. G. Kriger; A. V. Smirnov; O. V. Paklina; S. V. Berelavichus; D. S. Gorin, Russian Federation

P38.05

Hypertriglyceridemia Associated Acute Pancreatitis: Experience From A Single Tertiary Care Unit From Turkey O. Sezgin, E. Altintas, E. Ucbilek, S. Yaras, M. B. Koyuncu, Turkey

P38.06

Poster Area

12.40 pm 01.30 pm

P37.05

104


Results of the new approach to patients with acute necrotizing pancreatic infection in a single Hospital F. Garcia Borobia, A. Romaguera, A. Garcia Nalda, N. Bejarano, N. Garcia Monforte, P. Rebasa, R. Flores, S. Navarro, Spain

Poster Area

Poster Area

Poster Sessions

105

106

P41.01

Complete remission of refractory Hepatoblastoma post liver transplantation in a child with sorafenib monotherapy – A new hope? J. Valamparampil, N. Shanmugam, J. Xavier Scott, M. Vij, M. Rela, India

P41.02

Exercise improves outcomes of surgery on fatty liver and can be substituted through AMPK activation – An experimental study M. Linecker, P. Limani, L. Frick, M. Schneider, P. Kambakamba, P. Kron, C. Tschuor, N. Calo, M. Foti, J.-F. Dufour, R. Graf, B. Humar, P.-A. Clavien, Switzerland

P41.03

Which immunosuppressive drugs to be used in hepatocyte transplantation? – An in vitro analysis with primary human hepatocytes F. Oldhafer, M. Fabian, D. DeTemple, C. Falk, O. Beetz, M. Kleine, M. Jäger, F. Lehner, J. Klempnauer, M. Bock, F. Vondran, Germany

P41.04

Oncologic outcome of liver transplantation for incidental combined hepatocellular and cholangiocarcinoma: A case match analysis E. Gringeri, F. E. D‘Amico, M. Finotti, D. Bassi, R. Boetto, E. Fasolo, M. Di Giunta, C. Mescoli, M. Polacco, G. Zanus, M. Rugge, U. Cillo, Italy

P41.05

Fibrosis progression after liver transplantation by donor and recipient PNPLA3-genotype J. Mittler, C. Mittler, F. Abel, M. Hoppe-Lotichius, A. Lautem, A. Schad, G. Otto, P. R. Galle, H. Lang, T. Zimmermann, Germany

P41.06

Predictors of Outcome of Living Donor Liver Transplantation for Hepatocellular Carcinoma H. Zakaria, A. Sallam, I. Ayoub, S. Saleh, D. Maher, H. Omar, M. Abou-Shady, I. Salama, E.-S. Soliman, K. Abou El-Ella, T. Ibrahim, E. Hammad, Egypt

P41.07

Liver transplantation after complete hepatic artery avulsion secondary to blunt abdominal trauma L. Fernández Gómez-Cruzado, M. Prieto Calvo, M. Gastaca Mateo, A. Valdivieso Lopez, P. Ruiz Ordorica, A. Ventoso Castiñeira, I. Palomares Etxeberria, L. Fernández Cepedal, J. Larrea Oleaga, C. Perez Gonzalez, J. Ortiz de Urbina Lopez, Spain

12.20 pm 01.10 pm

P42 Cholecystectomy Chairs: C. Agalianos, Greece; J. Rystedt, Sweden

P42.01

Cholecystectomy for acute cholecystitis: Our experience F. Mazzotti, S. Vaccari, M. Cervellera, E. Picariello, F. Monari, B. Dalla Via, A. Caira, V. Tonini, Italy

P42.02

Percutaneous Cholecystostomy for severe Acute Cholecystitis: A life saving procedure S. Aroori, M. Clodagh, R. Lillian, United Kingdom

P42.03

Bouveret syndrom and high jejunal obstruction – A case report K. Toutouzas, D. Panagopoulos, K. Bramis, N. Alexakis, H. Markogiannakis, G. Zografos Greece

P42.04

The efficacy of late cholecystectomy for acute cholecystitis using propensity score matching analysis – Validation of Tokyo guideline 13 T. Abe, H. Amano, K. Hanada, T. Minami, A. Okazaki, Y.-k. Takemoto, N. Fujikuni, H. Okuda, M. Yamaki, S. Yonehara, T. Noriyuki, M. Nakahara, Japan

P42.05

Grade II acute cholecystitis: Laparoscopy or laparotomy? A retrospective cohort study using Propensity score adjustment analysis S. Zribi, M. Bouassida, M. F. Chtourou, S. Sassi, B. Mroua, M. M. Mighri, H. Touinsi, Tunisia

Poster Area

P41 Liver Transplantation Chairs: B. Aydinli, Turkey; A. Mehrabi, Germany

Poster Area

12.40 pm 01.30 pm

Friday, May 26, 2017

Poster Area

Poster Area

Poster Area

Poster Sessions

P42.06

Ninety-days readmissions after cholecystectomy at university hospital of Guadalajara, Spain R. Latorre-Fragua, A. Manuel-Vazquez, L. Diego, A. Medina, J. d. C. Valenzuela, C. García-Amador, V. Arteaga-Peralta, A. Kühnhardt, R. de la Plaza, J. M. Ramia, Spain

P42.07

Iatrogenic bile duct injury: delayed repair and treatment of complications – Case report K. Kobryń, P. Rykowski, R. Pietrzak, M. Nowosad, K. Dudek, W. Patkowski, M. Krawczyk, K. Zieniewicz, Poland

P42.08

Cholecystectomy for acute cholecystitis in octogenarians according to Tokyo guidelines 2013: Our experience S. Vaccari, F. Mazzotti, M. Cervellera, E. Picariello, A. Leone, M. Del Governatore, G.-A. Del Gaudio, V. Tonini, Italy

12.20 pm 01.10 pm

P43 HPB Surgery in Patients on Antiplatelet Therapy Chairs: E. Klar, Germany; J. Li, Germany

P43.01

Liver resection is safely performed in patients receiving antithrombotic therapy N. Emoto, T. Fujikawa, Y. Yoshimoto, Y. Kawamura, T. Nishimura, H. Kawamoto, T. Yamamoto, Y. Sakamoto, A. Tanaka, Japan

P43.02

Perioperative antiplatelet therapy and pancreatic surgery: Friend or foe? M. Sargut, A. Weinhuber, F. Scheufele, R. Schirren, E. Demir, E. Tieftrunk, H. Friess, G. Ceyhan, Germany

P43.03

Safety and feasibility of pancreaticoduodenectomy in antiplatelet-burdened patients with arterial thromboembolic risks N. Emoto, T. Fujikawa, Y. Yoshimoto, Y. Kawamura, H. Kawamoto, T. Yamamoto, A. Tanaka, Japan

P43.04

Impact of antiplatelet therapy on increased blood loss and bleeding complication in patients undergoing urgent cholecystectomy for acute cholecystitis T. Fujikawa, Y. Yoshimoto, Y. Kawamura, T. Nishimura, H. Kawamoto, T. Yamamoto, N. Emoto, Y. Sakamoto, A. Tanaka, Japan

P43.05

Evaluation of Thromboprophylaxis after Highly Advanced HepatobiliaryPancreatic Surgery Y. Minami, D. Kawaguchi, N. Yukawa, M. Ota, C. Kunisaki, R. Mori, T. Kumamoto, R. Matsuyama, H. Akiyama, I. Endo, Japan

P43.06

The role of splenic artery ligation as inflow modification in major hepatectomies M. Papoulas, N. Pinsker, M. Sodergren, O. Hadjicosta, S. Abdul-Hamid, P. Srinivasan, K. Menon, N. Heaton, A. Prachalias, United Kingdom

P43.07

A Comparative Analysis Of Stapler Versus Harmonic Scalpel In Major Liver Resections L. Mastrangelo, M. Masetti, M. Zanello, M. Serenari, R. Lombardi, S. Fiorino, E. Jovine, Italy

12.20 pm 01.10 pm

P44 ERCP for Bilary Diseases Chairs: P. Sandström, Sweden; H. C. Santvoort, Netherlands

P44.01

The risk of post-ERCP pancreatitis after single operator peroral SpyGlass cholangioscopy is highest in the beginning of practice A. Siiki, M. Ukkonen, J. Sand, J. Laukkarinen, Finland

P44.02

Distal malignant biliary obstruction: A prospective randomised trial comparing plastic and uncovered self-expanding metal stents M. Bernon, J. Shaw, S. Burmeister, G. Chinnery, S. Hofmeyr, C. Kloppers, E. Jonas, J. Krige, South Africa and others

107

P44.04

Does Endoscopic Retrograde Cholangiopancreatography influence the effectiveness of Percutaneous Transhepatic Biliary Drainage? P. Ignatavicius, R. Riauka, G. Barauskas, Lithuania

P44.05

Successful Treatment of a Benign Biliary Stricture with Biodegradable Metallic Biliary Stents H. Othman, Malaysia

P44.06

Management laparoendoscopic perforation post ERCP C. Bertona, Argentina

P44.07

Risk factors increasing post-ERCP complications: A referral center experience T. Canbak, A. Acar, F. Basak, K. Ozdil, G. Bas, E. Unal, Turkey

P44.08

Rationale surgical tacticts at iatrogenic bile duct injury A. Aliev, Russian Federation

12.20 pm 01.10 pm

P45 Klatskin Tumor 1 Chairs: O. Busch, Netherlands; M. Malago, United Kingdom

P45.01

Perihilar Cholangiocarcinoma – Correlation of Bismuth Type IV with T- and UICC-stage F. Bartsch, H. Lang, Germany

P45.02

The surgical treatment and adjuvant chemoradiotherapy for hilar cholangiocarcinoma Y. Kovalenko, Y. Zharikov, A. Zhao, Russian Federation

P45.03

Staging surgical resected peri-hilar cholangiocarcinoma: Comparison of the 7th and 8th ed. of the American Joint Committee on Cancer staging systems A. Ruzzenente, F. Bagante, F. Ardito, T. Campagnaro, I. Scoleri, S. Conci, F. Bertuzzo, C. Iacono, F. Giuliante, A. Guglielmi, Italy

P45.04

Liver resection for hilar Cholangiocarcinoma in patients over 70 years: Does preoperative cholangitis exclude older patients from surgery? F. E. D‘Amico, E. Gringeri, M. Finotti, E. Fasolo, R. Boetto, G. Noaro, M. Romano, G. Zanus, D. Bassi, U. Cillo, Italy

P45.05

Impact of extent of surgery on prognosis of patients with distal cholangiocarcinoma O. Beetz, M. Klein, H. Schrem, J. Gwiasda, F. Vondran, F. Oldhafer, S. Cammann, J. Klempnauer, M. Kleine, Germany

P45.06

The effectiveness of minimally invasive technologies in patients with tumor lesion of proximal bile ducts A. Mamoshin, A. Alyanov, A. Borsukov, A. Abolmasov, A. Dunaev, Russian Federation

Poster Area

P45.07

108

Poster Area

Retrograde and percutaneus transhepatic interventions in benign mechanical jaundice A. Khadjibaev, F. Khadjibaev, S. Tilemisov, Uzbekistan

Poster Area

P44.03


Results of portal vein and hepatic artery resection for surgical treatment of Klatskin tumor O. Kotenko, A. Popov, A. Korshak, D. Fedorov, A. Grinenko, A. Gusev, M. Grigorjan, A. Ostapishen, Ukraine

12.20 pm 01.10 pm

P46 Klatskin Tumor 2 Chairs: O. Rummo, Russian Federation; P. Schemmer, Austria

P46.01

Type IV Cholangiocellular Carcinoma in a Patient With Neurofibromatosis Type 1 A. B. Dogrul, Ö. Gül Utku, I. Osmanov, O. Abbasoglu, G. Gedikoğlu, D. Oğuz, Turkey

Poster Area

Poster Area

Poster Area

Poster Sessions

P46.02

Validation study of the post-operative mortality risk score after liver resection for perihilar cholangiocarcinoma S. Uemura, T. Noji, H. Saito, T. Kawamura, K. Tanaka, Y. Nakanishi, T. Asano, T. Nakamura, T. Tsuchikawa, K. Okamura, S. Hirano, Japan

P46.03

Preoperative biliary drainage reduces postoperative liver failure on patients undergoing major liver resection for perihilar colangiocarcinoma C. Muñoz, V. Molina, J. Sampson, E. Delgado, J. Ferrer, D. Calatayud, S. SanchezCabus, C. Fondevila, J. Fuster, J. C. Garcia-Valdecasas, Chile and others

P46.04

New definition of post-hepatectomy liver failure after major hepatectomy for perihilar cholangiocarcinoma T. Kawamura, T. Noji, H. Saito, K. Tanaka, Y. Nakanishi, T. Asano, T. Nakamura, T. Tsuchikawa, K. Okamura, S. Hirano, Japan

P46.05

Malignant obstructive jaundice: Rational method of surgical treatment A. Kuznetcov, M. N. A., R. P. A., Russian Federation

12.20 pm 01.10 pm

P47 Gallbladder Cancer Chairs: R. Lo Tesoriere, Italy; Y. Tekant, Turkey

P47.01

Surgical treatment of stage IV gallbladder cancer after complete radiological, metabolic and biochemical response with chemotherapy and Trastuzumab M. Prieto, A. Valdivieso, M. Gastaca, A. Ventoso, P. Ruiz, I. Palomares, A. Matarranz, J. Ortiz de Urbina, Spain

P47.02

Surgical Management of Locally Invasive Gallbladder Cancer: A Single Center Experience H. Ezzedine, M. Khalife, H. Nassar, A. Haydar, W. Faraj, Lebanon

P47.03

Gallbladder Polyps versus Cancer: Is there a role for prevention? Single Centre six-year experience in management of Gallbladder polyps R. Antakia, R. Clifford, C. Shingles, G. Abbott, J. Evans, D. Monk, S. Saha, United Kingdom

P47.04

A risk score model to predict incidental gallbladder cancer in patients scheduled for cholecystectomy B. Andersson, C. Muszynska, L. Lundgren, G. Lindell, R. Andersson, J. Nilsson, P. Sandström, Sweden

P47.05

The evaluation of tumor markers and their impact on prognosis in gallbladder, bile duct, and cholangiocellular carcinomas – A pilot study V. Liska, V. Treska, T. Skalicky, J. Fichtl, J. Bruha, O. Vycital, O. Topolcan, R. Palek, J. Rosendorf, J. Polivka, L. Holubec, Czech Republic

P47.06

Treatment of Intrahepatic Cholangiocarcinoma, Experience of a Reference Center A. B. Mendes Caldeira, C. Fernandes, R. Bessa Melo, M. Oliveira, L. Graça, J. Costa Maia, Portugal

12.20 pm 01.10 pm

P48 Neuroendocrine Tumors Chairs: M. Falconi, Italy; A. Frilling, United Kingdom

P48.01

Prognostic factors in an 85 patient series of digestive neuroendocrine tumours with surgery or endoscopic resection F. Sánchez-Bueno, P. Gil, J. de la Peña, D. Ferreras, M. Costa, M. Fuster, L. Frutos, P. Parrilla, Spain

109

110

P48.03

Non functioning neuroendocrine pancreatic tumors (PNET) in multiple endocrine neoplasia type 1 (MEN1) patients A. Manuel-Vazquez, M. Serradilla-Martín, P. Sanz-Muñoz, A. López-Marcano, T. González-Nicolás, A. Carabias-Hernández, A. Palomares, A. Serrablo, J. M. Jover, J. M. Ramia, Spain

P48.04

Pancreatic Non-Functioning Neuroendocrine Tumor and Lynch Syndrome: A new tumor association F. Garcia Borobia, A. Serracant, N. Bejarano Gonzalez, R. Carrera Salas, C. Blazquez, N. Garcia Monforte, A. Romaguera Monzonis, R. Bella Cueto, S. Navarro Soto, Spain

P48.05

Surgical management of insulinomas in 87 consecutive patients D. Hoskovec, Z. Krska, J. Svab, J. Skrha, J. Horejs, J. Ulrych, V. Fryba, Czech Republic

P48.06

A case of metastatic carcinoid tumor of the pancreas resected by laparoscopic distal pancreatectomy S. Takamatsu, T. Furuyama, S. Kato, H. Nagano, S. Ohtsukasa, Y. Kawachi, Japan

P48.07

A new scoring system to predict recurrent disease in grade 1 and 2 nonfunctional pancreatic neuroendocrine tumors C. Genc, A. Jilesen, S. Partelli, M. Falconi, F. Muffatti, F. van Kemenade, S. van Eeden, J. Verheij, S. van Dieren, C. van Eijck, E. Nieveen van Dijkum, Netherlands and others

P48.08

Surgical Strategies and Selection Criteria for Patients with Liver Metastasis from Neuroendocrine Tumors: Personal experience M. Massani, B. Pauletti, R. Bonariol, N. Bassi, Italy

12.20 pm 01.10 pm

P49 Benign Liver Tumors Chairs: F. Quenet, France; P. Gassmann, Germany

P49.01

Enucleation Plus Caudate Lobe Resection for Central Giant Hemangioma of the liver A. Recordare, F. Cimino, L. Baiano, F. Fiumara, A. Albanese, M. Rizzo, Italy and others

P49.02

Transarterial Embolization of Symptomatic Giant Liver Hemangiomas S. Savoliuk, S. Savoliuk, I. Altman, A.Nikishin, S. Kozlov, Ukraine

P49.03

Massive spontaneous liver haemorrhage and acute liver failure due to Peliosis Hepatitis in an immunocompetent patient R. Sanabria Mateos, L. Coady, N. Mansi, M. Ismail, L. Ferreira, A. McGuire, T. Gallagher, A. Stafford, D. Maguire, K. Conlon, J. Geoghegan, E. Hoti, Ireland

P49.04

Emergency Single Incision Laparoscopic Liver Resection (SILL) in ruptured Liver Adenoma: A Case Report S. Wabitsch, T. Denecke, D. Geisel, A.-C. von Brünneck, A. Andreou, M. Biebl, J. Pratschke, M. Schmelzle, Germany

P49.05

Laparoscopic liver resection for hemorrhagic hepatocellular adenoma in a pregnant patient F. Gryspeerdt, R. Aerts, Belgium

Poster Area

Meta-analysis on Recurrence After Curative Surgery of Pancreatic Neuroendocrine Tumors C. Genc, T. Mackay, S. van Dieren, C. van Eijck, E. Nieveen van Dijkum, Netherlands

Poster Area

P48.02


Poster Area

Poster Area

Poster Area

Poster Sessions

P49.06

Indices of lipid peroxidation and antioxidant protection after using argon plasma coagulation and monopolar cautery in patients with liver hemangiomas V. Petrushenko, S. Stukan, D. Grebeniuk, I. Radoga, V. Stoika, V. Sobko, S. Khytruk, K. Pankiv, Ukraine

P49.07

Treatment of the focal nodular hyperplasia of the liver. Is there any place for surgical indication? A. Perrakis, M. Andric, N. Vassos, R. Grützmann, R. Croner, Germany

12.20 pm 01.10 pm

P50 Imaging of Hepatic Tumors Chairs: C. Anthoni, Germany; F. Ardito, Italy

P50.01

Fluorescence in Hepatobiliary surgery: Novel technique or evolution of practice? A. D. Jones, J. Wilton, United Kingdom

P50.02

The efficacy of new intraoperative real time fusion imaging ultrasound system for hepatectomy S. Uchida, G. Nakayama, H. Ishikawa, Y. Akagi, Japan

P50.03

The imaging features in ultrasonography of cholangiocarcinoma: Correlation with pathological findings A. Deguchi, Y. Kokudo, T. Masaki, Japan

P50.04

Assessment of microinvasive patterns of HCC by IOUS: correlation with pathologic resected specimen M. Barabino, R. Santambrogio, C. Cigala, M. Maggioni, G. Scifo, E. Opocher, G. Bulfamante, Italy

P50.05

Reliability of imaging in the pre-operative assessment of microvascular invasion in HCC resected or Transplanted patients M. F. Valentini, G. Gigante, S. Roselli, L. G. Lupo, Italy

P50.06

The Role of Intraoperative Ultrasonography in the Verification of Choledocholithiasis K. Atstupens, G. Pupelis, Latvia

P50.07

Predictors of persistent common bile duct stones in mild acute biliary pancreatitis; the role of liver enzyme and dilated CBD on ultrasound L. Vidal Piñeiro, E. Pando Rau, P. Alberti Delgado, M. Caralt Barba, L. Blanco Cuso, C. Dopazo Taboada, J. L. Lázaro Fernández, I. Bilbao Aguirre, J. Balsells Valls, R. Charco Torra, Spain

12.40 pm 01.30 pm

P51 Local Treatment of Liver Tumors Chairs: A. Weinmann, Germany; C. Graeb, Germany

P51.01

Microwave ablation of resectable colorectal liver metastases – One year into the MAVERRIC study J. Freedman, Sweden

P51.02

Prior hepatectomy predicts local tumor progression and survival after percutaneous ablation of colorectal liver metastasis B. Odisio, S. Yamashita, S. Huang, S. Kopetz, K. Ahrar, Y. S. Chun, C. Conrad, T. Aloia, M. Hicks, S. Gupta, J.-N. Vauthey, United States

P51.03

Safety and efficacy of microwave ablation for colorectal metastases near a vessel: Short-term results of a single institute T. Piardi, R. Rhaiem, S. Cavallari, M. Chetboun, A. Cagniet, D. Sommaca le, R. Kianmanesh, France

111

The impact of radiofrequency-assisted transection on local hepatic recurrence after resection of colorectal liver metastases O. Morató, I. Poves, F. Burdio, Spain

P51.05

Predicting local regrowth after radiofrequency ablation of colorectal liver metastases by 3D merging of pre- and post-ablation imaging B. Sibinga Mulder, M. Burgmans, A. van Erkel, C. van de Velde, A. Vahrmeijer, S. Mieog, Netherlands

P51.06

Oncological outcomes of ablation and liver resection vs. liver resection alone for colorectal liver metastasis from a single centre S. S. Raza, B. Alaraimi, M. Ali, J. Ahmad, S. Khan, F. Lam, M. Dhillon, J. Harding, G. Marangoni, United Kingdom

P51.07

Poster Area

112

P53.02

Resection of initially unresectable colorectal liver metastases offers a survival benefit similar to those achieved in initially resectable metastases S. T. Alexandrescu, A. Diaconescu, R. Grigorie, Z. Ionel, D. Hrehoret, M. Boros, A. Croitoru, M. Grasu, G. Droc, I. Popescu, Romania

P53.03

Interdisciplinary Approach in Treatment of Primary Unresectable Liver Metastases of Colorectal Cancer: 8.5 Years Follow-up M. Vozdvizhenskiy, V. Solovov, A. Turin, R. Kniazev, A. Orlov, Russian Federation

P53.04

Results of surgical therapy of bilateral colorectal liver metastases M. Menzel, P. Polster, A. Klock, H. Neeff, S. Lang, S. Fichtner-Feigl, F. Makowiec, Germany

P53.05

Should 3 Tesla MRI be the new standard in diagnostic imaging for CRLM? G. A. Stavrou, M. Zeile, M. H. Fard-Aghaie, K. C. Wagner, A. Stang, K. J. Oldhafer, Germany

P53.06

International survey on resection margin for colorectal metastases in laparoscopic and open liver surgery D. Wicherts, A. Badran, M. Halls, A. Aljaiuossi, F. Giovinazzo, M. Abu Hilal, United Kingdom

P53.07

Metastatic colorectal cancer (mCRC): Adoption of progressive surgery and modern chemotherapy regimens leads to improved survival F. Primavesi, T. Jäger, J. Presl, S. Buchner, K. Tomanovà, T. Resch, M. Edlinger, J. Hutter, D. Öfner, S. Stättner, A. Dinnewitzer, Austria

12.40 pm 01.30 pm

P54 Laparoscopic Liver Surgery Chairs: H. Neeff, Germany; D. Seehofer, Germany

P52 Local Treatment Alternatives for Liver Metastases Chairs: W. Kneist, Germany; O. Kollmar, Germany

P52.01

Chemotherapy-associated Liver Injury prior to Surgery of Hepatic Colorectal Metastases – Comparison of Functional and Histopathological Damage J. Lock, C.-T. Germer, I. Klein, M. Stockmann, Germany

P52.02

The comparative analysis of the treatment efficacy in patients with primary and secondary cancer of the liver with the use of RFA and MWA M. Trandofilov; E. Prazdnikov; V. Svetashov; M. Rudakova; A.Sizova; K. Ryabov; P. Kruchko; D . Zinatulin, Russian Federation

P54.01

P52.03

Assessing the impact and benefits of radiofrequency-assisted parenchymal sparing liver resection on post hepatectomy liver failure A. Zanellato, I. Reccia, J. Kumar, T. Kusano, A. Giakostidis, A. Draz, S. Kirby, L. Jiao, D. Spalding, N. Habib, M. Pai, United Kingdom

The influence of the I Go MILS (italian group of minimally invasive liver surgery) registry on the implementation of MILS programs in a single center F. Ratti, F. Cipriani, G. Fiorentini, D. Palombo, M. Catena, M. Paganelli, L. Aldrighetti, Italy

P52.04

Thermoablation for neoplasms of the hepatic caudate lobe under CT guidance C. E. Alifieris, S. G. Delis, M. Tzeferakos, D. Fagkrezos, G. Kotsalis, J. Papailiou, Greece

P54.02

Laparoscopic resection of neoplasms in cirrhotic liver. A safe procedure M. A. Suarez Muñoz, J. Roldán de la Rúa, Y. Eslava Cea, C. Monje Salazar, J. L. Cuba Castro, L. C. Hinojosa Arco, E. Corrales Valero, R. de Luna Díaz, M. C. Leiva Vera, Spain

P52.05

Laparoscopic Microwave Ablation and Portal Vein Occlusion for Staged Hepatectomy (LAPS) R. Boetto, E. Gringeri, D. Bassi, F. E. D‘Amico, A. Vitale, F. D‘Amico, G. Zanus, U. Cillo, Italy

P54.03

The European experience of laparoscopic vs open liver resection for hepatocellular carcinoma: A meta-analysis N. Machairas, A. Prodromidou, P. Stamopoulos, G. C. Sotiropoulos, Greece

P52.06

Long-term outcome for intrahepatic cholangiocellular carcinoma: Is stereotactic radiofrequency ablation the new standard of care? E. Braunwarth, P. Schullian, M. Haidu, F. Primavesi, C. Margreiter, S. Schneeberger, R. Margreiter, D. Oefner, R. Bale, S. Staettner, Austria

P54.04

Laparoscopic liver resection for hepatocellular carcinoma: 5-year experience at a single center D. H. Ryu, J.-W. Choi, H. Choi, South Korea

P54.05

P52.07

Electrochemotherapy: New treatment approach for Hepatocellular Carcinoma: Results of a phase I study M. Dokić, D. Stanisavljević, M. Petrič, A. Tomažič, B. Trotovšek, G. Serša, M. Čemažar, D. Miklavčič, B. Kos, Slovenia

From an isolated island to mainland – How we started laparoscopic liver resections in a very young HBP department O. Ginghina, R. Iosifescu, M. Zamfir, T. Chapelle, G. Roeyen, D. Ysebaert, B. Bracke, V. Hartman, N. Iordache, Romania and others

12.40 pm 01.30 pm

P53 CRC Metastases Chairs: I. Cameron, United Kingdom; P. Piso, Germany

12.40 pm 01.30 pm

P55 ALPPS Chairs: E. Schadde, Switzerland; A. Schnitzbauer, Germany

P55.01

P53.01

Suspected major vessel involvement in patients with colorectal liver metastases (CRLM): Single Center Experience of 13 Cases J. Baumgart, P. Gaßmann, S. Heinrich, F. Bartsch, J. Mittler, W. Roth, H. Lang, Germany

Radiofrequency-assisted liver partition for staged hepatectomy (R-ALPPS) – A preliminary experience with a fully laparoscopic first stage approach M. Iaria, M. Rossini, C. Pellegrino, L. Lamecchi, R. Dalla Valle, Italy

Poster Area

Poster Area

12.40 pm 01.30 pm

The choice of surgical treatment of malignant liver lesions, depending on the functional state future liver remnant A. Shabunin, D. Grekov, M. Tavobilov, P. Drozdov, A. Belousova, Russian Federation

Poster Area

P51.04


Poster Area

Poster Area

Poster Sessions

113

Evolution of ALPPS: The simpler, safer and effective one – TELPP S. Y. Peng, X. A. Wang, C. Y. Huang, Y. Y. Zhang, J. T. Li, D. F. Hong, X. J. Cai, Y. F. Wang, B. Xu, J. W. Wang, China

P55.03

Comparison of RALLPS, portal vein embolisation (PVE) and portal vein ligation (PVL) in prevention of posthepatectomy liver failure R. Alikhanov, M. G. Efanov, O. V. Melekhina, J. V. Kulezneva, V. V. Tsvirkun, N. S. Starostina, P. P. Kim, I. V. Kazakov, A. N. Vankovich, Russian Federation

P55.04

Transition from open to laparoscopic ALPPS: The initial experience M. A. Machado, F. Makdissi, T. Basseres, R. Surjan, E. Schadde, Brazil and others

P55.05

A systematic review and meta-analysis of ALPPS versus two-stage hepatectomy (TSH) Y.-N. Shen, X.-L. Bai, T. Ma, T.-B. Liang, China

P57.04

Encouraging observed 5-year survival with upfront resection and adjuvant therapy for pancreatic ductal adenocarcinoma in a large contemporary series O. Strobel, P. Lorenz, U. Hinz, M. Gaida, A. K. Stadler, T. Hank, W. Niesen, F. Bergmann, T. Hackert, M. Büchler, Germany

P57.05

Pancreaticoduodenectomy for ductal adenocarcinoma. Which patients may have a 5 year survival? S. Barbaro, A. Shamali, L. Tanno, M. Fontana, M. Abu Hilal, United Kingdom

P57.06

Adjuvant therapy confers no survival benefit following curative surgery for peri-ampullary adenocarcinoma: A Meta-Analysis A. Acharya, S. R. Markar, M. H. Sodergren, G. Malietzis, A. Darzi, T. Athanasiou, A. Z. Khan, United Kingdom

P57.07

KRAS and TP53 mutations are correlated with lower survival rate in resected pancreatic ductal adenocarcinoma M. Masetti, D. de Biase, R. Lombardi, D. Tumiati, G. Acquaviva, S. di Giacomo, A. Fornelli, E. Jovine, Italy

P56 Acute Pancreatitis Chairs: K. Kobryń, Poland; E. Martin-Perez, Spain

P56.01

HIV positive vs. HIV negative acute pancreatitis: Etiology, severity and outcomes in the post ARV era L. Prodehl, M. Mauser, M. Brand, South Africa

12.40 pm 01.30 pm

P58 Vascular Resection During Pancreas Surgery Chairs: R. Alikhanov, Russian Federation; M. Schäfer, Switzerland

P56.02

Understanding antibiotic use in acute pancreatitis M. Baltatzis, S. Jegatheeswaran, A. Siriwardena, United Kingdom

P58.01

P56.03

Lumbo-Retroperitoneal and Subcostal Approach is Associated with Low Complication Rate and Mortality in Different Types of Necrotizing Pancreatitis V. Fokins, G. Pupelis, Latvia

Anastomoses between major hepatic arteries. How one can use this knowledge in pancreatic and liver surgery? Experience of 9 cases V. Egorov, R. Petrov, N. Starostina, Russian Federation

P58.02

Major pancreatic resection in Jehovah‘s witness patients: A single institute experience M. De Bellis, A. Ruzzenente, F. Bagante, S. Conci, T. Campagnaro, G. Lazzari, E. Lombardo, A. Guglielmi, C. Iacono, Italy

P58.03

Intraoperatively diagnosed median arcuate ligament syndrome during pancreaticoduodenectomy K. Karabulut, S. Usta, H. Artas, Turkey

P58.04

Aorto-mesenteric bypass: An alternative reconstruction technique to resect pancreatic tumors with long SMA involvement P. Senra, C. Gallego, R. Melendez, R. Carracedo, E. Casal, F. Ausania, Spain

P56.04

Open necrosectomy or a step-up approach for infected necrotizing pancreatitis I. A. Kryvoruchko, Ukraine

P56.05

The role of extra-pancreatic infections in the prediction of severity and local complications in acute pancreatitis E. Pando Rau, P. Alberti Delgado, C. Dopazo Taboada, M. Caralt Barba, J. L. Lázaro Fernández, I. Bilbao Aguirre, J. Balsells Valls, R. Charco Torra, Spain

Poster Area

12.40 pm 01.30 pm

P56.06

Mortality in Severe Acute Pancreatitis: Are we getting better? C. W. T. Huey, Y. P. Tan, Singapore

P56.07

EUS guided management of pancreatic related fluid collections S. Burmeister, D. Levin, M. Bernon, C. Kloppers, S. Thomson, E. Jonas, South Africa

P58.05

One visceral artery is enough. Pancreatectomy in a patient with total occlusion of the celiac and superior mesenteric arteries E. Tagkalos, F. Jungmann, H. Lang, S. Heinrich, Germany

12.40 pm 01.30 pm

P57 Pancreaticoduodenectomy Chairs: O. Belyaev, Germany; M. Bockhorn, Germany

P58.06

Celiac artery compression in case of pancreatic surgery – Experiences at the surgical department at the Landesklinikum Wiener Neustadt (Austria) A. Pötscher, F. Längle, Austria

P57.01

Possible applications of cryodestruction Y. Stepanova, D. Ionkin, V. Vishnevsky, A. Chzhao, Russian Federation

12.40 pm 01.30 pm

P59 Post-operative Management in Pancreas Surgery Chairs: N. Belev, Bulgaria; N. Russilio, Italy

P57.02

Oncological and long term outcomes after pancreatoduodenectomy for ampullary carcinoma: A 9-year experience from a tertiary referral centre in the UK J. Chang, V. Mavroeidis, M. Soo, A. Gibbs, P. Osuri, M. Silva, S. Reddy, Z. Soonawalla, United Kingdom

P59.01

A systematic review into patient reported outcomes following pancreaticoduodenectomy for malignancy B. Y. Patel, J. Allington, T. Satyadas, United Kingdom

P59.02

Impact of abdominal composition CT-profile on postoperative complications after curative resection for pancreatic cancer O. Belyaev, M. Fraziano, T. Herzog, W. Uhl, Germany

P59.03

Relation of gut hormone and gastric motility after PPPD; initial experience J. H. Lim, H. S. Kim, J. S. Park, D. S. Yoon, South Korea

P57.03

114

Poster Area

P55.02


Extended pancreatectomy in patients with locally advanced pancreatic cancer L. Pererva, V. Kopchak, K. Kopchak, I. Khomyak, O. Duvalko, V. Khanenko, S. Andronik, I. Skrypnychuk, Ukraine

Poster Area

Poster Area

Poster Area

Poster Area

Poster Sessions

115

P59.04

Correlation of specific post-pancreatectomy morbidity and postoperative plasmatic biomarkers (BM) and inflammatory scores (IS) F. J. Tejero Pintor, M. Rodriguez Lopez, B. Perez Saborido, A. Barrera Rebollo, D. Pacheco Sánchez, E. Asensio Díaz, P. Pinto Fuentes, S. Mambrilla Herrero, M. Bailon Cuadrado, K. T. Plua muniz, J. L. Marcos Rodriguez, Spain

P59.05

Effects of preoperative biliary stenting on surgical outcomes after pancreatoduodenectomy: A prospective cohort analysis M. Rodriguez-Lopez, B. Perez-Saborido, F. J. Tejero Pintor, S. Mambrilla-Herrero, M. Bailon-Cuadrado, E. Asensio-Diaz, L. M. Diez-Gonzalez, D. Pacheco-Sanchez, P. Pinto-Fuentes, A. Barrera-Rebollo, Spain

Poster Area

P59.06

116

Impact of Diabetes Mellitus on The Outcomes After pancreaticoduodenectomy for Pancreatic Ductal Adenocarcinoma A. Shehta, A. Elnakeeb, Egypt

P59.07

Pseudoaneurysm of the hepatic artery after pancreaticoduodenectomy S. Paterna-López, M. Serradilla-Martín, A. Palomares-Cano, J. M. Rodríguez Artigas, R. Martínez-García, A. Serrablo-Requejo, Spain

12.40 pm 01.30 pm

P60 Management of Pancreatic Fistula Chairs: M. Adham, France; R. Cañada Surjan, Brazil

P60.01

Moderating postoperative pancreatic fistula achieved by selective use of pancreaticogastrostomy G. Kazantsev, A. Spitzer, R. Ramirez, P. Peng, C. Chang, United States

P60.02

Relevance of Day 3 Amylase in defining clinically relevant postoperative pancreatic fistula (CRF) following Pancreaticoduodenectomy V. R. Vutukuru, India

P60.03

Evaluation of preoperative CT parameters associated with postoperative pancreatic fistula after pancreaticoduodenectomy F. Giovinazzo, F. Soggiu, R. Mitchell-Hay, J. Straiton, M. Mariappan, N. Youakim, B. Al-Kari, I. Ahmed, United Kingdom

P60.04

Fistula risk-based use of external pancreatic drainage and modified Blumgart anastomosis minimize the postoperative fistula risk in high-risk patients T. Georgiev-Hristov, A. Gomez Valdazo, S. González Ayora, A. Celdrán Uriarte, Spain


Poster Area

Poster Area

Poster Sessions

P60.05

A propensity score-matched analysis of modified Blumgart vs. Cattell-Warren duct-to-mucosa pancreatojejunostomy in robotic pancreatoduodenectomy F. Menonna, N. Napoli, E. Kauffmann, S. Iacopi, M. Lucchesi, C. Lombardo, F. Costa, U. Boggi Italy

P60.06

Preoperative predictive risk scores of pancreatic fistula following pancreatoduodenectomy E. Martin-Perez, M. di Martino, I. Mora-Guzmán, J. L. Muñoz de Nova, M. Cantalejo Díaz, Y. García Blanco-Traba, Spain

P60.07

The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 Years After G. Marchegiani, International Study Group on Pancreatic Surgery (ISGPS), Italy

P60.08

Assessing surgeons performance using CUSUM analysis of risk adjusted POPF occurrence K. Roberts, R. Marudanayagam, R. Sutcliffe, D. Mirza, United Kingdom

117



E-Video Sessions

E-Video Sessions

BioGlue® sealed fish-mouth closure of the pancreatic remnant as a feasible alternative to stapler closure during laparoscopic distal pancreatectomy M. Bahra, F. Klein, R. Zorron, J. Pratschke, Germany Laparoscopic central pancreatectomy for IPMN S. Dokmak, B. Aussilhou, F.S. Fteriche, R. Chérif, F. Cauchy, A. Sauvanet, France

Poster Area

Cystic Lymphangioma of the Pancreas D. Kostov, G. Kobakov, Bulgaria

10.00 am 06.00 pm

Laparoscopic resection of the uncinate process of the pancreas due to a branch-type IPMN I. Poves, O. Morató, F. Burdío, L. Grande, Spain

Laparoscopic segment 6 resection for alveolar echinoccus of the liver G. Ozturk, E. Korkut, N. Aksungur, S. Kara, Turkey Importance of intraoperative laparoscopic sonography in pancreatic surgery: Turning a pancreaticoduodenectomy into a laparoscopic uncinatectomy R. Cañada Surjan, F. Ferrari Makdissi, T. Basseres, M. A. Cesar Machado, Brazil

Poster Area

Radical Antegrade Modular Pancreatosplenectomy (RAMPS) in left sided pancreatic cancer M. A. Suarez Muñoz, J. Roldán de la Rúa, Y. Eslava Cea, C. Monje Salazar, J. L. Cuba Castro, R. de Luna Díaz, Spain

Free e-Video Session 3

The extraglissionian approach for laparoscopic right hemihepatectomy H. Neeff, P. Holzner, S. Lang, S. Fichtner-Feigl, Germany

Laparoscopic distal pancreatectomy with preservation of splenic vessels. Lateral to medial aproach M. A. Suarez Muñoz, J. Roldán de la Rúa, Y. Eslava Cea, A. M. Caffarena López Hermida, L. C. Hinojosa Arco, E. Corrales Valero, R. de Luna Díaz, Spain Pancreatogastrostomy as reconstructive technique after pancreatoduodenectomy M. A. Suarez Muñoz, J. Roldán de la Rúa, Y. Eslava Cea, A. M. Caffarena López Hermida, L. C. Hinojosa Arco, J. L. Cuba Castro, C. Monje Salazar, E. Corrales Valero, R. de Luna Díaz, Spain

Poster Area

10.00 am 06.00 pm

Free e-Video Session 1

Poster Area

10.00 am 06.00 pm

10.00 am 06.00 pm

Free e-Video Session 4 Laparoscopic Cholecystectomy for Retained Gallbladder Remnant T. Erol, O. Abbasoğlu, Turkey Laparoscopic Reversal ALPPS M. A. Machado, F. Makdissi, T. Basseres, R. Surjan, Brazil

Free e-Video Session 2 A method for the transection of the liver parenchyma using ultrasound-based energy devices: So we still need the CUSA? T. Y. Tsui, Germany Our first laparoscopic right hepatectomy. A challenge for a surgical team M. A. Suarez Muñoz, J. Roldán de la Rúa, C. Monje Salazar, Y. Eslava Cea, A. M. Caffarena López Hermida, E. Corrales Valero, J. L. Cuba Castro, L. C. Hinojosa Arco, R. de Luna Díaz, M. C. Leiva Vera, Spain Intrahepatic Glissonian approach for single-port laparoscopic left lateral sectionectomy M. A. Machado, R. Surjan, T. Basseres, F. Makdissi, Brazil

118

119

Friday, 26 May, 2017 E-Video Sessions

Poster Area

10.00 am 06.00 pm

Notes

Free e-Video Session 5 Technical feasibility of an action cam for video documentation in HPB surgery O. Belyaev, T. Herzog, A. Luu, W. Uhl, Germany Interactive 3D learning module for vascular anatomical variations in HPB surgery M. F. Can, Turkey Right hepatectomy after down-staging by Y90 microspheres radioembolisation M. Ouali, N. Golse, L. Tselikas, E. Vibert, France Operation video: Associating Liver Partition and Portal Vein Transection for Staged Hepatectomy C. Liu, X. Shi, Q. Tang, X. Yu, L. Xu, China

Poster Area

10.00 am 06.00 pm

Free e-Video Session 6 Parenchymal sparing laparoscopic liver resections of colorectal liver metastases E. Schadde, C. Soll, R. Stärkle, F. Grieder, S. Breitenstein, United States ALPPS for bleeding HCC in HBV cirrhosis: A safety strategy G. B. Levi Sandri, M. Colasanti, P. Lepiane, G. Vennarecci, G. M. Ettorre, Italy Laparoscopic left liver resections and right portal vein ligation: First step of two stage hepatectomy for colorectal liver metastases R. Lo Tesoriere, N. Russolillo, S. Langella, F. Forchino, S. Perotti, A. Ferrero, Italy Laparoscopic Liver Surgery: Techniques in minor laparoscopic resection H. Neeff, P. Holzner, S. Lang, S. Fichtner-Feigl, Germany

120

121

Sponsors We thank our sponsors for their kind support.

Gold Sponsors

Silver Sponsors

Further Sponsors

122

Exhibitors Applied Medical Deutschland GmbH

30

Arthrex GmbH

31

ASANUS Medizintechnik GmbH

29

Astellas Pharma GmbH

19

B. Braun Aesculap

15

Baxter Healthcare Corporation

08

BK Ultrasound

17

BOWA-electronic GmbH & Co. KG

33

Bracco Imaging Deutschland GmbH

02

CAScination AG

16

CryoLife Europa Ltd.

06

Dr. Franz Köhler Chemie GmbH

14

E-AHPBA | IHPBA

26

ERBE Elektromedizin GmbH

23

FUJIFILM Corporation

24

Gilead Sciences GmbH

07

HEXAL AG

04

Humedics GmbH

20

IHPBA 2018

27

Inomed Medizintechnik GmbH

01

Integra

13

Intrasense

32

Intuitive Surgical

18

Johnson & Johnson Medical GmbH - Ethicon

12

KARL STORZ GmbH & Co. KG

05

Medtronic GmbH

10

MeVis Medical Solutions AG

21

Organ Assist

03

Roche Pharma AG

09

Sirtex Medical Europe GmbH

25

Söring GmbH

28

Takeda Pharma Vertrieb GmbH & Co. KG

11

Thompson Surgical Instruments, Inc.

22 123

Floor Plan & Transparency

Travel Grants

Floor Plan

The E-AHPBA traditionally offers two travel awards to members of the association, who are up to 35 years of age, attend the meeting and present their scientific work. Eligible members receive a travel support of EUR 600. The announcement of the Travel Awards will be during the meeting. The Boehringer Ingelheim Foundation has provided a Grant to Young Researchers for this congress. Young surgeons and scientists were eligible for this grant. An abstract had to be submitted, and abstracts of the highest rating in the official review process of the meeting were selected. These abstracts will be presented during the main scientific program and discussed by an expert in the field. The grant covers registration, travel expenses and accommodation. The following researchers have been awarded the Boehringer Ingelheim Foundation Grant:

1st floor Speakers‘ Lounge & Media Centre

Argentina

Surgeon specializing in Hepatobiliary Surgery

Hospital Italiano, Buenos Aires

Amr Badawy

Japan

Clinical Researcher in Hepatobiliary and Liver Transplant Surgical Department

Kyoto University Hospital

Mechtheld de Jong

Netherlands

Surgical Resident – Specializing in Surgical Oncology

Zuyderland Medical Center, Heerlen and Sittard

Jakob Kirkegård

Denmark

Surgical Resident in HPB Surgery, PhD Student

Aarhus University Hospital

Giovanni Marchegiani

Italy

Attending Surgeon

University Hospital of Verona

Andreas Fulop

Hungary

Surgical Resident, PhD Student

Semmelweis University, Medical School

Aisha Isaeva

Russian Federation

Surgical Oncology Resident

Moscow Oncology Research Institute

Benedikt Kaufmann

Germany

Medical Student

Technical University Medical Center Munich

Victoria Ardiles Gutenberg-Saal A

Gutenberg-Saal B

Poster Area

Kongress-Saal Gutenberg-Saal C

Gutenberg-Saal D

Poster Area

Booth

Catering

Transparency The following companies disclose their support in accordance with the FSA Code or with internal transparency rules: Baxter Healthcare Corporation (EUR 45.000), Bracco Imaging Deutschland GmbH (EUR 3.120), Dr. Franz Köhler Chemie GmbH (EUR 3.600), Gilead Sciences GmbH (EUR 5.000), Hexal AG (EUR 3.120), Merck Serono GmbH (EUR 13.500), Roche Pharma AG (EUR 18.000), Takeda Pharma Vertrieb GmbH & Co. KG (EUR 18.000). The amounts mentioned are used for booth rental and promotional purposes.

124

In addition, we were able to support another 11 young surgeons through this Boehringer Ingelheim Foundation Grant.

With the kind support of

125

XXX

XXX

Opening Ceremony & Welcome Reception

Congress Party



Opening Ceremony First part:

▪ Georges Bizet: No. 1 Prelude (from “L‘Arlesienne” Suite No. 1 for orchestra)

Second part: ▪ Georges Bizet: No. 4 Habanera (from “Carmen”) ▪ Georges Bizet: No. 9 Seguedille (from “Carmen”) Third part:

▪ Gustav Mahler: “Urlicht” [Primal Light] (from “Des Knaben Wunderhorn” [The Youth’s Magic Horn] for voice and orchestra)

▪ Richard Strauss: “Zueignung” [Dedication] op. 10 No. 1 (for voice and orchestra, a setting of a poem by Hermann von Gilm zu Rosenegg)

▪ Georges Bizet: Movements from the Premiere Suite de “Carmen” - No. 1 Prelude - No. 2 Aragonaise - No. 6 Les toreadors Susanne Schaeffer (mezzosoprano), Sinfonietta Mainz (orchestra) and Frederic Mörth (conductor) Sinfonietta Mainz The orchestra established 44 years ago has developed over the past 20 years under the baton of its principle conductor, Michael Millard, to become one of the largest and most successful non-professional symphony orchestras in the Rhine-Main region. Frederic Mörth, conductor For Frederic Mörth, this concert marks the first collaboration with the Sinfonietta Mainz. Mörth studied the violin in Dresden and subsequently with Professor Simon Fischer at the renowned Guildhall School of Music and Drama in London. He currently continues his studies in singing and conducting at the „Hochschule für Musik und darstellende Kunst“ in Frankfurt.

Congress Party Join the E-AHPBA Congress Party in one of the most beautiful 17. Century renaissance buildings in Europe. The Kurfürstliches Schloss in the carnival city of Mainz satisfies with its historical ambience. It offers an absolutely exclusive and extraordinary framework for the evening. You will be provided with food and drinks while enjoying live music by Jammin‘ Cool. Jammin‘ Cool Band The name says it all. For 25 years Jammin’ Cool has been outstanding due to cool grooves and lots of spontaneity. Joining purely authentic U.S. American singers and experienced musicians is Jammin‘ Cool‘s formula of success created by bandleader Heiko Schulz. As an educated and skilled pianist and singer he is the heart of the formation.

Let’s groove tonight! May 25, 2017, 07.30 pm Kurfürstliches Schloss Diether-von-Isenburg-Strasse 1 D-55116 Mainz The ticket price for the Congress Party is EUR 65,00 (including food and drinks). Additional tickets are available at the registration desk.

Welcome Reception After the Opening Ceremony, you are invited to the Welcome Reception in the Foyer of the Rheingoldhalle. Drinks and snacks will be offered, and the Iris Oettinger Swing Trio will entertain us with exciting jazz music. Iris Oettinger Swing Trio: This band stands for playfulness and exciting jazz. Its musical diversity, ranging from traditional New Orleans „Hot“ Jazz to Swing, from Blues to Jump´n Jive and Latin American rhythms, always inspires its audience. You can expect great improvisations, jazzy vocals, a few hours of music with drive and a swinging lightness that will not let you sit still. Each musician is well-known in the international music scene with appearances at national and international jazz festivals, at various television shows, playing for well-known politicians (Angela Merkel for example) and through numerous CD recordings. Iris Oettinger: drums, lead Helmut Dold: trumpet, vocals Martin Giebel: piano Fotos: © Landeshauptstadt Mainz

128

129

General Information

General Information

Abstract Handling On Site All presentations will be discussed in certain Symposia, Free Paper, Free Video or Free Poster Sessions. To transfer your presentation to the lecture rooms we kindly ask you to upload your file in the media centre one hour prior to your session at the latest.

Recognition of EACCME Credits For accredited activities, EACCME credits can be exchanged for their national equivalent by contacting your national CME authority. EACCME credits are recognised throughout Europe and in North America. A record of your CME credit status will also be kept for future reference. Physicians should only claim those hours of credit spent in this educational activity. You will receive an attendance certificate with the number of credits (depending on your booking) with your name tag at the registration desk on site.

Oral Presentation The presentation format is power point 16:9, must be uploaded before the session in the central media centre (via USB-drive) on site. Poster Presentation The poster has to be printed by yourself. Posters must be prepared in A0 size (841 x 1189 mm), portrait format, in English language. Posters should be mounted by 08.00 am on the day of your presentation. They will remain accessible to all attendees on that day, but have to be dismounted by the end of the presentation day. Please note, that remaining posters cannot be stored and will be disposed of. Video Presentation The full video presentation – mp4, format 16:9, 1080i with H264 compression – must be uploaded at the media centre (via USB-drive) on site and will be shown during the indicated session period. E-Video The presentation – mp4, format 16:9, 1080i with H264 compression – must be uploaded at the media centre (via USB-drive) on site and will be shown during the indicated session period. The presentation should not exceed 10 minutes and will not be discussed. All abstracts can be found online as a „Book of Abstracts“, please visit www.eahpba2017.com.

Lost-and-Found Office The lost-and-found office is located at the registration desk. In case of missing items, please contact the staff of the registration desk. Media Centre The media centre is located on the balcony at the Rheingoldfoyer. All presentations must be uploaded at the media centre. For further questions, please refer to the registration desk. Opening Hours | Congress & Registration Desk Tuesday, 23 May, 2017: 08.30 am – 06.30 pm Wednesday, 24 May, 2017: 07.00 am – 07.30 pm Thursday, 25 May, 2017: 07.00 am – 07.30 pm Friday, 26 May, 2017: 07.00 am – 05.00 pm Opening Hours | Exhibition Wednesday, 24 May, 2017: 08.00 am – 06.00 pm* Thursday, 25 May, 2017: 08.00 am – 05.30 pm Friday, 26 May, 2017: 08.00 am – 04.00 pm * 06.30 pm – 10.00 pm (Opening Ceremony in Kongress-Saal and Welcome Reception at Rheinfoyer/industrial exhibition)

Automatic Teller Machine The next ATM is located opposite of the venue inside the car park of the casino, 1. basement. Contact For questions please do not hesitate to contact the congress organisation at the registration desk. Continuing Medical Education & European Continuing Medical Education Credits The 12th Biennial E-AHPBA Congress 2017 was granted 8 CME credits per day by the Landesärztekammer Rheinland-Pfalz (in total 32 credits for attendance from 23 May to 26 May), The E-AHPBA Congress was also granted 17 European CME credits (ECMEC) (24 May to 26 May, 2017) by the European Accreditation Council for Continuing Medical Education (EACCME). The Postgraduate Course was granted 6 ECMEC as well as the 10th Anniversary of ALPPS with 4 ECMEC (23 May, 2017). To receive your CME credits, please scan your EF number each day at the registration desk or send the certificate of participation to your Medical Association.

130

Printing your Poster on site If you prefer to print the posters locally, we recommend the shop „copy print“, which is nearby Rheingoldhalle. Printing data needs to be submitted as follows: – PDF-file or alternatively jpeg without any password protection – high resolution (about 150 dbi) – printing data must be prepared in A0 size / DIN-format For further questions please visit the website www.copyprintmainz.de or contact: + 49 131 6024180 | [email protected]

131

General Information

Imprint

Ticket Prices Congress Tickets E-AHPBA / AHPBA / A-PHPBA / IHPBA Member* EUR 680,00 Non-Member EUR 780,00 Trainee* E-AHPBA / AHPBA / A-PHPBA / IHPBA Member EUR 480,00 Trainee Non-Member EUR 580,00 Nursing staff* EUR 300,00 Students* EUR 50,00

Venue

Day Tickets E-AHPBA / AHPBA / A-PHPBA / IHPBA Member EUR 340,00 Non-Member EUR 390,00 Trainee E-AHPBA / AHPBA / A-PHPBA / IHPBA Member EUR 240,00 Trainee Non-Member EUR 290,00 Nursing staff EUR 150,00 Member of DGCH or DGAV* You will receive a discount of EUR 50,00 on all registration fees (excluded are nursing-staff and one-day ticket holders). * Proof will be required.

Taxi To order a taxi please call +49 6131 910 910. Also the staff of the registration desk is happy to assist. Wardrobe You are welcome to use the wardrobe located at the registration area. WiFi Free WiFi is available during the congress. WiFi Network: eahpba Password: mainz2017

Rheingoldhalle Mainz Rheinstrasse 66 D-55116 Mainz

Congress Chairman Professor Dr. med. Hauke Lang, MA, FACS University Medical Centre of Johannes Gutenberg University Mainz General, Visceral and Transplantation Surgery Langenbeckstrasse 1 D-55131 Mainz

Congress Secretariat / Scientific Programme PD Dr. med. Stefan Heinrich University Medical Centre of Johannes Gutenberg University Mainz General, Visceral and Transplantation Surgery Langenbeckstrasse 1 D-55131 Mainz

Congress Organisation

wikonect GmbH Hagenauer Strasse 53 D-65203 Wiesbaden Phone: +49 611 20 48 09-0 Fax: +49 611 20 48 09-10 Email: [email protected] www.wikonect.de mainzplus CITYMARKETING GmbH Rheinstrasse 66 D-55116 Mainz www.mainzplus.com

Print Run 1.200

Print Date 10 May, 2017 Subject to change without prior notice. 132

133

Notes

138

E-AHPBA 2017 APP and Session Planner The E-AHPBA 2017 Session Planner: Find all presenters alphabethically and be always up to date. Please visit eahpba17.smart-abstract.com or scan the QR-Code.

Be up to date with the E-AHPBA Congress App! Create your own individual conference programme, see all presenters, lectures, sponsors and exhibitors, as well as important information.

▪ Conference Programme ▪ Invited Speakers, Chairs and Authors ▪ Exhibitors & Sponsors ▪ My Conference & Notes ▪ Push Messages The E-AHPBA 2017 App is available for iOS and Android operating systems and can be downloaded in the stores.

www.eahpba2017.com #EAHPBA2017